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ABSTRACT 
Human breast milk is a complex species-specific biological fluid universally known as the optimal 
post-natal source of nutrition for infants and therefore, recommended by the World Health 
Organization as the exclusive food for infants in the first six months of life. Despite the importance of 
human breast milk in infant health, study of its composition, especially the bacteriome (bacterial 
communities) and metabolome (complete set of metabolites), and their relationship to infant health 
and growth have not yet been comprehensively characterized. This is particularly true in low- and 
middle-income countries. We therefore conducted a cross-sectional study, nested within an existing 
birth cohort, the Drakenstein Child Health Study, to describe the bacteriome and metabolome of 
human breast milk samples collected between 6-10 weeks postpartum from lactating women living in 
South Africa. The determinants of these components of human breast milk and their role in infant 
growth were also investigated.  
Four commercial DNA extraction kits were compared for DNA extraction from human breast milk 
samples. The kit showing the best results, including quality and quantity of DNA, as well as best 
reproducibility, was chosen for further extractions. Using 16S rRNA gene amplicon next generation 
sequencing, a reproducible bioinformatics sequencing pipeline, and robust multivariate statistical 
analysis, we confirmed the presence of a diverse bacterial community in human breast milk and 
identified a core bacteriome, present in 80% of the samples. The bacteriome was shown to cluster into 
three different profile groups (biotypes) according to the predominant bacterial genus present. 
Bacterial interactions were suggested by the finding of positive correlations between the relative 
abundances of bacteria usually found in the oral or skin microbiota. Apart from study site (a proxy for 
ethnicity in this study), infant birth length and maternal age, no other associations were found between 
potential socio-demographic and psychosocial determinants and the composition of the human breast 
milk bacteriome. 
Using Nuclear Magnetic Resonance spectroscopy, we quantified forty-nine metabolites in all human 
breast milk samples. A subset of women with low levels of lactose concentrations were identified. 
Low lactose was associated with an increase in metabolites associated with mixed acid fermentation 
and microbial dysbiosis (staphylococcal-predominant biotype). Low-lactose (vs normal lactose) 
human breast milk correlated with a reduced median duration of exclusive breastfeeding and reduced 
infant growth (reduced weight and length z-scores) during the period of exclusive breastfeeding. 
These results suggest that bacterial fermentation of lactose results in low-lactose breast milk, which in 
turn impacts on breastfeeding outcome. 
Taken together, the results presented in this thesis provide a better understanding of human breast 
milk composition among lactating mothers living in South Africa, their potential determinants and 
their role in infant growth. Knowledge about the composition of human breast milk may provide 
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opportunity for diagnostic and therapeutic interventions and help promote (exclusive) breastfeeding 
for the recommended period to improve infant health.   
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CHAPTER 1 
GENERAL INTRODUCTION 
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1.1 Background and Rationale 
Infant breast feeding (BF) emerged as an evolutionary strategy subsequent to the divergence of 
mammals millions of years ago and natural selection has made milk uniquely suited to nourish 
infants of each species (1). Human breast milk (HBM) is uniquely adapted and is universally 
regarded as the optimal post-natal source of nutrition for the growing infant. Breast-fed infants have 
been shown to have a lower morbidity and mortality during 1st year of life, and reduced risk of 
respiratory and gastrointestinal infections (2, 3). The components of HBM including water, protein, 
fatty acids, microbes, immunological factors, glyco-conjugates and metabolites all play important 
roles in the beneficial properties of BF.  
Although analysis of HBM was not included in Human Microbiome Project (HMP), a project 
designed to comprehensively characterize the presence and function of microbiome colonizing 
different body sites, several studies have shown that HBM harbours its own microbiome (4-7). The 
term microbiome was first mentioned in 2001 by Joshua Lederberg as a descendant of the word 
‘genome’ and was described as “the ecological community of commensal. symbiotic, and 
pathogenic microorganisms that literally share our body space” (8). These micro-organisms include 
the bacteria, archaea, fungi, lower and higher eukaryotes, and viruses (9). The microbiome has, 
more recently, been defined as “the entire habitat, including the microorganisms, their genomes and 
the surrounding environmental conditions” (10), while the collection of all bacteria residing in or on 
humans (i.e. the bacterial component of the human microbiome) is referred to as the bacteriome (8, 
11). 
Recently, next-generation sequencing (NGS) has been adopted for microbial identification by 
profiling of 16S rRNA gene amplicons or whole metagenome shotgun sequencing. The bacterial 
diversity in HBM has been shown to be larger than originally thought, with more than 600 
Operational Taxonomic Units (OTU)s having been identified (4, 7). NGS has also been used to 
analyse the temporal stability of the bacterial community in HBM, and various factors that lead to 
variability in HBM bacterial profiles between women have been identified (4).  
HBM bacteria are one of the main sources of microbes to the neonate postnatally and may play an 
important role in ‘shaping’ the intestinal microbiome early in life including priming and maturation 
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of the infant’s gut immune system (7, 12). Breast-fed infants have been reported to have a decreased 
faecal species richness with less colonization by bacteria known to be pathogenic, compared with 
formula-fed infants (13, 14). Recent reports suggest that early microbial colonization has an 
important role in promoting health and may contribute to reducing the risk of diseases (15-17). 
In addition to microbes in HBM, there are numerous nutritive and non-nutritive bioactive factors 
that elicit protective and promoting effects during the early infant years (13). One of such 
components is the metabolome defined as “complete complement of all small-molecule (<1500 Da) 
metabolites found in a specific cell, organ or organism” (18). In HBM, human milk oligosaccharides 
(HMOs), lactose, lipids, amino acids and biogenic amines are some examples of the metabolites 
present. A recent study has shown the influence of the HBM metabolome on promoting growth in 
infants, in part through interaction with the bacteriome (19). For example, fermentation of HMOs by 
bacteria in the infant’s gut produces short chain fatty acids which promote gut epithelial barrier 
function and modulate immune responses (20, 21).  
Despite a complex and diverse bacteriome and metabolome in HBM, previous studies have been 
limited by sample size with few studies having been performed in sub-Saharan Africa. HBM 
composition is influenced by a number of maternal, infant, and environmental factors including 
geographical location, maternal weight and body mass index, maternal health, maternal dietary 
intake and lactational stage (22-25), though the impact of these variations on the different 
components of HBM and its health outcomes on the infant is not fully understood. Moreover, the 
relationship between the HBM metabolome and microbiome has not been well-studied and related 
to infant health and growth. Thus, a comprehensive analysis of the HBM bacteriome and 
metabolome is presented in this thesis, including their influence on the breastfeeding outcomes and 
the health and growth of an infant. We addressed the following questions: 
i. What is the composition of HBM bacteriome and metabolome in a cohort of South African 
mothers enrolled in the Drakenstein Child Health Study? 
ii. Do maternal (mode of delivery, maternal BMI, maternal age), infant and environmental 
factors (smoking, dwelling type, alcohol use) influence the composition of HBM 
bacteriome and metabolome? 
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iii. Is there an association between the composition of the HBM bacteriome and metabolome, 
and breastfeeding outcomes and infant growth in the first year of life? 
1.2 Thesis Outline 
Chapter 2 is an in-depth literature review into the immunomodulatory, metabolic, and anti-
infective role of the HBM bacteriome and its effect on infant health. Key information from the 
literature was provided by exploring the possible origin of microbial communities in HBM, the 
bacterial diversity in this niche, the concept of a “core” HBM bacteriome, and the determinants 
influencing the HBM bacteriome. Lastly, the role of the HBM bacteriome in maternal infectious 
disease (human immunodeficiency virus infection and mastitis), and cancer was investigated. Key 
gaps in HBM bacterial research are also identified.  
Chapter 3 is a review of the literature regarding the metabolomic diversity of HBM, the technical 
approaches to studying the HBM metabolome, immune modulatory and anti-infective role of HBM 
metabolites and their effects on infant health and development. The literature on potential 
determinants of the HBM metabolome, including maternal infectious diseases such as human 
immunodeficiency virus infection and mastitis was also reviewed.  
Chapter 4 explores the influence of laboratory technical procedures (DNA extraction and milk 
skimming) on HBM bacterial profiling. This chapter compares four commercial DNA extraction 
kits and milk skimming in relation to HBM bacterial profiles using ten healthy donor breast milk 
samples. The kits were evaluated based on their ability to extract high quantities of pure DNA from 
HBM, and how well they extracted DNA from bacterial communities present in a commercial mock 
microbial community standard spiked into HBM. Finally, the kits were evaluated by assessing their 
extraction reproducibility. Bacterial profiles were assessed using Illumina MiSeq sequencing 
targeting the V4 region of the 16S rRNA gene. 
Chapter 5 describes our findings from 16S rRNA amplicon sequencing information on the bacterial 
composition of HBM samples in a large cohort of lactating women living in South Africa. It also 
provides information on possible determinants of the HBM bacterial composition including 
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maternal, socio-demographic and psychosocial factors. Finally, bacterial interactions were studied 
using co-occurrence networks.  
Chapter 6 describes the metabolic profiles of HBM samples from a large cohort of lactating women 
living in South Africa, as determined by nuclear magnetic resonance spectroscopy. In particular, the 
relationship between the HBM metabolome and microbiome and their effect on breastfeeding 
outcomes and infant health is studied.  
Chapter 7 concludes the dissertation by summarizing the important findings and main conclusions 
of each result chapter, limitation of the technical approaches and study design, and 
recommendations for further research and planned future work.  
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Abstract 
It is well-known that, beyond nutritional components, human breast milk (HBM) contains a wide 
variety of non-nutritive bio-factors perfectly suited for the growing infant. In the pre-2000 era, 
HBM was considered sterile and devoid of micro-organisms. Though HBM was not included as part 
of the human microbiome project launched in 2007, great strides have been made in studying the 
bacterial diversity of HBM in both a healthy state and diseased state, and in understanding their role 
in infant health. HBM provides a vast array of beneficial micro-organisms that play a key role in 
colonizing the infant’s mucosal system, including that of the gut. They also have a role in priming 
the infant’s immune system and supporting its maturation. In this review, we provide an in-depth 
and updated insight into the immunomodulatory, metabolic, and anti-infective role of HBM 
bacteriome (bacterial community) and its effect on infant health. We also provide key information 
from the literature by exploring the possible origin of microbial communities in HBM, the bacterial 
diversity in this niche and the determinants influencing the HBM bacteriome. Lastly, we investigate 
the role of the HBM bacteriome in maternal infectious disease (human immunodeficiency virus 
(HIV) and mastitis)), and cancer. Key gaps in HBM bacterial research are also identified. 
Keywords: bacteriome; human breast milk; bacterial community; mastitis; human 
immunodeficiency virus (HIV); cancer 
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2.1 INTRODUCTION 
Human breast milk (HBM) is a complex, specific, physiological fluid universally known as the 
optimal post-natal source of nutrition for infants (1-3). It consists not only of essential nutrients 
(vitamins, minerals, protein), cells, hormones, immunological and immunomodulatory factors 
(cytokines, immunoglobulin A, microRNAs), but also of non-nutritive bio-molecules (glyco-
conjugates, oligosaccharides) (4) and a vast array of microbes (the bacteria, archaea, viruses, 
protozoa and anaerobic fungi) known as the human milk microbiota (5-7). 
2.2 Human Breast Milk Bacteriome  
The presence of bacteria in HBM as both an evolutionary strategy subsequent to the divergence 
of mammals millions of years ago and an effect of natural selection has made it uniquely suited to 
nourish infants (8). For example, an infant consuming an average of 800 mL HBM per day has been 
reported to ingest 104–106 commensal bacteria (9). These bacteria are not merely present or 
transient but are rather transcriptionally active and functioning participants in the infant’s gut 
community (10). These bacteria serve as a physiological and continuous source of commensal and 
potential probiotic bacteria to the infant’s gut (2, 11, 12). In addition to the role of HBM bacteria in 
infants, these bacteria also help in maintaining the mother’s health, i.e., aiding in the prevention of 
mastitis (13). 
2.3 Bacterial Diversity in Human Breast Milk 
In the pre-2000 era, HBM was considered sterile and devoid of micro-organisms (2). However, 
in 2003, Martin et al. described the presence of commensal and probiotic bacteria in HBM. The 
study used culture-dependent techniques and found, in all samples, a predominance of the lactic 
acid bacteria Lactobacillus gasseri and Lactobacillus fermentum (14). Lactic acid bacteria, 
including species of genera Lactobacillus and Bifidobacterium, are of interest in matters of human 
health. They are known to limit the growth of potential pathogenic organisms in the gastrointestinal 
tract due to their ability to produce acetate and lactate from the metabolism of ingested sugars. 
Bifidobacterium was not initially regarded as a typical lactic acid bacteria due to their unrelated 
genetic structure, however, their habitat overlaps with that of lactic acid bacteria and they produce 
lactic acid as an end-product of fermentation (15). According to FAO/WHO, select lactic acid 
bacteria strains with proven probiotic properties are thereby referred to as probiotics (16). 
These early descriptions of bacterial diversity in HBM came from utilizing culture-dependent 
techniques which allowed for the detection of facultative anaerobic bacteria, their close-relatives 
Gram-positive bacteria and lactic acid bacteria in aseptically collected HBM (9, 14). The more 
fastidious organisms, such as strict anaerobes which require a more exacting culture media and 
stricter growth requirements, were not detected (11). More recently, and only using culture-
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independent DNA-based techniques including denaturing gradient gel electrophoresis (DGGE), 
temperature gradient gel electrophoresis (TGGE) and next generation sequencing (NGS), additional 
bacterial genera have been detected. These include the obligate anaerobes, particularly 
Bifidobacterium spp., Bacteroides spp., and members of the Clostridia class (5, 17).  
In the first NGS study of HBM samples, the diversity of bacterial communities, or bacteriomes, 
was characterized using 454 pyrosequencing to target the 16S rRNA gene. The most abundant 
genera were found to be Streptococcus, Staphylococcus, Serratia and Corynebacterium (5). In 
another study by Jost et al. (2013), NGS revealed gut anaerobes including Clostridia whose 
members produce the metabolite butyrate which helps maintain colon health (11). The bacterial 
diversity of HBM over the course of lactation (colostrum, transitional and mature milk) was also 
characterized using same technique (18). Several micro-organisms including Streptococcus spp., 
Staphylococcus spp. and lactic acid bacteria (Weisella spp. and Leuconostoc spp.) were found 
throughout; mature milk samples, however, possessed additional bacterial genera that typically 
dwell in the oral cavity (18). Similar bacterial diversity patterns were seen using NGS with Illumina 
MiSeq (19), as well as in two studies using metagenomic approaches (6, 13). While 16S amplicon 
approaches target bacteria, metagenomic studies allow for the detection of other microorganisms 
such as fungi, protozoa, archaea and viruses. Another advantage of metagenomic methods is that 
they allow for taxonomic identification at the species level, whereas 16S can only confidently 
identify organisms until the genus level. Firmicutes and Proteobacteria were the dominant phyla 
observed in both the metagenomic studies and the 16S sequencing studies. At the genus level, 
however, the relative abundance of Streptococcus and Staphylococcus was relatively low (6, 13). A 
systematic review of the HBM bacteriome using culture-independent techniques has revealed that 
these two genera (Staphylococcus and Streptococcus) may be universally predominant regardless of 
differences in geographical area or methodological approach (20). 
2.4 The Core Milk Bacteriome? 
Hunt and co-workers (2011) suggested that there is a “core” HBM bacteriome of nine bacterial 
genera including Staphylococcus, Streptococcus, Serratia, Pseudomonas, Corynebacterium, 
Ralstonia, Propionibacterium, Sphingomonas, and Bradyrhizobium. The operational taxonomic 
units (OTU) were found to represent about half of the observed microbial community, though their 
relative abundances varied quite significantly among women (5). Since then, various studies have 
confirmed the hypothesis of a core bacteriome (13, 19, 21). This “core” was not observed across 
colostrum samples, suggesting that the acquisition of a stable microbial profile is gradual (22).  
The core bacteriome may consist of species needed for maintaining efficient ecosystem 
homeostasis whose loss (or gain) may negatively impact the structure and function of other 
members in the ecosystem (23). Interestingly, however, it is assumed that the core bacteria are less 
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affected by the environmental factors (diet, obesity, stress) which are known to alter the 
composition of the other bacteriome (24).  
Differences in this “core” bacteriome have been reported across various studies (5, 19, 21). 
These differences could be a result of the following factors: sample collection methods (electric 
pump vs. manual expression, skin cleaning vs. decontamination), use of different DNA extraction 
kits, storage conditions and freeze/thaw cycles of samples, sequencing platforms, possible biases 
introduced by the use of primers with the amplification of different 16S rRNA gene hypervariable 
regions and use of different pipelines in analyzing sequence reads (6, 21). Despite these factors, the 
identified core bacteria genera commonly included Staphylococcus, Streptococcus, Lactobacillus 
and Propionibacterium (see Figure 2.1). Formal meta-analysis of studies characterizing the core 
HBM bacteriome in different geographical locations, however, is required. 
 
Figure 2. 1: The core human breast milk bacteriome. *QIAamp® DNA Stool Kit (Qiagen), V6 region of 
bacterial 16S rRNA gene, Ion Torrent platform. ˠQIAmp DNA Stool Mini Kit (Qiagen), V3–V4 region of 
bacterial 16S rRNA gene, Illumina MiSeq platform. ‡QIAamp DNA Mini Kit (Qiagen) with previous 
mechanical and enzymatic lysis, V1–V2 region, Pyrosequencing. 
2.5 Origin of The Human Breast Milk Bacteriome 
There have been several debates about the origin of bacterial communities in HBM. In 2003, 
Martin et al. used randomly amplified polymorphic DNA (RAPD) polymerase chain reaction (PCR) 
to analyze lactic acid bacteria from HBM, breast skin and areola. It was observed that the lactic acid 
bacteria isolated from HBM had DNA profiles that were different from those isolated from either 
the breast skin or the mammary areola (14). Obligate anaerobes (Bacteroides spp. and/or 
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Bifidobacterium spp.) which are unlikely to survive the aerobic conditions of the breast skin have 
also been isolated from HBM (12, 21).  
In addition, an experiment conducted by Hunt et al. (2011) showed that although the 
bacteriome in the sebaceous skin and HBM share many of the same phylotypes, differences were 
found. Streptococcus, one of the most abundant genera in HBM samples globally, was only a minor 
component of the sebaceous skin bacteriome. Propionibacterium, on the other hand, reported as one 
of the most abundant in sebaceous skin genera, was not among the most abundant genera found in 
HBM samples (5). Bacteriome found in HBM using Illumina MiSeq were distinct from the areolar 
skin in both composition and diversity (25).  
2.5.1 Retrograde Flow 
It is possible that some bacteria found in HBM come from the transfer of oral and skin bacteria 
which enter the mammary ducts during suckling in a process called retrograde flow (26). This 
hypothesis was investigated by Ramsay and colleagues who used ultrasound imaging to 
demonstrate that there is a high degree of retrograde flow of milk from the infants’ mouth back into 
the mammary ducts during breastfeeding, providing an ideal route for the exchange of bacteria back 
into the mammary ducts (26). Streptococcus, one of the most abundant bacterial genera in the HBM 
bacteriome, also dominates the salivary bacteriome (5, 27) lending support to the retrograde flow 
mechanism, however, investigation into whether both bacterial communities share identical species 
and strains of Streptococcus spp. is warranted.  
2.5.2 Gut–Mammary-Axis 
Another more recent hypothesis on the origin of the HBM bacteriome is the entero-mammary 
pathway where non-pathogenic, intestinally derived bacteria may be transported to other locations 
such as mucosal surfaces of the lactating mammary gland through the endogenous cellular pathway 
known as the mononuclear cells (2, 3, 28).  
The translocation of the gut bacteria to the mammary glands is aided by the physiological and 
hormonal changes during late pregnancy and the increased permeability of the intestinal epithelial 
lining (27). In support of this hypothesis, animal studies have shown increased bacterial 
translocation of both aerobic and anaerobic organisms from the gut to the mesenteric lymph nodes 
and mammary glands in pregnant and lactating mice (28).  
In addition, Zhou et al. have found similar bacterial signatures in the dendritic cells (DC), 
breast milk (BM), intestines and lymph nodes of lactating mice (29) suggesting translocation of 
bacteria from the intestines by the DC, into the lymphatic system and carried through to the 
mammary gland environment. 
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2.5.3 Mammary Gland Bacteriome 
The human breast tissue bacteriome has recently been determined (30, 31) from breast tissue 
biopsies collected from different sites within the breast. The viability of the bacteria was confirmed 
by culture. As in HBM bacteriome, the principal phylum, Proteobacteria, was the major phylum 
detected in human breast tissue bacteriome. Moreover, the two microbial communities share several 
bacteria genera (6, 21). 
The breast ductal bacteriome has recently been described by analyzing nipple aspirate fluid 
(NAF) (32). NAF is regularly secreted by the epithelial cells lining the breast ducts that can be 
collected non-invasively from the duct in most women by applying negative pressure with a syringe 
attached to a suction cup (33). The duct is in constant communication with the external environment 
through the areola. There is likely to be interaction of microbes between these various 
compartments in the mammary environment. 
Together, we may view the ecological niches in the human bacteriome, not as isolated 
environments, but as a network of inter-related communities experiencing constant exchange (5). It 
seems likely that the HBM bacteriome may be constantly influenced by exposure to other microbial 
populations associated with mother and child.  
2.6 Factors Which May Affect the Human Breast Milk Bacteriome 
Many factors have been identified to contribute to the variability of the HBM bacterial 
community between different women and within the same woman while she is experiencing 
different physiological, hormonal and pathological conditions. Both maternal and infant factors 
have been shown to contribute to this variation. While factors such as infant gender have been 
shown to have no influence (19), studies have shown that maternal health and geographical location 
play a major role (see Table 2.1).  
1. Mode of delivery: An estimate by qPCR (34, 35) claims that women who delivered via 
caesarean section (CS) have been shown to have a lower abundance of Lactobacillus spp. 
(L. fermentum and L. salivarius), Bifidobacterium spp. when compared with the higher 
bacterial counts of women who delivered vaginally. The HBM of mothers who had 
elective CS also showed decreased members of the family Leuconostocaceae and 
increased Carnobacteriaceae, when compared with women who delivered vaginally (18). 
However, in a study by Urbaniak and colleagues which utilized a more robust statistical 
analysis (19), no difference in bacterial profiles was observed between women who 
delivered vaginally and those who delivered via emergency CS. It was suggested that this 
could be due to the initiation of the labor process, including physiological stress and 
hormonal signals which may influence increased permeability of intestinal epithelial lining 
for translocation (18, 19). 
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2. Maternal weight: Higher levels of Staphylococcus spp. and lower levels of 
Bifidobacterium spp. were observed in HBM from overweight mothers as compared with 
normal-weight mothers (36); and a less diverse bacterial community has also been 
observed in obese mothers (18). This may be due to the metabolic capacity of the 
bacteriome of obese individuals which has an increased capacity to harvest energy from 
diet (37). 
3. Antibiotics and Chemotherapy: A lower abundance of lactobacilli and bifidobacteria was 
detected in HBM of mothers who were exposed to antibiotics during the perinatal stage 
(35). Exposure to anti-cancer chemotherapy also resulted in a reduction of the genera 
Bifidobacterium, Eubacterium, Staphylococcus and Cloacibacterium (38).  
4. Maternal health: Gronlund et al. (2007) described that the bacteriome is influenced by 
maternal health. In his study using direct PCR analysis, allergic women exhibited a 
significantly lower Bifidobacterium spp. in their BM, with their infants also having lower 
fecal bifidobacteria counts (39). African women with HIV–RNA in their HBM had an 
increased bacterial diversity and higher abundance of Lactobacillus spp. compared to 
controls (40). Lower abundance of Bifidobacterium spp. and Bacteroides fragilis group 
have been detected in HBM of women with celiac disease (41). 
5. Lactation stage: A higher bacterial diversity but lower total bacterial count and less 
bifidobacteria species were detected in colostrum when compared with mature HBM (18). 
Bifidobacterium spp. and Enterococcus spp. counts, along with total bacteria increased as 
the lactation stage progressed (34). In a similar study, however, transition milk samples 
were observed to possess higher diversity than colostrum and mature milk (7, 34). 
6. Geographical location: The bacterial genera found in HBM of Spanish mothers were 
different to those of Americans (5, 7), or Finnish women (18) using sequencing techniques 
with a similarly high throughput. In a study by Kumar et al., Chinese women had high 
levels of Actinobacteria in comparison to the similarly high levels of Bacteroidetes 
detected in Spanish women (42).  
7. Gestational age: Bifidobacterium spp. were observed to be higher in HBM of women with 
term babies than in preterm gestation.  
16 
 
Table 2. 1: Factors influencing human breast milk bacteriome. 
Factors Influencing Human 
Breast Milk Bacteriome 
Bacteriome References 
Mode of delivery   
Caesarean section 
↓ Bifidobacterium spp., ↑ Proteobacteria, ↓ Lactobacillus 
spp (L. fermentum and L salivarius), ↓ 
Leuconostocaceae, ↑ Carnobacteriaceae 
(18, 34, 35) 
Vaginal delivery ↑ Bifidobacterium spp., ↑ Lactobacillus spp. (34, 35) 
Maternal weight   
Overweight mothers ↑Staphylococcus, ↓ Bifidobacterium (36) 
Obese mothers Less diverse bacterial community (18) 
Antibiotic and Chemotherapy   
Perinatal antibiotics usage ↓ Lactobacillus/Bifidobacterium (35) 
Chemotherapy 
↓ Bifidobacterium, ↓ Eubacterium, ↓ Staphylococcus and 
↓ Cloacibacterium 
(38) 
Maternal health   
Allergy ↓ Bifidobacterium (39) 
Celiac disease ↓ Bifidobacterium spp., ↓ Bacteroides fragilis group (41) 
HIV ↑ Bacterial diversity, ↑ Lactobacillus spp. (40) 
Geographical location    
Spanish women ↑ Bacteroidetes (42) 
Chinese women ↑ Actinobacteria (42) 
Lactation stage   
Colostrum 
↑ Bacterial diversity, ↓ Bifidobacterium spp., ↓ Total 
bacterial count  
(18) 
Transition milk  
↑ Bifidobacterium, ↑ Enterococcus spp. counts, ↑ Total 
bacteria count  
(7, 34) 
HIV: human immunodeficiency virus, ↑ and ↓ corresponds to increase and decrease levels of specific bacteria 
genera respectively. 
2.7 Plausible Functions of Human Breast Milk Bacteria 
The HBM bacterial communities play a role in reduction of the incidence and severity of 
infections in the breastfed infant via mechanisms such as competitive exclusion and production of 
antimicrobial compounds. HBM bacteriome also improve the intestinal barrier function by 
increasing mucin production and reducing intestinal permeability (2, 3).  
2.7.1 Vertical Transmission and Seeding of Infant Gut by HBM Bacteria 
Evidence for vertical transmission of maternal bacteria, via milk, to the infant’s gut has been 
shown in humans (12, 14). Lactobacillus spp. sequences isolated from infant feces showed identical 
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patterns to those found in their respective maternal HBM but differed from the profiles found in the 
maternal vagina (14). Identical bacterial strains of bifidobacterium (Bifidobacterium breve and 
Bifidobacterium longum subsp. longum), and Lactobacillus plantarum have been confirmed in 
HBM and infant feces of mother-infant pairs, suggesting vertical transfer from the mother’s milk to 
the infant (21, 43, 44).  
Recently, additional supporting evidence for vertical transmission of maternal microbes has 
been published. Shotgun metagenomics was used to demonstrate the transfer of specific strains of 
Bifidobacterium spp., Ruminococcus bromii, and Coprococcus comes within different mother-infant 
pairs (10). Another study compared the fecal bacteriome of breastfed infants, whose gut is 
dominated by Bifidobacterium spp. and Lactobacillus spp. transmitted from HBM, to that of 
formula-fed infants, whose gut is predominantly colonized by enterococci, enterobacteria and 
Clostridium difficile—a pathogen associated with enteric and atopic diseases (45, 46). 
2.7.2 Anti-Infective Activities of HBM Bacteria 
In vitro studies show that Lactobacillus rhamnosus and Lactobacillus crispatus, isolated from 
HBM have anti-infective properties against Staphylococcus aureus (S. aureus). S. aureus has been 
implicated in mastitis (9), antibiotic-resistant nosocomial infections, and neonatal infections. HBM-
derived lactobacilli strains, particularly Lactobacillus salivarius (L. salivarius) CECT5713, produce 
not only in vitro antibacterial activity, but also a protective effect against Salmonella enterica 
serovar Cholerasuis (S. enterica) CECT4155 in animal models. This is mediated through inhibiting 
the adhesion of S. enterica to mucins and increasing the likelihood of survival of infected mice (47).  
Additionally, HBM lactic acid bacteria protect the physiological environment of the gut 
through mechanisms such as the production of organic acids and the lowering of pH to inhibit the 
growth of various facultative and anaerobic bacteria (47, 48). 
2.7.3 Immuno-Modulatory Activities of HBM Bacteria 
HBM bacteria provide a source of bifidobacteria to the infants’ gut. Bifidobacteria in turn 
activate T-regulatory cells which can result in improved resistance to pathogenic microorganisms 
(2, 45). In addition, the human milk metagenome has been shown to contain immunomodulatory 
DNA motifs which may help decrease exaggerated inflammatory responses to colonizing bacteria 
(6). HBM derived probiotic strains, Lactobacillus fermentum CECT5716 and Lactobacillus 
salivarius CECT5713, have demonstrated in vitro immunomodulatory activity by modulating the 
activation of peripheral blood mononuclear cell (PBMC) subsets, CD8+ natural killer cells, Treg 
cells, and several cytokines and chemokines. This effect was not seen with probiotic bacteria of 
non-milk origin (49). 
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2.7.4 Anti-Allergic Properties of HBM Bacteria 
A beneficial association has been proposed between HBM lactic acid bacteria and allergies. 
For example, animal studies have shown that probiotic lactobacilli (of HBM origin), Lactobacillus 
gasseri  together with Lactobacillus coryniformis, decrease the occurrence and severity of allergic 
responses to cow milk protein (50). Although a randomized, controlled trial showed that probiotic 
supplementation in the first six months of life did not reduce the risk of atopic eczema (51), other 
studies found that supplementation with specific Lactobacillus spp. and/or Bifidobacterium spp. in 
mothers led to a reduced infant eczema at one year and two years of age (52, 53). The Hygiene 
Hypothesis suggests that the anti-allergy properties of probiotics are due to the down-regulation in 
the production of Th2 cytokines by inducing a Th1 response (50). Disturbance in the regulation of 
the immune system is considered an underlying cause of allergies (54). 
It is also interesting to note that the presence of viridans streptococci, one of the dominant 
bacterial groups in HBM, seems to be a feature of a healthy infant gut in contrast to that of atopic 
infants whose gut is dominated by Klebsiella spp. (55). Animal studies have shown that defective 
maturation of the immune system in animals that lack appropriate host–microbe interactions during 
early life makes them prone to allergic immune responses. This defective immune maturation 
occurs with the introduction of even a single strain of bacteria such as Bifidobacterium spp. during 
the neonatal phase (56).  
2.7.5 Metabolic Activities of HBM Bacteria 
HBM bacteria are essential for the digestion of oligosaccharides (the fourth main component of 
HBM). Infants lack the necessary enzymes to digest these and, instead, the HBM microbes ingested 
during feedings break them down into short chain fatty acids (SCFA); this end-product also serves 
as one of the main energy sources for colonocytes (57). This is helpful for increased nutrient 
absorption as the gut of an infant is much shorter than in adults leading to quick transit of food (7). 
2.7.6 Anti-Tumour Properties of HBM Bacteria  
HBM bacteriome may have an anti-tumor role. In vitro studies have demonstrated that the heat-
killed cells and cytoplasmic fractions of Enterococcus faecalis and Staphylococcus hominis isolated 
from HBM possess anti-tumor activity against a breast cancer cell line (58). Another in vitro study 
has demonstrated the therapeutic, anti-cancer activity of lactic acid bacteria, Lactococccus lactis 
subsp. lactis, against colon cancer (59), This is relevant to both mother and infant health. 
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2.8 Implications of The Human Breast Milk Bacteriome In Disease 
2.8.1 Mastitis 
Lactational mastitis is an inflammatory condition of the mammary gland that occurs in about 
30% of breastfeeding women (60, 61). It is characterized by local symptoms (localized warmness 
and soreness on the affected breast, pain, redness, swelling of the breast), in addition to systemic 
symptoms (fever). It is also a major reason breastfeeding (BF) is discontinued (62, 63). 
Mastitis is a dysbiosis of the HBM bacteriome characterized by rapid growth of opportunistic 
pathogenic bacteria including members of Staphylococcus and/or Streptococcus, Corynebacterium 
and depletion of commensal bacteria (Lactococcus and Lactobacillus) (60, 64, 65). In acute mastitis, 
the bacteria count of Staphylococcus aureus (S. aureus) is said to increase greatly to about 4.0 log10 
cfu/mL from 1.5–3.0 log10 cfu/mL in healthy subjects. Another species, Staphylococcus 
epidermidis (S. epidermidis), normally appearing on skin and mucosa, is an under-recognized 
causative agent of lactational mastitis. This lack of recognition may occur if the clinician believes 
its presence stems from contamination of HBM samples with skin flora (60), however, recent 
studies have shown it plays an increasing role (13).  
Coagulase-negative staphylococci (CNS) and S. epidermidis have been isolated in HBM of 
women with chronic mastitis. The chronic nature is because S. epidermidis forms biofilms and is 
resistant to many antibiotics (63). Recent studies also show that the HBM metagenome in women 
with mastitis is different based on the stage/type of infection. While S. aureus was the most 
common etiological agent of acute mastitis, S. epidermidis was found to be the most common 
bacteria in subacute mastitis (13).  
A reduced bacterial diversity and species richness has been observed in HBM of women with 
mastitis (13, 64). Phage related sequences were also observed in HBM of women with acute 
mastitis. This is because the virulence factors of S. aureus are encoded inside phages, making it 
easier for the bacteria to evade the host’s immune system (13). 
Patel et al. (2017) observed members of the genus Staphylococcus to be differentially abundant 
in sub-acute mastitis. Genes related to bacterial chemotaxis and invasion of epithelial cells, bacterial 
motility proteins and secretion system were enriched in women having sub-acute and acute mastitis 
(64).  
A randomized clinical trial has shown that HBM derived probiotics, Lactobacillus salivarius 
CECT5713 and Lactobacillus gasseri CECT5714, when compared with antibiotics (65), are a 
complementary and effective substitute for the treatment and control of mastitis. 
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2.8.2 Human Immunodeficiency Virus (HIV) 
HBM of women infected with HIV has been shown to have a different bacterial composition 
compared with non-infected women. An increase in both bacterial diversity and Lactobacillus spp. 
frequency has been observed. In contrast, Staphylococcus hominis (S. hominis) and S. aureus were 
significantly reduced (40) in HIV-infected women. The reduction of these two Staphylococcus 
species may be due to the inhibitory features of lactic acid bacteria against S. aureus (40). In 
addition, a pathological or disturbed HIV-positive immune system could be a reason for the 
observed results. In a similar study, however, there was no difference either in bacterial diversity or 
in the bacterial profiles between HIV-positive and HIV-negative women (66). The discrepancies in 
these results are unknown but could, however, be due to a difference in geological location, 
methodological differences or the small sample sizes used in the later study. 
2.8.3 Cancer 
Although there has been no direct study on breast milk bacteriome and (breast) cancer, as 
women with cancer seldom breastfeed, the microbial ecology of other compartments within the 
mammary environment such as the breast tissue bacteriome and breast ductal bacteriome (using 
nipple aspirate fluid) have been linked to cancer (32, 67).  
Microbial dysbiosis was implicated in breast cancer in a study by Urbaniak and colleagues. 
There was a depletion of the lactic acid bacteria, Lactococcus spp. and Streptococcus spp., and an 
increased abundance of Bacillus spp., Staphylococcus spp. and the family Comamonadaceae and 
Enterobacteria. Escherichia coli isolated from breast cancer patients in the same study induced 
DNA double-stranded breaks (67). 
Bacteria may have a systemic influence in the host, promoting, regulating and training the 
immune system (68). Bacteria maintain the health of breast tissue by stimulating resident immune 
cells. In dysbiosis, a condition characterized by the reduction of specific bacterial taxa, there may be 
lower immune cell stimulation by such bacteria. This in turn creates an environment which may be 
conducive for breast tumor formation. Xuan et al. found that compared with the adjacent normal 
tissue, there was a significant reduction of Sphingomonas yanoikuyae in breast cancer patients (69). 
In a similar study, a member of the Sphingomonadaceae family was enriched in nipple aspirate fluid 
from healthy controls while Alistipes was enriched in breast cancer patients (32).  
The mechanisms, e.g., inflammation and DNA damage, through which bacteria play a role in 
cancer should be studied further, using animal models, as it’s unsure whether the association of 
specific bacteria with tumors could be due to their ability to thrive well in particular milieus or 
because they cause cancer (70). 
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2.9 CONCLUSIONS 
In conclusion, the HBM bacteriome has been shown to play a role in anti-infection, 
immunomodulation and metabolic activity and is known to be influenced by maternal and socio-
economic factors. A better understanding of the factors influencing HBM bacteriome may make it 
possible to manipulate bacterial communities to improve the health and development outcomes of 
infants. Lastly, the HBM bacteriome may be associated with, or cause, specific disease conditions. 
2.9.1 Gaps Identified 
1. There are very limited animal studies demonstrating the specific role of breast milk 
bacteria in disease conditions. 
2. There are few integrative studies exploring the interplay between HBM bacteriome and its 
metabolites, and their collective role in diseased condition. 
3. There is insufficient data on some of the identified HBM bacterial groups. It isn’t enough 
to simply characterize the bacterial diversity of HBM; rather, the role that each of the 
bacterium play in maintaining the microbial ecology of the HBM bacteriome and their role 
in infant and maternal health must be understood. 
4. There are few studies on HBM bacteriome and the factors influencing low socio-economic 
regions, such as many African settings. These regions also boast less research of infant 
nutrition and this research is necessary to know if there are any underlying genetic 
mechanisms involved.   
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CHAPTER 3 
THE DETERMINANTS OF THE HUMAN BREAST MILK 
METABOLOME AND ITS ROLE IN INFANT HEALTH 
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Abstract 
Human breast milk is needed for optimal growth as it satisfies both the nutritional and biological 
needs of an infant. The established relationship between breastfeeding and an infant’s health is 
attributable to the nutritional and non-nutritional, functional components of human breast milk 
including metabolites such as the lipids, amino acids, biogenic amines and carbohydrates. These 
components have diverse roles, including protecting the infant against infections and guiding the 
development of the infant’s immature immune system. In this review, we provide an in-depth and 
updated insight into the immune modulatory and anti-infective role of human breast milk 
metabolites and their effects on infant health and development. We also review the literature on 
potential determinants of the human breast milk metabolome, including maternal infectious diseases 
such as human immunodeficiency virus and mastitis. 
Keywords: metabolome; human breast milk; metabolite profiles; human immunodeficiency virus , 
mastitis. 
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3.1 INTRODUCTION 
Human breast milk (HBM) is the optimal nutrition for infants, and the WHO recommends 
exclusive breastfeeding (EBF) for the first 6 months of life (1) with continued breastfeeding (BF) up 
to two years of age. EBF, especially during the first 6 months of life, has a protective effect against 
acute respiratory tract infection (RTI) and mortality due to diarrheal illness in developing countries 
(2, 3). In pre-term infants or (very) low birth weight infants, EBF has been linked to a reduction in 
infant morbidity and mortality in the first year of life (4, 5).  
The benefits of BF an infant are long-lasting, and extend beyond the period of BF (6). For 
example, BF has been shown to be beneficial for cardiovascular health and for the prevention of 
hypertension and type I and II diabetes during childhood and later adolescent life (7). Also, EBF has 
been linked to a lower risk of childhood obesity, which is fast becoming a global epidemic (8). It 
has also been estimated that by increasing the rate of BF in low and middle-income countries 
(LMIC), 823,000 child deaths per year due to gastrointestinal disorders could be prevented (9).  
In full-term infants, HBM is almost always sufficient in providing essential nutrients for infant 
growth and development, irrespective of the mother’s own nutritional status (10). The components 
of HBM including water, protein, fatty acids, microbes, immunological factors, human milk 
oligosaccharides and metabolites all play important roles in the beneficial properties of BF.   
3.2 Human Breast Milk Metabolome 
HBM metabolites are low molecular weight compounds which include the intermediate and 
end products of metabolism, originating from different metabolic processes in the mammary gland. 
Some metabolites, such as lactose, are produced in the endoplasmic reticulum of the milk secretory 
cells (11). Other metabolites are produced through the metabolic processes of resident microbes in 
HBM or originate from other cell types and are filtered through the mammary epithelium from 
bloodstream (12, 13). While the abundance of some metabolites, such as fatty acids, is highly 
variable, the abundance of other metabolites, e.g., urea, is highly conserved suggesting a specific 
functional role in the infant (13). This review describes the nutritional and non-nutritional 
biologically active metabolites of HBM, their determinants and their role in infant immune 
development, gut microbial colonization, and infant health and developmental outcomes.  
The HBM metabolome can be investigated using two main technical approaches: proton 
nuclear magnetic resonance spectroscopy (1H NMR) and mass spectrometry (MS). 1H-NMR 
spectroscopy has the following advantages: (1) it is a highly reproducible technique that specifically 
identifies small molecule in a non-targeted, non-destructive manner from biological fluids; (2) it 
does not require extra steps during sample preparation, such as separation or sample derivatization; 
(3) it allows for the identification of a wide range of compounds and provides information about 
chemical structure; (4) it is the preferred method for the detection of hydrophilic and uncharged 
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compounds, such as sugars, which are often undetectable by liquid chromatography-mass 
spectrometry (LC–MS) methods (14-16). MS, on the other hand, is (1) highly sensitive, with a 
detection limit in the nanomolar range; (2) requires only a small volume of sample as its starting 
material; (3) it is the recommended technique for targeted analysis; (4) when coupled with gas 
chromatography, it is preferred in the detection of hydrophobic and volatile compounds, such as 
lipids (17). Overall, both techniques can be used in a complementary manner to maximize the 
identification of different metabolites within the HBM sample. 
The first metabolomic study on HBM was conducted in 2012 by Marincola et al (18) using 
both NMR spectroscopy and gas chromatography-mass spectrometry (GC-MS) to study the aqueous 
and lipid fractions, respectively, of preterm HBM. Compared to the metabolites in pre-term formula 
milk, the aqueous extracts of preterm HBM were shown to have high lactose concentrations. The 
pre-term formula milk, on the other hand, had a higher concentration of maltose (18). The HBM 
metabolome was further explored by Practico et al (19) with NMR spectroscopy. Twenty HBM 
samples were analyzed and a total of 43 metabolites were detected at least once in all HBM samples 
including amino acids, short chain fatty acids, oligosaccharides, sugars, phenolic compounds, 
tricarboxylic acid (TCA) cycle intermediates and N-trimethyl moieties (choline and acetyl-L-
carnitine) (19).  
Using mass spectrometry coupled with both gas chromatography and liquid chromatography, 
Qian et al (20) confirmed the unique metabolic profile of HBM and highlighted the significant 
differences between HBM and bovine or formula milk, in relation to both the presence and 
abundance of most metabolites (20). For example, non-esterified fatty acids such as saturated fatty 
acids with aliphatic tails <16 carbons (capric acid, myristic acid, lauric acid), mono-unsaturated 
fatty acids (oleic acid, palmitoleic acid, eicosenoic acid) and essential polyunsaturated fatty acids 
(PUFAs) such as linoleic acid and α-linolenic acid were highly abundant in HBM compared with 
bovine or formula milk (20).  
3.3 Specific Human Breast Milk (HBM) Metabolites and Their Role in 
Health 
3.3.1 Carbohydrates 
3.3.1.1 Lactose 
Lactose represents the most abundant metabolite and the major carbohydrate in HBM (21). It is 
the primary source of calories, providing about 40% of total energy value of HBM to the infant. It is 
the major osmotic component regulating HBM volume by drawing water into the intracellular 
secretory vesicles (13, 21). Lactose concentration ranges between 6.7-7.8 g/dl in mature HBM, and 
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its concentration is the least variable of the macronutrients as it is tightly regulated by the mammary 
gland (22, 23).  
 
Lactose induces innate immunity by upregulating gastrointestinal antimicrobial peptides 
(AMPs), as demonstrated in the colonic epithelial cell line T84 and in THP-1 monocytes and 
macrophages. This induction may promote intestinal homeostasis and protection of the gut against 
pathogenic micro-organisms (24). In addition, a recent study has demonstrated an antagonistic 
effect of lactose on growth of specific bacteria. The concentration of lactose in HBM was shown to 
be negatively correlated with the HBM bacterial genera Enterobacter spp. and Actinomyces spp. 
(25) which contain important opportunistic and multi-resistant bacterial species (26, 27).  
Lactose concentration has been shown to be positively correlated with the volume of HBM 
intake and the number of HBM feeds per day (28, 29). Unlike lipids, lactose concentration was 
shown to be positively associated with infant weight and adiposity gains between 3 and 12 months 
of life (28). Also, the influence of HBM lactose on infant growth has been confirmed in a computer 
model of a newborn baby (from birth to age 6 months) which simulates the baby’s metabolism of 
HBM to understand the mechanisms of infant growth (30).  
Lactose also forms part of many carbohydrate-based bioactive compounds in HBM, such as 
forming the backbone of oligosaccharides (10). Lactose aids mineral absorption in infants including 
calcium, copper, magnesium and manganese (31). 
3.3.1.2 Human milk oligosaccharides  
HMOs are a group of bioactive compounds representing the third most abundant metabolite in 
HBM, after lactose and lipids (32). Compared to other mammalian milk, HBM contains a higher 
variety (>200), and more complex structures of soluble oligosaccharides, of which 162 chemical 
structures have been characterized (33). Although diverse and structurally complex, each lactating 
mother synthesizes a unique compositional subset (34).  
HMOs are complex sugars with a lactose core at the reducing end, and are differentiated based 
on the linkages with one or more building blocks: D- glucose (Glc), L- fucose (Fuc), D- galactose 
(Gal), N-acetylglucosamine (GlcNAc) or N-acetylneuraminic acid (Neu5Ac) residues (32). HMO 
composition depends, in part, upon the expression of two specific genes and as such, individual 
women synthesize different sets of oligosaccharides (13). For example, fucose residues may be 
attached to a lactose core by an α 1, 2-linkage, which is catalyzed by the enzyme, fucosyltransferase 
2 (FUT2), encoded by the secretor gene (Se) or by means of α 1, 3/4-linkages catalyzed by the 
enzyme, fucosyltransferase 3 (FUT3), which is encoded by the Lewis gene (Le) (Figure 1) (13). 
Women can therefore be differentiated into being a secretor or a non-secretor depending on the 
expression of active FUT2 enzymes. As such, women can have either of four different phenotypes 
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namely Lewis-positive Secretors (Se+Le+), Lewis-negative Secretors (Se+Le−), Lewis-positive 
non-Secretors (Se−Le+) or Lewis-negative non-Secretors (Se−Le−) depending on the expression of 
FUT2 and/or FUT3 gene as shown in Figure 3.1 (35). Non-secretors have low or undetectable 
concentrations of 2’-fucosyllactose (2’-FL), lactodifucotetraose (LDFT), lacto-N-fucopentaose 
(LNFP) I, or lacto-N-difucohexaose (LNDFHI) I in their HBM which are all α-1,2-linked 
fucosylated HMOs (13). 
 
 
Figure 3. 1: Graphical representation of the enzymatic processes that lead to the different HMO 
phenotypes. Adapted from Bode 2012 (36). FUT2: Fucosyltransferase 2; FUT3: Fucosyltransferase 3. 2’-FL: 
2’-fucosyllactose; 3’-FL: 3’-fucosyllactose  
HMOs act as prebiotics which selectively stimulate the function of beneficial bacteria such as 
Bifidobacterium spp. while suppressing the growth of pathogens (37). HMOs are resistant to 
digestion during their passage through the alimentary canal as human infants lack the glycolytic 
enzymes needed to break them down. Instead, they are digested by certain commensal bacteria in 
the infant gut to produce short chain fatty acids (SCFAs) which help in establishing a stable 
ecosystem in an infant’s gut by modulating the immune system and promoting the gut epithelial 
barrier function (38, 39). SCFAs drive the development and function of regulatory T (Treg) cells 
thereby limiting intestinal inflammation. They also serve as an energy source for the epithelial cells 
of the colon and produce an acidic milieu in the gut, making it inhospitable to potentially pathogenic 
microbes (40, 41). SCFAs such as butyrate, regulate gene expression through inhibition of histone 
deacetylase. This action may lead to the inhibition of interferon-γ production and suppression of 
nuclear factor κB (NF-kB) activation in human colonic epithelial cells (42). NF-κB, for example, is 
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responsible for early immune inflammatory responses and its dysregulation is seen in inflammatory 
bowel diseases (IBDs) (43).  
 
HMOs inhibit many enteric pathogens, such as toxin-producing Escherichia coli, which causes 
diarrhea in infants (44), Campylobacter spp. (45) and Norovirus spp. (46) by acting as a decoy 
receptor for pathogens. HMOs are structurally related to glycans on the intestinal epithelial cell 
surfaces, to which pathogenic bacteria bind. Breastfed infants, for example, are protected against 
Campylobacter jejuni, which causes diarrhea, as 2’-fucosyllactosamine found on intestinal cells, 
which acts as a receptor for C. jejuni, is also present on HMOs (38, 47). HMOs have also been 
shown to reduce attachment of the protozoan parasite, Entamoeba histolytica (E. histolytica), and 
associated cell toxicity in a human colon adenocarcinoma cell line. The main adhesion-related 
virulence factor in E. histolytica is a lectin which binds with galactose and N-acetyl-galactosamine, 
and HMOs containing terminal galactose, such as Lacto-N-tetraose (LNT), act as decoy receptors 
(48). Cell culture studies have shown that pooled HMOs reduced the invasion and virulence of 
Candida albicans in human premature intestinal epithelial cells (pIECs) by delaying the induction 
of hyphal morphogenesis after inoculation of C. albicans onto pIECs (49).  
Different groups of HMOs often exhibit specific properties. For example, sialylated HMOs 
provide sialic acid needed for neural development, function and cognition (36). Also, a significantly 
lower concentration of disialyllacto-N-tetraose (DSLNT) has been observed in HBM of mothers 
whose infants developed necrotizing enterocolitis compared to healthy infants, suggesting a possible 
protective role of DSLNT to the intestinal tissues of preterm infants and very-low-birth-weight 
infants (50).  
3.3.2 Lipids 
Lipids in HBM are complex and diverse and provide 45% - 55% of the total energy needed by 
infants to support optimal growth (51). Compared to other macronutrients, the lipid composition of 
HBM is highly variable, and can be affected by duration of breastfeeding, time of day, stage of 
lactation, maternal nutritional status, and particularly, maternal diet (related to geographic location) 
(51-53).  
Lipids play a role in membrane structure, signal transmission and cell recognition in signaling 
pathways, lipoprotein metabolism and as a source and carrier of lipid-soluble vitamins (54). For 
example, palmitic acid, which is a saturated fatty acid, is not only an energy source for the infant but 
also acts as a pulmonary surfactant that reduces the surface tension at the alveolar air-liquid 
interface and prevents collapse of alveoli (55). Triacylglycerides are the most abundant lipids in 
HBM. The remaining lipid classes include diacylglycerides, monoacylglycerides, cholesterol, 
phospholipids (phosphatidylinositol, phosphatidylserine, sphingomyelin, phosphatidylcholine, 
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phosphatidylethanolamine), and free fatty acids (Table 3.1) (53). Phospholipids play a vital role in 
the infant’s immune and inflammatory responses, while sphingomyelin plays a role in central 
nervous system myelination (56). In a randomized control trial, low birth weight infants randomized 
to receive sphingomyelin-fortified milk showed improved neurobehavioral development during 
infancy compared with the control group which received only milk (57).  
 
Table 3. 1: Lipid classes in human breast milk. Adapted from (53). 
Lipid classes Proportion of total lipids in HBM (%) 
Triacylglycerides 98.1–98.8 
Phospholipids 0.26–0.8 
     Phosphatidylinositol ND 
     Phosphatidylserine ND 
     Sphingomyelin ND 
     Phosphatidylcholine ND 
     Phosphatidylethanolamine ND 
Cholesterol 0.25–0.34 
Non-esterified fatty acids (free fatty acids) 0.08–0.4 
Diacylglycerides 0.01–0.7 
Monoacylglycerides Traces 
ND: Not determined 
 
All these components make up the milk fat lipid globules (MFLG) which are produced by the 
alveolar cells of the mammary gland. The MFLG consists of a core of triacylglycerides and a 
membrane of phospholipids (58). Triacylglycerides are molecules comprised of mixtures of three 
fatty acids esterified to a glycerol backbone. Triglyceride synthesis involves specific positioning of 
the fatty acids at the outer sn-1 and sn-3, and center sn-2 positions of the glycerol molecule (59).  
Palmitic acid with a 16-carbon backbone (16:0) is the most common saturated fatty acid in 
HBM and has a preferential positioning of its fatty acids at the sn-2 position, instead of the sn-1,3 
positions that are typical of human tissue lipids, infant formula and vegetable oils common in 
human diets (59). Studies have shown that this specific position of triglycerides in palmitic acid 
improves the absorption of both palmitic acid and macroelements such as calcium and magnesium. 
This improved absorption decreases constipation and enhances the BF infant’s intestinal well-being 
(59, 60).  
Lipid fractions in HBM include ~34% to 47% saturated fatty acid with mainly ~17%–25% of 
palmitic acid, ~31% to 43% monounsaturated fatty acids, ~ 12% to 26% n-6 polyunsaturated fatty 
acids (PUFA), and ~ 0.8% - 3.6% of n-3 PUFA. PUFA are fatty acids containing two or more 
double bonds along their carbon backbones and include two biologically important subgroups in 
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HBM, the n-3 and n-6 essential fatty acids represented by α-linolenic acid (ALA) and linoleic acid 
(LA) respectively. Both ALA and LA are needed for the growth and maturation of various organs in 
the infant, especially the brain and eye (61). Although PUFA have been shown to prevent various 
allergic diseases in several studies, recent systematic reviews concluded that there is insufficient 
evidence that HBM PUFA influence the risk of childhood allergic and respiratory outcomes (62, 
63). 
ALA can be converted to the long chain-polyunsaturated fatty acids (LC-PUFA), 
eicosapentaenoic acid (EPA) and docohexaenoic acid (DHA) while LA is converted to arachidonic 
acid (AA) through consecutive steps involving desaturation and elongation. LC-PUFA of the n-3 
and n-6 series are indispensable nutrients with anti-inflammatory and inflammatory activities 
respectively (62). Table 3.2 below summarizes the major LC-PUFA in HBM, their source and 
functions. 
 
Table 3. 2: Long chain-polyunsaturated fatty acids (LC-PUFA) in HBM. 
Long chain-polyunsaturated 
fatty acids (LC-PUFA) 
Source, functions and determinants References 
n-3 series 
Docohexaenoic acid (DHA) Higher DHA concentration in HBM leads to 
improved neurodevelopmental and vision outcomes in 
infants. 
DHA concentration is greatly influenced by dietary 
intake especially of fish or fish oil supplements in lactating 
mothers. 
A dose dependent relationship exists between 
maternal DHA intake and its concentration in HBM, as an 
increased DHA concentration in HBM has been observed 
in lactating women supplemented with DHA. 
A lower AA to DHA ratio is found in HBM of 
women from Asian and Scandinavian countries due to 
higher feeding of DHA-rich fish. 
(51, 53, 61, 
64, 65) 
Eicosapentaenoic acid (EPA) EPA competes with AA for 5-lipoxygenase and 
cyclooxygenase enzymes needed for the metabolism of 
AA, thereby antagonizing the pro-inflammatory effects of 
AA. 
Lower concentrations of EPA and DHA in HBM 
have been associated with allergy in children. 
(66, 67) 
n-6 series 
Arachidonic acid (AA) AA is the most abundant of the PUFA with ~0.5% of 
total fatty acids in HBM. 
AA content of HBM is relatively stable among 
women despite variations in diet and lifestyles as it is 
derived from pre-existing maternal stores. 
AA serves as a progenitor to signaling molecules, 
leukotrienes (LTs), thromboxane and the prostaglandins. 
These products have inflammatory and atherogenic effects 
(53, 66, 67) 
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on cells.  
High AA:EPA ratio in HBM has been associated with 
the development of allergy symptoms at 18 months. 
3.3.3 Biogenic amines  
Biogenic amines are low molecular weight nitrogenous organic bases that are secreted in 
HBM. They include the polyamines (spermine, spermidine and putrescine), together with the 
monoamines (tyramine) and diamines (histamine and cadaverine) (68). The polyamines are the main 
biogenic amines found in HBM, with the most abundant being spermine and spermidine. 
Polyamines are synthesized from the precursor, ornithine, through the action of the enzyme, 
ornithine decarboxylase. HBM is the first source of exogenous polyamines for the growing infant 
(69). Polyamines inhibit cytokine synthesis in human mononuclear cells, downregulating the pro-
inflammatory cytokine response (70). Polyamines are involved in cell growth and proliferation (68, 
71). Rapidly growing tissues, such as the mucosa of an infant’s gut require high concentrations of 
polyamines (69). 
A higher polyamine concentration has been observed in HBM of women with preterm babies 
compared to those with full term babies in early lactation (69), suggesting a greater requirement of 
this metabolite for the undeveloped intestinal tissues of preterm babies.  
A qualitative case study and mathematical model which evaluated the correlation between 
mean spermine concentration of HBM in the first month of life and allergy appearance estimated 
that at least 5.02 nmol/ml of spermine is needed to prevent the appearance of allergy in breastfed 
infants (72). Another study showed that putrescine and spermine concentrations were lower in 
mature HBM from atopic mothers than non-atopic mothers (73). 
3.3.4 Nonprotein Nitrogen Molecules 
HBM nonprotein nitrogen comprises many bioactive molecules including the nucleotides, free 
amino acids, amino sugars, creatine, urea, carnitine and nucleic acids. These make up approximately 
25% of the total nitrogen in HBM (56, 74, 75).  
3.3.4.1 Free amino acids  
Free amino acids including alanine, glutamate, glutamine, isoleucine, threonine and valine, are 
more readily absorbed than protein-derived amino acids and they provide a nitrogen source for 
growing infants (76). Free amino acids are also known to give HBM its unique taste as each free 
amino acid has its own flavor and can be sensed by receptors in the taste-goblet (20). 
Glutamine is the most abundant free amino acid and supplies ketoglutaric acid for the citric 
acid cycle. It also serves as a major energy substrate for enterocytes and as a brain neurotransmitter 
(10). Glutamate, on the other hand, is a signaling molecule involved in sustaining gut barrier 
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function and neuroendocrine reflexes. Glutamate serves as an important precursor for other 
bioactive molecules, including glutathione and proline (77). Taurine helps in structural and 
functional development of retina receptors and may also aid in fat absorption (78). Together, 
glutamine, glutamate, taurine and alanine make up 50% of the total free amino acids in HBM. 
3.3.4.2 Creatine 
Creatine is an essential metabolite needed for normal neural development (74). Neurological 
symptoms such as speech delay, intellectual disability and epilepsy are displayed in children with 
inborn errors of creatine synthesis or transport. Creatine helps to buffer cellular adenosine 
triphosphate (ATP) levels when energy demand is transiently greater than ATP synthesis rate (79). 
Creatine also serves as an energy vector between the sites of ATP synthesis and use. Creatine is 
spontaneously and irreversibly broken down to creatinine which is excreted in urine. Therefore, 
there is a continuous need to replace creatine to meet the growing infant's expanding tissue mass 
(79).  
Infants receive their dietary creatine from mother's HBM. Edison et al (74), however, showed 
that a breast-fed infant only receives about 9% of the creatine needed from the diet (74). The 
remainder is provided through de novo synthesis in the infant in which creatine is produced from 
the amino acids, glycine and arginine. 
3.4 Determinants of The Human Breast Milk Metabolome 
Several maternal and infant factors have been identified as potential determinants of the HBM 
metabolome (Table 3.4). Some of these factors are explored further below.  
1. Mastitis: Lactational mastitis is a lobular inflammation of the mammary gland caused by 
Staphylococcus spp. and/or Corynebacterium spp. with clinical symptoms including fever, 
chills and localized inflammation of the breast tissue (80). It often results in early cessation 
of EBF and may affect up to 33% of lactating women (68). Mastitis is associated with 
increased concentrations of the biogenic amines: spermine, putrescine, and histamine (68). 
Biogenic amines are usually produced due to the metabolic activity of certain 
microorganisms including some Staphylococcus epidermidis strains with activity for 
decarboxylation of amino acids; high concentration of biogenic amines in a mastitic breast 
could be due to increased decarboxylase activity (81). Mastitis is associated with an 
increased free fatty acid (FFA) concentration, although no change is observed in the total 
lipids and phospholipids, suggesting increased lipolysis within HBM (82). The release of 
FFA in an infected body site is one of the hallmarks of Staphylococcus aureus infection; 
elevated FFA may be a nonspecific immune response to bacteria-associated lactational 
mastitis (82, 83). 
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2. Human Immunodeficiency Virus (HIV): Normal HMO composition in HBM is disrupted 
in maternal HIV infection. Several studies show an increased abundance of 3’- sialyllactose 
(3′-SL) in HBM of HIV-positive mothers compared to HIV-negative mothers (50, 84, 85). 
Also, a higher proportion of 3′-SL amongst total HMOs was observed in HBM of HIV-
negative women with lower CD4 counts (86). On the other hand, LNT and LNnT were 
more abundant in HBM of HIV-negative mothers (84).  
Among secretors, significantly higher absolute concentrations of 2’-FL, LNT and LNFP I 
and higher relative abundance of difucosyllacto-N-tetraose (DFLNT) and fucosyl-
disialyllacto-N-hexaose (FDSLNH) was observed in HBM of HIV-infected women 
compared to uninfected secretor women (86). In non-secretors, only the relative abundance 
of DFLNH was higher in HBM of HIV-infected women compared with HIV-uninfected 
non-secretors (86). 
A higher proportion of 3′-SL per total HMOs in HBM has been associated with an increased 
risk of HIV transmission to infants and with markers of advanced HIV disease, while higher 
total HMO, LNnT and non-3’-SL HMO concentrations in HBM were associated with 
reduced vertical HIV transmission from mother to child (85). HMO composition of HBM 
has been found to influence the survival of HIV-exposed, uninfected (HEU) children born 
to HIV-infected mothers in Zambia up to 2 years of age (86). During the BF period, higher 
concentrations of 2′-FL, 3′-FL, and LNFP I, II/III were significantly associated with 
reduced mortality among HEU children (86). 
3. Maternal weight: Compared to HBM of women with normal weight, HBM of overweight 
mothers had a higher abundance of saturated fatty acid, lower abundance of n-3 PUFA and 
also, a lower ratio of unsaturated to saturated fatty acids (87). Lower total polyamines have 
also been observed in HBM of obese mothers compared to HBM of mothers with normal 
body weight (71).  
4. Chemotherapy: A case report has shown that DHA and inositol concentrations are reduced 
in HBM of a mother who underwent a chemotherapy cocktail for Hodgkin’s lymphoma as 
compared with healthy controls (88). 
5. Maternal diet: Dietary intake in the United States is skewed towards omega-6 fatty acids 
and associated with high content of LA in HBM of American mothers, and a particularly 
low DHA concentration (61). Unlike an omnivorous diet, a vegetarian diet provides high 
concentration of LA and ALA; hence a high concentration of these essential fatty acids in 
HBM of vegans (89).  
6. Maternal education: In a study conducted by Nayak et al (2017) among low income 
families in an urban area in Bangladesh and India, higher level of maternal education was 
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associated with decreased saturated fatty acids, and increased ratio of polyunsaturated fatty 
acids to saturated fatty acids in HBM (90) possibly due to better informed food choices. 
7. Geographical location: Significant differences in metabolite profiles have been observed 
based on geographical locations (91-94). With respect to HMOs, HBM of Chinese women 
had highest concentrations of 3′-FL and LNFP III, Spanish women had the highest 
concentration of 2’-FL, while the highest concentration of LNFP I was observed in HBM of 
women from Finland (91). Other metabolites including fatty acids, ethanolamine, n-6 
PUFA, creatine, lactose and 2-oxoglutarate, pyruvate and lactate, methanol, polyamines, 
tyrosine have also been found to differ significantly between different geographical 
locations (91, 93, 94).  
8. Ethnicity: Compared to Caucasian women, black women had higher HBM concentrations 
of 2-oxoglutarate, betaine and glycerophosphocholine and lower HBM valine concentration 
(93). HBM of Caucasians, on the other hand, had significantly lower concentrations of 
lactate and fucose compared to Asian women (93). 
9. Gestational age: The HBM metabolite profile of full term babies shows higher 
concentrations of carnitine, caprylate, caprate, pantothenate, β-hydroxybutyrate and urea as 
compared with pre-term HBM, which has higher concentrations of lactose, phosphocholine, 
choline, glutamate, DHA, total polyamine, 3’-SL, and 6’-sialylactose (6’-SL) (69, 95, 96).   
10. Stage of lactation: The composition and concentration of HMOs in HBM varies over the 
period of lactation (97, 98) with the mean total HMO concentration decreasing from 20.9 
g/l in colostrum to 12.9 g/l in mature HBM at 4 months postpartum (99). The mean lactose 
concentration increases with period of lactation, from 56 g/L on day 4 to 68.9 g/L at 4 
months postpartum (99).  
11. Course of lactation: The last milk of a feed, the hind HBM, has been found to contain up 
to two or three times the total lipid concentration of foremilk (at the beginning of a feed) 
(23). Preterm low birthweight infants have been shown to exhibit increased weight gain 
when EBF hind HBM (100). 
12. Mode of delivery: Though the impact of mode of delivery on metabolite profiles was found 
to be dependent on geographical location in a recent study (91), overall, women who had a 
vaginal delivery had significantly higher HBM concentrations of 3-hydroxybutyrate and 
LNFP III, while higher HBM concentrations of butyrate, urea, ethanolamine and proline 
were observed among women who underwent caesarean section (CS) delivery (91).   
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Table 3. 3: Factors Which May Influence the Human Breast Milk (HBM) Metabolome 
Factors influencing human 
breast milk (HBM) 
composition 
Metabolome References 
Maternal Health 
 
 
   HIV ↑ 3′-SL, ↓ LNT ↓LNnT (50, 84, 85) 
   Mastitis ↑ spermine, ↑ putrescine, ↑ histamine, ↑ FFA (68) 
   Maternal weight 
 Overweight mothers ↑ SFA, ↓ n-3 PUFA, ↓ Unsaturated FA: 
Saturated FA 
(87) 
 Obese mothers ↓ Polyamines (71) 
   Medication   
 Chemotherapy ↓ Docosahexaenoic acid, ↓ Inositol (88) 
Sociodemographic factors   
   Maternal diet   
 Vegetarian diet ↑ LA, ↑ ALA, ↓ DHA (61, 89) 
 Maternal education   
    ↑ Higher education ↑ PUFA: SFA (90) 
    Geographical location   
   Chinese women ↑ n-6 PUFA, ↓ SFA, ↑ 3′FL, ↑ LNFP III (91, 92) 
   Spanish women ↑ 2’-FL, ↑ Putrescine (91, 94) 
   Finland women ↑ LNFP I, ↑ spermidine (91, 94) 
   South African women ↑ Lactose, ↑ 2-oxoglutarate, ↑ citrate (93) 
Infant factors   
     Gestational age   
         Pre-term ↑ DHA, ↑lactose, ↑ HMO conc., 
↑phosphocholine, ↑choline, ↑glutamate, ↑3’-SL, ↑ 6’-
SL, ↑ polyamine conc., ↓ spermidine/spermine 
(69, 95, 96, 101-
103) 
         Full term ↑carnitine, ↑caprylate, ↑caprate, ↑pantothenate, 
↑β-hydroxybutyrate, ↑urea 
(95) 
HBM factors   
Lactational stage 
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   Colostrum ↑ HMOs, ↑ LNnT, ↑ 2’-FL, ↑ 3’-SL, ↓ Lactose, 
↑ Leucine, ↑ Betaine, and ↑ Creatinine 
(38, 95, 98) 
   Mature HBM ↓ Total HMOs, ↑ 3’-FL, ω6/ ω3 PUFA, ↑ oleic 
acid, ↑ palmitoleic acid, ↑ linoleic acid, ↑ tri-, di-, 
mono-glycerides, ↓ cholesterol, ↓ phospholipids, ↓ α-
tocopherol, ↓ fucose, ↓ furanose isomers, ↓ D- 
glucosaminic acid, ↑ Alanine, ↑ caprylate, ↑ caprate, 
↑ glutamate 
(13, 21, 90, 95, 98, 
104, 105) 
Course of lactation   
   Foremilk ↑ free amino acids, ↑ phenylalanine, ↑ 
threonine, ↑ valine, ↑ alanine, ↑ glutamine, ↑ serine 
(100) 
Delivery mode 
   Vaginal delivery ↑ 3-hydroxybutyrate and ↑ LNFP III (91) 
   CS delivery  ↑ Butyrate, ↑ urea, ↑ ethanolamine and ↑ proline (91) 
↑: Increase concentrations, ↓ Decrease concentrations, SFA: Saturated fatty acids, PUFA: Polyunsaturated 
fatty acids; FFA: Free fatty acids; LNFP: Lacto-N-fucopentaose: 2’-FL: 2′-fucosyllactose; 3’-SL: 3’-
sialyllactose; 6’-SL; 6’-sialyllactose; LA: Linoleic acid: ALA: α-Linolenic acid; DHA: Docosahexaenoic acid; 
LNT: lacto-N-tetraose LNT; LNnT: lacto-N-neotetraose; HIV: Human Immunodeficiency Virus. 
 
3.5 CONCLUSION 
HBM is a rich source of metabolites which contribute to HBM’s beneficial properties, needed 
for optimal growth and development of infants. Our current knowledge of the HBM metabolome is 
largely restricted to studies from industrialized/westernized countries, with under-representation of 
samples from Sub-Saharan Africa. Further studies of geographically and ethnically diverse 
populations are needed.  
A thorough understanding of HBM metabolites, their role in the developing infant and 
potential determinants is important for our understanding of its nutritional and bioactive value.  
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CHAPTER 4 
THE INFLUENCE OF DNA EXTRACTION AND MILK SKIMMING ON 
HUMAN BREAST MILK BACTERIAL PROFILES  
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Abstract 
Culture-independent molecular techniques have advanced the characterization of environmental and 
human samples including the human breast milk (HBM) bacteriome. However, extraction of high-
quality genomic DNA that is representative of the bacterial population in samples is crucial. Fat 
removal from HBM prior to DNA extraction is common practice but this may influence the 
bacterial population detected. The objective of this study was to compare four commercial DNA 
extraction kits and milk skimming in relation to HBM bacterial profiles. Four commercial DNA 
extraction kits, QIAamp® DNA Microbiome Kit, ZR Fungal/Bacterial DNA MiniPrep™, 
QIAsymphony DSP DNA Kit and ZymoBIOMICS™ DNA Miniprep Kit, were assessed using ten 
healthy donor breast milk samples. The kits were evaluated based on their ability to extract high 
quantities of pure DNA from HBM, and how well they extracted DNA from bacterial communities 
present in a commercial mock microbial community standard spiked into HBM. Finally, the kits 
were evaluated by assessing their extraction reproducibility. Bacterial profiles were assessed using 
Illumina MiSeq sequencing targeting the V4 region of the 16S rRNA gene. The ZR 
Fungal/Bacterial DNA MiniPrep™ and ZymoBIOMICS™ DNA Miniprep (Zymo Research Corp., 
Irvine, USA) kits extracted the highest DNA yields with the best purity. DNA extracted using ZR 
Fungal/Bacterial DNA MiniPrep™ best represented the bacteria in the mock community spiked into 
HBM. In un-spiked HBM samples, DNA extracted using the QIAsymphony DSP DNA kit showed 
statistically significant differences in taxa prevalence from DNA extracted using ZR 
Fungal/Bacterial DNA MiniPrep™ and ZymoBIOMICS™ DNA Miniprep kits. The only difference 
between skim and whole milk is observed in bacterial profiles with differing relative abundances of 
Enhydrobacter and Acinetobacter. DNA extraction, but not fat removal, substantially influences 
bacterial profiles of HBM samples, emphasizing the need for careful selection of a DNA extraction 
kit to improve DNA recovery from a range of bacterial taxa.  
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4.1 INTRODUCTION 
There is a growing interest in the role that human breast milk (HBM) microbes play in infant and 
maternal health. The HBM microbiota has been shown to have a role in the development of the 
infant gut bacteriome and in promoting programming of the immune system (1, 2). Randomized 
clinical trials have shown that in mothers, these microbes could prevent and serve as an alternative 
treatment for lactational infectious mastitis caused by Staphylococcus aureus (3, 4).  
Studies characterizing the bacterial diversity in HBM initially used bacterial culture, which has 
several limitations including detection of only viable organisms and being labour-intensive (5-7). 
Culture-independent molecular techniques, enabled by next-generation sequencing (NGS), can 
profile bacteria in complex environments and provide detailed phylogenetic information (8, 9). For 
this however, high quality genomic DNA that is representative of the microbial communities is 
required.  
DNA extraction methods from samples such as faeces (10, 11), insects (12), soil (13), saliva (14) 
and colonic tissue (15) have been studied, yet, to our knowledge, no studies have documented 
optimization of DNA extraction from HBM samples. This is crucial as methodological variation 
such as the use of different DNA extraction kits may impact on microbial community profiling (16). 
Moreover, the effect of removing the fat layer of milk prior to DNA extraction is unknown, even 
though this approach is commonly used (17-19). Fat-rich tissue can cause difficulties in DNA 
extraction due to fat interfering with tissue disruption or by influencing the chemistry of the DNA 
isolation buffers (20).  
Optimization of DNA extraction from HBM is necessary as HBM is known to have a relatively low 
bacterial biomass, and interfering substances (such as proteins) pose a challenge to the extraction of 
large amounts of quality DNA (21). In addition, the HBM bacteriome has been reported to contain a 
variety of gram-positive and gram-negative bacterial species (17) with differing cell wall 
composition which makes some species more difficult to lyse than the other. Improper lysis of these 
two groups of bacteria may result in a biased representation of the bacterial community present in 
HBM samples. Hence, methods need to be tested for their effectiveness, efficiency to lyse bacterial 
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cells, and the quality of the extracted DNA (12). We also incorporated a mock microbial community 
with predetermined DNA ratios from a mixture of bacterial species to assess bias of the DNA 
extraction kits.  
The aim of this study was to compare and evaluate the extraction of bacterial genomic DNA from 
HBM samples using four commercial DNA extraction kits. Selection of kits used in this study was 
based on their availability and prior use for HBM bacteriome studies. Also, whole milk (WM) and 
skim milk (SM) were compared to determine whether the removal of the fat layer affected the 
bacterial population detected in HBM. 
4.2 MATERIAL AND METHODS  
4.2.1 Subjects and sample collection 
HBM samples were collected from ten healthy lactating women residing in Cape Town, South 
Africa, after obtaining their consent. The women were asked to wash their hands, their nipples and 
surrounding breast area with soap and water. Milk was collected manually by hand expression into a 
50 ml sterile collection bottle after discarding the first few drops. After collection, the samples were 
transported on ice and stored at −20◦C until further processing. This study received ethical approval 
from the University of Cape Town Human Research Ethics Committee, South Africa (HREC REF: 
649/2016). 
4.2.2 Methods of DNA extraction 
Each of the ten HBM samples was processed as un-spiked SM (n=10) and WM (n=10). DNA was 
extracted in duplicate from each SM and WM sample, using 4 different kits (total number of 
extracts=160, Figure 4.1A). In addition, as an extraction control, one HBM sample was divided into 
SM and WM, with each 1ml sample spiked with 75 µl (1x 109 cells) of Zymobiomics Microbial 
Community Standard ((ZMCS), (Catalogue no. D6300, Zymo Research Corp., Irvine, USA), 
Appendix 1, Table 1).  Commercial ZMCS was employed as the mock community because it’s 
readily available and affordable, and also manufactured by Zymo Research Corp., Irvine, USA, 
same company which manufactured two of the DNA kits assessed in the study. DNA was extracted 
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from replicas (on consecutive days) of the same spiked sample with each of the 4 kits (n=16) 
(Figure 4.1B).  
 
 
Figure 4. 1: Human breast milk samples collection per milk type and DNA extraction method. (A) DNA 
extraction from un-spiked skim milk and whole milk samples. (B) DNA extraction from spiked skim milk and 
whole milk samples. 
 
HBM samples were homogenized by vortexing and SM was prepared according to a previously 
published protocol (22). In brief, the samples were centrifuged at 3500 g for 20 minutes at -10 °C, 
and the fat layer discarded. The supernatant was thereafter centrifuged at 7600 g for 10 minutes at 
room temperature, and the pellet used for further processing. The pellet from WM was prepared by 
centrifugation of the original milk sample at 7600 g for 10 minutes at room temperature. DNA was 
extracted from un-spiked HBM samples (n=160) and spiked HBM samples (n=16) using the 
recommended starting volume of the four different commercial DNA kits (Table 4.1).  
Kit A: 500 μl Buffer AHL (host cell lysis buffer) was added to either 1ml of WM (or SM) for DNA 
extraction from WM and SM respectively.  
Kit B: The pellet obtained from centrifugation of 1ml of WM (or SM), was resuspended in 250 μl 
of the resultant supernatant before proceeding to add 750 μl Lysis Solution (Zymo Research Corp., 
Irvine, USA) to the tube. 
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Kit C: The pellet obtained from centrifugation of 1ml of WM (or SM), was resuspended in 250 μl 
of the resultant supernatant before proceeding to add 750 μl Lysis Solution (Zymo Research Corp., 
Irvine, USA). An “off-board” mechanical lysis step followed using ZR BashingBeadTM (Zymo 
Research Corp., Irvine, USA). Following mechanical lysis, the lysate was centrifuged at 5800 g for 
1 min, and 400 µl of the supernatant was used for DNA extraction on the QIAsymphony® SP 
instrument (Qiagen, Hombrechtikon, Switzerland).  
Kit D: The pellet obtained from centrifugation of 1ml of WM (or SM), was resuspended in 250 μl 
of the resultant supernatant before proceeding to add 750 μl ZymoBIOMICS™ Lysis Solution 
(Zymo Research Corp., Irvine, USA) to the tube. 
An elution volume of 50 µl was used for all the kits except kit C in which the minimum elution 
volume was 60 µl as set by the supplier. For homogeneity and to ensure higher concentrations of 
DNA samples (as recommended by the manufacturer), 50 µl elution volume was used for Kit D. 
With the exception of Kit D which was eluted in DNase/RNase Free Water, DNA eluted from other 
kits were extracted in elution buffers. All bead-beating steps were performed in the TissueLyser LT 
(Qiagen) at a frequency of 50Hz for 5 min. 
 
Table 4. 1: DNA extraction kits used in this study 
Name of kit Manufacturer’s 
details 
Extraction 
method 
Kit name 
abbreviation 
Recommended 
starting volume 
(µl) 
Elution 
volume 
used (µl) 
QIAamp® DNA 
Microbiome Kit 
Qiagen, Hilden, 
Germany 
Manual kit A 1000 50 
ZR Fungal/Bacterial 
DNA MiniPrep™ 
Zymo Research 
Corp., Irvine, 
USA 
Manual kit B 250 50 
QIAsymphony DSP 
DNA Kit 
Qiagen, Hilden, 
Germany 
Automated kit C 400 60 
ZymoBIOMICS™ 
DNA Miniprep Kit 
Zymo Research 
Corp., Irvine, 
USA 
Manual kit D 250 50 
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4.2.3 DNA quantification 
The concentration and purity of DNA was measured using a NanoDrop™ ND-2000c 
Spectrophotometer (Thermo Scientific, Inc.). DNA yield was obtained by multiplying the DNA 
concentration by the final elution volume. The DNA yield from all samples was also assessed by 
16S qPCR using a protocol previously described (23). Each 30 µl PCR reaction contained 2.5 µl 
DNA template, 1µl of probe, 15 µl Sensifast Probe No-rox (BIO-86020), 9.5 µl of MilliQ water and 
1 µl each of 0.333 µM forward and reverse primer with conditions as described (Appendix 1, Table 
2A). The qPCR was carried out on a 7500 Fast Real-Time PCR System (Applied Biosystems, CA 
94404 USA).  DNA was stored at -20 °C until further processing. 
4.2.4 Extraction and sequencing controls 
The respective elution buffer from each of the kits under investigation was processed as a negative 
extraction control. The ZMCS was extracted using all four kits and served as a positive extraction 
control. As per manufacturer’s specifications, the genomic DNA abundance (%) for each bacteria 
species is 12% while the microbial OTU relative abundances are Pseudomonas spp. (4.6%), 
Enterobacteriaceae 1 (11.3%), Enterobacteriaceae 2 (10.0%), Listeria spp. (15.9%), Staphylococcus 
spp. (13.3%), and Lactobacillus spp. (18.8%) (Appendix 1, Table 1). DNA extraction on all HBM 
samples was done in duplicate on two consecutive days using the respective kits to evaluate 
extraction reproducibility. In addition, DNA extracts from two samples were randomly selected for 
repeat processing (library preparation and sequencing) to evaluate reproducibility of steps following 
DNA extraction. 
In low biomass samples such as HBM samples, a portion of sequence reads may result from 
exogenous DNA contributed by reagent contaminants used during the process of DNA extraction 
and 16S rRNA gene library preparation. To allow in silico correction for contamination, 
cyanobacteria (Arthrospira spirulina) DNA extract obtained from a pure culture of Cyanobacterium 
(Arthrospira spirulina) , was spiked into DNA extracts from each of the respective negative controls 
(elution buffers) at a 16S rRNA gene concentration similar to that of HBM samples as assessed by 
qPCR. Since negative controls have little or no “competing” naturally present bacterial DNA, 
amplification of this small amount of background DNA may lead to over-estimation of the 
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contribution of contaminants to bacterial profiles. We compensated for this effect by spiking an 
amount of known bacterial DNA into control samples at an equivalent concentration to that found in 
HBM samples. These “cyanobacteria-spiked-elution buffers” were included in the library 
preparation and sequencing steps alongside the samples.  
4.2.5 16S ribosomal ribonucleic acid (rRNA) amplicon library preparation 
A two-step amplification approach described by Wu and colleagues (24) was employed to avoid 
PCR amplification biases associated with the use of adapter and index sequences. In the first PCR 
reaction, the hypervariable V4 region of the 16S rRNA gene was amplified using primers and PCR 
cycling conditions as previously described (25) (Appendix 1, Table 2B). Each 25.25 µl PCR 
reaction contained 12.5 µl 2X MyTaq™ HS Mix (BIO-25046), 2 µl of 0.8 µM forward and reverse 
primers, 1 µl of MilliQ water, 0.75 µl dimethyl sulphoxide (catalogue no D4540, Sigma-Aldrich®, 
MO, USA) and 7 µl bacterial genomic DNA.  
In the second PCR reaction, the same reagents were used as above, except that the template was 7 µl 
of the amplicon product from the first PCR reaction, and the reverse primers contained Illumina 
adapters and various unique index sequences at the 3’ end for each sample (26). The PCR 
conditions are the same with the short PCR run as described except for an additional 20 cycles in 
the PCR run (25) (Appendix 1, Table 2C).  
Amplicon products were cleaned with Agencourt SPRIPlate 96 super Magnet Plate and 
QuantiFluor™ dsDNA System was used to quantify cleaned amplicons (25). The integrity of the 
cleaned amplicons was checked by UV illumination of the gel. Briefly, 5 µl of each cleaned 
amplicon was analyzed on a 2% agarose gel containing 1% ethidium bromide. Amplicons were 
normalized by pooling at an equimolar concentration of 100 ng, and purified using Agencourt 
AMPure system (Beckman Coulter, UK). Pooled library was extracted on 1.5% agarose gel. 
QIAquick Gel Extraction Kit (Qiagen, MA, USA) was used for gel purification with the following 
minor modification to manufacturer’s protocol. The elution buffer, Tris-EDTA buffer (pH 8.0), was 
heated at 70 °C to improve amplicon recovery (step 13). Qubit® dsDNA BR Assay Kit was used for 
final quantification of the pooled 16S library. 
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4.2.6 16S ribosomal ribonucleic acid (rRNA) gene sequencing 
The pooled 16S library was paired-end sequenced on the Illumina MiSeq® system using the 
MiSeq® Reagent v3 kit (600 cycles). The quality control steps entailed 1) the quantitation of 
adapter-ligated dsDNA and 2) analysis of fragment size of the pooled library using the KAPA 
Library Quantification Kits (Illumina®) (KAPA Biosystems, MA, USA) and Agilent High-
Sensitivity (HS) DNA Kit (Agilent Technologies, CA, USA) respectively. The library pool was 
thereafter diluted to 4nM and denatured using Buffer EB (Qiagen) and 0.2 N NaOH respectively. 
The mixture was neutralized and further diluted with HT1 Buffer (Illumina®) to 5.5 pM which was 
loaded to the sequencer according to the manufacturer’s instructions (27), alongside the sequencing 
control (PhiX library) spiked into the 16S library at 15% (v/v). 
4.2.7 Bioinformatics workflow 
The sequencing quality of FASTQ files was assessed using FASTQC (v0.10.1) package (28). 
Forward and reverse sequences were then merged using UPARSE (v7.0.1090) allowing 3 
mismatches in overlaps (fastq_maxdiff set to 3), followed by quality filtering using USEARCH9 
fastq_filter (sequences truncated to 250bp). Reads with a maximum expected number of error  >0.1 
were discarded (fastq_maxee set to 0.1) (29). De-replication and selection of sequences occurring 
more than once was performed by sortbysize command in USEARCH9. Clustering of sequences 
into operational taxonomic units (OTUs) (with a clustering radius of 3) was done using 
USEARCH9 cluster_otus command. The USEARCH9_uchime2_ref tool was used to detect and 
remove chimeras and OTU counts were obtained using USEARCH9 usearch-global (30).  
Decontamination of biological samples was done by first removing cyanobacteria sequences from 
the four “cyanobacteria-spiked-NTC” controls. Sequences remaining after the removal of 
cyanobacteria sequences were identified as “contaminant sequences”. The latter were screened 
against biological samples by aligning biological sample sequences to spiked control sequences at 
100% similarity using align_seq.py, based on PyNAST (31). An average number of reads was 
calculated for each of the “contaminant sequences” matching at 100% similarity to biological 
sample sequences. “Contaminant sequences” were removed from biological samples by removing 
the average number of reads calculated from the four “cyanobacteria-spiked-NTC” controls. 
60 
 
Further processing of data was performed using Quantitative Insights Into Microbial Ecology 
(QIIME) 1.9.1 suite of software tools (32). OTU picking was occurred at 97% sequence similarity 
and taxonomic assignment was carried out against SILVA database (Version 132.) (33) using RDP 
classifier (v2.2) in QIIME (v1.9.1) (32). Rarefaction plot of Shannon diversity against sequencing 
depth was also generated in QIIME using  alpha_rarefaction.py (32). The raw sequencing reads 
were deposited in the NCBI Sequence Read Archive (SRA) database with accession number 
PRJNA510564. 
4.2.8 Data analysis  
Data analysis and graphical illustrations of the data (bar plots, boxplots, dendograms) were 
generated in R statistical package (version 3.4.1) and R studio 1.1.456 (34). Agglomerative cluster 
dendograms were generated by complete linkage hierarchical clustering (35) using the [hclust] 
function (36). This hierarchical clustering method is based on the Bray-Curtis dissimilarity index 
(37) of the R vegan package (38). Cluster dendogram was performed for all OTUs with relative 
abundance of > 0.5%. Alpha diversity within each sample was measured using the Shannon–
Weaver index with function [diversity] in the R package vegan (39), which measures both the 
richness and evenness of organisms within a given sample. Analysis of Variance Table (Type II 
tests) (40) was used to test the significance difference in alpha diversity between groups and to 
generate a p-value with a significance threshold of p < 0.05, while error estimates were based on 
Pearson residuals. Log-ratio biplots using a Bayesian prior technique for adjustments of zero counts 
were made as previously described (41) and employed lambda-scaling to ensure evenness in the 
“total spread” of the data sets (42). Log-ratio biplots were used to show multivariate clustering 
patterns as they are specific for proportions/percentages (43).  
Generalized linear models (GLM) were used to test the effect of SM and WM, and the four DNA 
extraction kits on HBM bacterial profiles at different taxonomy levels. The negative binomial 
distribution (44) in the package stats with the Quasi-Poisson family function (45) was applied to 
model over-dispersion. “Breast milk” bacteria profiles were removed from the HBM sample spiked 
with ZMCS to investigate the eight bacteria genera expected in the ZMCS. Following this, bacteria 
genera in the known “theoretical” ZMCS were compared with similar bacteria profiles in the HBM 
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sample spiked with ZMCS. Benjamini–Hochberg method for multiple correction was used to 
correct all p-values, set at a 5% significance level, by the false discovery rate (FDR) (46). Tukey’s 
Honest Significant Differences (HSD) method was used to generate a single-step multiple 
comparison of means procedure with 95% family-wise confidence intervals (47). Notched box-plots 
(48) were made to show distribution analysis of the data, as they display the 95% confidence 
interval for the median. 
4.3 RESULTS 
4.3.1 Influence of DNA extraction kits and milk skimming on yield and quality of DNA 
extracted from un-spiked human breast milk samples 
The efficiency of four DNA extraction kits were compared based on yield and purity of the 
extracted DNA from un-spiked HBM samples (n=160) with NanoDrop™ ND-2000c 
Spectrophotometer (Figure 4.2). A significant difference in the yield of DNA extracted was 
observed between the kits (p = 8.71e-09) (Figure 4.2A). Kits B and D gave the highest DNA yield; 
Tukey’s HSD revealed no significant difference between these two kits (p = 0.96). No significant 
difference was observed in DNA yield when comparing SM and WM (Appendix 1, Figure 1A). 
However, when comparing bacterial 16S DNA concentration from HBM samples, using qPCR, no 
significant difference was observed between kits (p=0.253) (Appendix 1, Figure 2A). Similarly, no 
significant difference was observed in 16S DNA concentration when comparing SM and WM 
(p=0.524) (Appendix 1, Figure 2B).   
DNA purity was assessed using the 260/280 absorbance ratio measure and no significant differences 
were observed between the four kits (p = 0.327) (Figure 4.2B) though the purity of DNA varied 
between the kits. Kits B and D had DNA purity closest to the recommended range of 1.8-2.0, while 
kit C showed a large variation in DNA purity between samples. There was no significant difference 
in DNA purity between SM and WM (Appendix 1, Figure 1B). 
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Figure 4. 2: DNA yield and purity of the four different commercial kits. Notched box plots showing (A) 
the DNA yield and (B) the DNA purity (260/280 absorbance) obtained by using each of the four kits. The 
notched box signifies the 75% (upper) and 25% (lower) quartile showing the distribution of 50% of the 
samples. The line inside the box plot represents the median, and the notch the 95% confidence interval for the 
median. The whiskers (top and bottom) represent the maximum and minimum values. Outliers, which are 
beyond 1.5 times the interquartile range above the maximum value and below the minimum value, are shown 
with open circles. *** represents p<0.001. 
4.3.2 Influence of DNA extraction kits and milk skimming on bacterial profiles obtained 
from mock microbial community standard spiked into human breast milk  
To evaluate which DNA extraction kit best extracted the bacterial communities in the known ZMCS 
community, composition and abundance were assessed after spiking this community into WM and 
SM of sample 1 (extracted by each of the 4 kits in duplicate) (Appendix 1, Figure 3B). When 
comparing the bacterial 16S DNA concentration in the spiked vs. un-spiked sample, >99.7% of the 
total 16S DNA within the spiked sample originated from the ZMCS (Appendix 1, Table 3B), and 
therefore, the contribution of the indigenous bacterial flora of this sample to the profiles generated 
from this sample would be negligible.  
Hierarchical cluster analysis was used to create a dendogram of the bacterial composition of the 
ZMCS spiked into the HBM sample alongside the community profile provided by the manufacturer 
(Appendix 1, Figure 3B). Bacterial profiles did not cluster based on whether DNA was extracted 
from WM or SM, but rather based on the DNA extraction kit used. Overall, kit A showed a very 
different profile compared to ZMCS and the other three kits under investigation. Kit A only 
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extracted DNA from three of the eight bacterial genera/families present in ZMCS. The three other 
kits (kits B, C and D) represented all the eight bacterial genera/families albeit in differing 
abundance. Kit C showed the widest variation in composition between replicates, with the samples 
clustering on different clades of the dendogram. Kit B (and some replicates for kit C) clustered 
closest to the ZMCS suggesting the best representation of the microbial community standard.  
Beta diversity (Bray-Curtis dissimilarity index) was also computed to show the differences in 
bacterial composition between the composition of ZMCS and DNA extracted from each kit for WM 
and SM spiked samples. A lower beta diversity value would mean greater similarity between the 
composition of ZMCS and the HBM sample spiked with ZMCS. For SM, kit B had the lowest beta 
diversity of 0.06, meaning it most closely represented the bacterial profiles of the ZMCS. For WM, 
the lowest beta diversity of 0.16 was seen for kits B and C (Appendix 1, Table 4).  
We further evaluated the differences in relative abundances of the eight bacterial genera/families 
expected from the known “theoretical” bacterial profile of ZMCS and those resulting from the 
extraction kits (Figure 4.3). Gram-negative organisms present in ZMCS were substantially under-
represented in samples extracted with Kit A (Figure 4.3 A-C). Kit B best represented the gram-
negative organisms in the known mock community with relative abundances closest to the mock 
community (Figure 4.3 A-C). The relative abundances of gram-negative organisms in the ZMCS 
was over-represented in DNA extracted using Kit C and Kit D (Figure 4.3 A-C). In relation to the 
five gram-positive organisms, no kit showed an ideal representation of all (Figure 4.3 D-H). Kit B 
and Kit C resulted in the closest proportional representation of Lactobacillus spp. to the ZMCS. On 
the other hand, they showed a lower relative abundance of Listeria spp. and Staphylococcus spp. 
compared with ZMCS. There were no differences in relative abundances of taxa in ZMCS extracted 
from SM vs. WM (Figure 4.4 A-H).   
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Figure 4. 3: Relative abundances of bacterial taxa extracted by kits in comparison to the commercial 
ZMCS composition.  The horizontal line in each box indicates the relative abundance of the organism in 
question in the commercial ZMCS as given by the manufacturer. P values refer to differences in relative 
abundance of each bacterial taxon between different kits (p < 0.05: ∗; p < 0.01: ∗∗). P-values were generated by 
Anova test in stats package of R and adjusted using Benjamini–Hochberg’s false discovery rate. ZMCS= 
Zymobiomics Microbial Community Standard. 
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Figure 4. 4: Relative abundances of bacterial taxa extracted by skim milk and whole milk in 
comparison to the commercial ZMCS composition. The horizontal line in each box indicates the relative 
abundance of the organism in question in the commercial ZMCS as given by the manufacturer. P > 0.05 
shows a non-statistically significant difference in relative abundance of each bacterial taxon in the HBM 
sample spiked with ZMCS as extracted by skim milk and whole milk. P-values were generated by Anova test 
in stats package of R and adjusted using Benjamini–Hochberg’s false discovery rate. ZMCS= Zymobiomics 
Microbial Community Standard. 
 
Due to the poor performance of kit A in extracting DNA from Pseudomonas spp., 
Enterobacteriaceae, Enterococcus spp. and Bacillus spp. in the HBM sample spiked with ZMCS, the 
spiked sample were re-extracted with kit A, however on this occasion, the first steps of the 
manufacturer’s guidelines involving the initial host DNA depletion step (benzonase treatment) were 
omitted; a decision based on communication with the manufacturer. The benzonase steps are 
intended to deplete extracellular bacterial DNA. This modification of the extraction protocol 
resulted in substantially improved representation of the bacteria in the ZMCS (Figure 4.5). 
However, at this point, kit A was excluded from further analysis of (un-spiked) HBM samples. 
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Figure 4. 5: Complete linkage hierarchical clustering showing the relative abundances of bacterial taxa 
in the HBM sample spiked with ZMCS. (A) Kit A DNA extraction protocol as per manufacturer’s 
recommendations and (B) Kit A DNA extraction protocol in which the initial steps (steps 1 to 4) involving 
degradation and digestion of host DNA were omitted. Samples were processed in duplicate. WM-whole milk, 
SM-skim milk. ZMCS: Zymobiomics Microbial Community Standard reference. 
 
4.3.3 Influence of DNA extraction kit and milk type on bacterial diversity in un-spiked 
HBM samples 
A total of 3,559,506 high-quality filtered raw paired-end reads was obtained from 160 HBM 
samples. The number of post-filtered reads after the removal of contaminant sequences was 
263,464. The median and mean sequence read count per sample was 1,405 and 1,670 (range 163-
5,681) respectively. Alpha rarefaction curves showed that Shannon diversity plateaued at a 
sequence depth of 100 (Appendix 1, Figure 4).  
The dominant phyla in HBM samples were Firmicutes and Proteobacteria, followed by a relatively 
low abundance of Actinobacteria and Cyanobacteria. At the genus level, the predominant bacteria 
were Staphylococcus spp., Streptococcus spp., Lactobacillus spp., Acinetobacter spp., and members 
of the family Enterobacteriaceae (Appendix 1, Figure 5). 
The influence of DNA extraction kits and extraction from SM vs. WM were compared with respect 
to bacterial alpha diversity (Shannon diversity index). Overall; there were no significant differences 
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in alpha diversity between DNA extracted by different kits (p=0.11) (Figure 4.6). Tukey HSD 
multiple comparisons of means also showed no significant difference in alpha diversity of samples 
between each of the kits. Similarly, there were no statistically significant differences in alpha 
diversity of DNA extracted from WM vs. SM (p=0.88) (Figure 4.6). Therefore, extraction kit and 
milk type did not influence the alpha diversity of bacterial composition in HBM samples. 
 
 
Figure 4. 6: Shannon diversity index of the un-spiked HBM samples based on kits and milk type. Each 
HBM sample is represented by a rectangle. The horizontal cyan and orange lines represent bacterial alpha 
diversity from skim milk and whole milk respectively. The alpha diversity in bacterial DNA extracted by each 
kit is indicated by coloured boxes. Kits B, C and D are represented by red, blue and grey lines respectively. 
WM=whole milk, SM=skim milk. 
 
Unsupervised hierarchical clustering of samples based on Bray-Curtis dissimilarity index showed 
clustering largely based on HBM donor, rather than on the basis of DNA extraction kit used (Figure 
4.7).  
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Figure 4. 7: HBM samples cluster primarily based on the donor. Complete linkage unsupervised 
hierarchical clustering based on the relative abundances of bacteria genera in un-spiked HBM samples show 
that DNA extraction kits and milk type affects bacterial profiles less when compared to the source. W: whole 
milk, S: skim milk; 1-10 represents each donor; kit B: ZR Fungal/Bacterial DNA MiniPrep™, kit C: 
QIAsymphony DSP DNA Kit, and kit D: ZymoBIOMICS™ DNA Miniprep Kit. 
Furthermore, exploration of bacteria with abundances > 0.5% using log ratio biplots did not show 
clustering of HBM samples associated with either DNA extraction kit used (B, C or D) or milk type 
(SM or WM) either at the phylum level (Appendix 1, Figure 6A-B) or genus level (Appendix 1, 
Figure 7A-B), suggesting that neither extraction kit nor use of WM vs. SM were major drivers of 
differences between samples. In contrast, clustering was observed among samples from each donor, 
irrespective of the kit used for extraction or whether WM or SM was extracted (Appendix 1, Figure 
6C; Appendix 1, Figure 7C). Therefore, donor, rather than extraction kit or milk type, was the major 
determinant of bacterial profiles identified in HBM samples. 
GLM and Turkey HSD were used to compare the different taxa observed in HBM samples in 
relation to DNA extraction kit used and between WM and SM. Appendix 1, Table 5 summarizes the 
mean relative abundance of statistically significant bacteria at the different taxonomy levels for the 
kits, and WM and SM. Comparison of different bacteria taxa between samples processed with the 
different DNA extraction kits showed significant differences in relative abundances of six bacterial 
genera (Ralstonia spp., Pseudomonas  spp., Haemophilus spp., Acinetobacter  spp., OTU_52 
belonging to the family Rhodobacterales, and Lactobacillus spp.), while WM and SM differed only 
for two bacterial genera, Enhydrobacter spp., and Acinetobacter spp., both belonging to the family 
Moraxellaceae. No significant differences in relative abundances were observed between Kit B and 
Kit D at any taxonomy level. 
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4.3.4 Reproducibility of extractions  
DNA extraction was carried out in duplicate, on consecutive days to evaluate the reproducibility of 
each DNA extraction kit. The total read count of each OTU in each duplicate set (per kit and per 
milk type) was tested using multiple R-squared, representing the proportion of variance reproduced 
by replicating the reads.  
Reproducibility (R2) ranged from 0.4751 to 0.9483 (Appendix 1, Table 6). For WM, kit D produced 
the most reproducible results with R2 of 0.9483, followed by kit C with R2 of 0.7421 while kit B 
produced the least reproducible results with R2 of 0.4908. For SM, kit D produced the most 
reproducible results with R2 of 0.7976, followed by kit B with R2 of 0.7581 while kit C produced 
the least reproducible results with R2 of 0.4751. We observed wide variations in reproducibility of 
SM and WM for kit B and kit C, unlike kit D where reproducibility was better, independent of milk 
type. The multiple R2 generated for the two sequencing controls included during the 16S library 
preparation was 0.9713. 
4.4 DISCUSSION 
We compared different methods of bacterial nucleic acid extraction from HBM prior to 16S 
microbiome profiling, including the effect of removing the fat layer. To our knowledge there are no 
published studies exploring this method. We observed a significant difference in DNA yield and 
purity, relative abundance of specific taxa, and the ability to represent the bacteria composition in a 
known mock microbial community when different DNA extraction kits were employed to extract 
DNA from HBM samples. On the other hand, skimming of milk prior to DNA extraction had 
limited impact on bacterial profiles, only showing a small influence on the relative abundance of 
two specific taxa within the phylum Proteobacteria. 
In agreement with previously published literature (2, 17, 49), HBM has a vast population of 
bacterial communities in healthy individuals and dominated at the phylum level by Firmicutes and 
Proteobacteria, followed by Actinobacteria. At the genus level, we found that Staphylococcus spp., 
Streptococcus spp., Lactobacillus spp., Acinetobacter spp., and members of the family 
Enterobacteria were the dominant members.  
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DNA extraction has been validated for several bacteriome studies including feces, oral cavity, 
turkey cecum and soil using evaluation criteria such as DNA yield and purity, DNA shearing, 
reproducibility, quantitative PCR (5, 15, 50-52), 16S rRNA gene sequence-based taxonomic 
signatures (50-52), bacterial community fingerprints (10, 16), and custom designed phylogenetic 
microarray profiles (15). However, to our knowledge, no study has previously compared different 
DNA extraction methods for HBM. 
In this study, DNA extraction methods were evaluated based on DNA yield and purity, bacterial 
diversity and reproducibility. HBM has a high fat content which may present challenges in 
extraction of DNA for molecular testing (21, 53). Furthermore, given the low microbial biomass 
present in HBM, it would be expected that the bacterial DNA yields would be substantially lower 
than those of other specimen types, for example faecal specimens, posing a challenge for 16S rRNA 
based studies (54). Despite these potential complications, high DNA yields and within-range DNA 
purity were achieved by kits B and D, both from Zymo Research Corp., Irvine, USA.  
Low biomass specimens are prone to contaminating microbial DNA which is ubiquitous within 
DNA extraction kits, PCR reagents and other laboratory reagents. (55, 56). This contaminating 
DNA may distort the relative abundances of microbial composition in datasets, thereby leading to 
erroneous interpretations (55). We therefore mitigated this effect by in-silico decontamination of our 
biological samples. The variation experienced with kit C might be because the DNA yields were 
very low, thus a higher risk of cross-contamination. 
In addition to the above criteria, we also evaluated the kits based on representation of the bacterial 
profile in a commercial mock microbial community standard. A bacterial community with a defined 
composition and abundance (5) is unlike environmental or human samples, which can be 
complicated by an unknown type and number of indigenous microorganisms. In the study by 
Willner and colleagues, a mock community was also used in identifying methodological 
contaminants, identifying detection limits and empirical cut-off values for 16S pyrosequencing in 
order to filter out spurious OTUs, and also to compare method reproducibility (57).  
Using 16S rRNA gene sequencing we compared the ability of four commercial DNA extraction kits 
to recover DNA from bacteria from a known commercial mock microbial community containing 
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eight bacterial species, which had been spiked into HBM by comparing the expected bacterial 
profiles in the HBM sample spiked with ZMCS to the theoretical bacterial composition of the mock 
microbial community standard. Importantly, the proportion of the total 16S bacterial DNA within 
the spiked samples was derived almost exclusively (>99.7%) from the mock community, and so one 
would not expect these profiles to be affected by the indigenous bacterial community within the 
spiked HBM sample. Whilst extraction using three of the kits resulted in reasonable representation 
of the mock community composition, as with other studies (5, 51), significant differences in 
bacterial profiles were shown when DNA from mock bacterial communities was extracted with 
different kits.  
Gram-positive organisms are more difficult to lyse; however, kits B, C and D showed an over-
representation of the genus Bacillus despite an under-representation of similar hard-to-lyse bacteria 
like Enterococcus. In a study by Yuan et al. (2012) which evaluated six commonly used DNA 
extraction procedures from the Human Microbiome study, the observed relative abundance of 
Lactobacillus iners in a mock community was higher than its expected relative abundance (5). In a 
previous study which evaluated the influence of four DNA extraction methods on oral bacterial 
profiles, only one method was able to represent all bacteria in the mock community (51). Overall, 
kits B, C and D represented all eight expected bacterial genera/families, though in differing 
abundance.  
Kit A performed markedly differently from the other kits. This kit had a considerably lower DNA 
yield, perhaps because the initial steps incorporate the depletion of human DNA to yield enriched 
bacterial DNA. This supports the report of Wen et al. (2016) in which a microbial DNA extraction 
method with pre-treatment of depletion of host nucleic acid by benzonase resulted in significantly 
lower DNA concentrations of samples (58). Bacterial profiles in HBM spiked with the mock 
community and extracted with Kit A revealed a biased composition with over-representation of 
gram-positive organisms, with Staphylococcus spp. dominating. This may have been due to lysis of 
gram-negative bacteria during the early extraction steps, and subsequent depletion by benzonase 
treatment. On repeating this extraction, but omitting the initial benzonase treatment steps, a good 
representation of all the eight bacterial genera in the mock standard was shown. It’s therefore 
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imperative that researchers fully understand the importance of each step in any DNA extraction 
protocol and its impact on the bacterial community of their samples. 
We showed no impact of DNA extraction kit on alpha diversity (reported using the Shannon-
diversity index), as has previously been shown on salivary bacterial communities (14). When 
considering beta diversity (reported using Bray-Curtis dissimilarity index), samples clustered 
together based on donor, irrespective of the DNA extraction kit used or whether HBM was skimmed 
or not prior to DNA extraction. A study evaluating variation in human gut microbiota profiles due to 
DNA extraction methods, confirmed this. In this study, the main source of variation in a 
dissimilarity matrix was related to donor, followed by the DNA extraction method (16). Another 
study by Wesolowska-Andersen et al. (2014) which assessed the effect of bacterial DNA extraction 
method from faeces, observed a higher inter-individual variation than that seen for the extraction 
method (59).  
We observed in our study that DNA extraction kits had an impact, albeit relatively minor, on the 
relative abundances of specific bacterial taxa from extracted DNA of samples. Other studies have 
also observed significant differences in relative abundances of bacterial taxa based on DNA 
extraction methods for faecal specimens (59, 60). 
Though a major strength of this study is the use of mock microbial community, this study was faced 
with some limitations. One is that the bacterial composition in the commercial mock community is 
not a true reflection of microbes usually found in HBM. However, seven bacterial genera that are 
commonly isolated in HBM were represented in the mock standard at the genus level. A further 
limitation is associated with the use of 16S rRNA gene targeted sequencing which gives low 
phylogenetic resolution power of bacteria up to the species level. Also, the mock microbial 
community was not extracted independently and processed by itself. Lastly, the “theoretical” 
bacterial profiles may differ from our experimental profiles due to factors such as the use of 
different 16S gene variable region and sequencing approaches. 
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4.5 CONCLUSION 
In summary, we have shown that DNA extraction method, but not fat removal, has an important 
influence on characterization of the HBM bacteriome by 16S rRNA sequencing. Detailed 
understanding of the impact of individual steps within an extraction procedure is required to prevent 
significant bias in determining the composition of the HBM bacteriome.  
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Abstract 
The human breast milk (HBM) bacteriome is an important, continuous source of microbes to the 
neonate in early life, playing an important role in shaping the infant’s intestinal bacteriome. Study 
of the composition of the HBM bacteriome is an emerging area of research, with little information 
available, particularly from low- and middle-income countries. The aim of this study was to 
characterize the diversity of bacterial communities in HBM samples collected between 6-10 weeks 
postpartum from lactating South African women, and to study potential influencing factors of the 
bacteriome. Using 16S rRNA gene sequencing of samples from 554 women, we demonstrated that 
the HBM bacteriome was largely dominated by the phyla Firmicutes (mean relative abundance: 
71.1%) and Actinobacteria (mean relative abundance: 16.4%). The most abundant genera identified 
from the HBM bacteriome were Streptococcus (mean relative abundance: 48.6%), Staphylococcus 
(mean relative abundance: 17.8%), Rothia (mean relative abundance: 5.8%) and Corynebacterium 
(mean relative abundance: 4.3%). “Core” bacterial genera including Corynebacterium, 
Streptococcus, Staphylococcus, Rothia, Veillonella, Gemella, Acinetobacter, Micrococcus and a 
genus belonging to the family, Enterobacteriaceae, were present in 80% of samples. HBM samples 
were classified, according to their bacteriome, into three major clusters, dominated by the genera 
Staphylococcus (cluster 1), a combination of Staphylococcus and Streptococcus (cluster 2) and 
Streptococcus (cluster 3). The cluster groups differed significantly for Shannon and chao1 richness 
indices. Bacterial interactions were studied using co-occurrence networks with positive associations 
observed between the abundances of Staphylococcus and Corynebacteria (members of the skin 
microbiota) and between Streptococcus, Rothia, Veillonella and Gemella (members of the oral 
microbiota). HBM from older mothers had a higher Shannon diversity index. Study site was 
associated with differences in HBM bacteriome composition (PERMANOVA, p < 0.05). No other 
tested socio-demographic or psychosocial factors were associated with HBM bacterial composition. 
Keywords: Human breast milk; bacteriome; microbiome; 16S rRNA gene sequencing; bacterial 
profiles; socio-economic; psychosocial; Africa.  
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5.1 INTRODUCTION 
The bacterial community (the bacteriome) present in human breast milk (HBM) is diverse and 
plays an important role in the health of both mothers and their infants (1, 2). HBM bacteria are one 
of the main sources of continuous microbes to the infant in early life and play a role in shaping the 
infant’s intestinal bacteriome (3). Several bacterial genera, including Streptococcus, 
Staphylococcus, Corynebacterium, Pseudomonas, and lactic acid bacteria (LAB; Lactobacillus spp. 
and Bifidobacterium spp.) have been identified as key components of the HBM bacteriome, with the 
phyla Firmicutes and Proteobacteria typically dominating (4-6).  
The concept of a core bacteriome has been proposed (7), with Staphylococcus and 
Streptococcus uniformly present (1, 8, 9), but with variation in other genera (10). Despite a core 
bacteriome, substantial variability in HBM bacterial profiles occurs and has been linked to various 
exposures. For example, HBM from women who delivered vaginally showed a different bacterial 
profile compared to those who had caesarean section delivery (6). Other factors, such as 
geographical location, maternal weight and body mass index, maternal health, maternal dietary 
intake and lactational stage have also been shown to influence the HBM bacteriome composition (5, 
6, 11-13). However, previous studies have been limited by sample size (n=10 to 133), with few 
studies having been performed in sub-Saharan Africa (5, 14) and studies have not yet evaluated 
socio-demographic and psychosocial factors in detail.  
We therefore conducted a large cross-sectional study, nested within an existing birth cohort, to 
describe the bacteriome of HBM from a cohort of South African women and the associated factors. 
5.2 MATERIALS AND METHODS  
5.2.1 Study settings: Drakenstein Child Health Study 
This was a cross-sectional study nested within an existing birth cohort study, the “Drakenstein 
Child Health Study” (DCHS) (15). The primary aim of the DCHS is to investigate the early life 
determinants of child health in two poor communities in South Africa, a Low and Middle-Income 
Country (LMIC). The birth cohort is based in the Drakenstein sub-district, a semi-rural area 60 
kilometers outside Cape Town, South Africa and has an estimated population of 200,000. The study 
sites include the TC Newman community health clinic (which serves a population with mixed 
ancestry), and Mbekweni (which serves a population with predominately black African isiXhosa 
ancestry). These two study sites are approximately 5 km apart. Inhabitants live in informal housing 
or crowded conditions, with high levels of unemployment, a high prevalence of tobacco smoke 
exposure, alcohol misuse, malnutrition and other poverty-related exposures (15).  
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5.2.2 Clinical data and sample collection 
Pregnant women, 18 years of age or older (n = 1137), were enrolled between 20- and 28-weeks 
of gestation and were followed up until their infants were 5 years old. Written informed consent was 
obtained from all participating mothers. On recruitment, detailed demographic and risk factor data 
were collected. Mothers underwent physical examination and metrics such as maternal height and 
weight were collected (15).  
HBM samples were collected from 554 women at 6-10 weeks postpartum. All participating 
women were asked to wash their hands, nipples and surrounding breast area with soap and water to 
minimize the presence of skin bacteria. HBM was collected manually by hand expression into a 
sterile collection container after discarding the first few drops. After collection, the samples were 
transported on ice to the research laboratory at the University of Cape Town and stored at −80oC 
until further processing.  
Ethical approval for the present study and the parent study (DCHS) was obtained from the 
University of Cape Town (UCT) Human Research Ethics committee (reference numbers 649/2016 
and 401/2009).  
5.2.3 Bacterial nucleic acid extraction and quantification 
HBM samples were homogenized by vortexing and skim milk preparation was adapted from a 
previously published protocol (16). In brief, the samples were centrifuged at 3500 g for 20 mins at -
10 °C, and the fat layer discarded. The supernatant was then centrifuged at 7600 g for 10 mins at 
room temperature, and the pellet was used for DNA extraction. Total genomic DNA was extracted 
using the commercial manual extraction kit, ZR Fungal/Bacterial DNA MiniPrep™ (Zymo 
Research Corp., CA, Irvine, USA), which incorporates a bead-beading step. All bead-beating steps 
were performed in a TissueLyser LT (Qiagen) at a frequency of 50Hz for 5 min.  
The quantity and purity of DNA was measured using a NanoDrop™ ND-2000c 
Spectrophotometer (Thermo Scientific, Inc.). DNA was stored at -20°C until further processing. The 
bacterial 16S rRNA gene was quantified using a 16S qPCR protocol previously described (17). 
Each 30 µl PCR reaction contained 2.5 µl DNA template, 1 µl of probe (16S-P1 (FAM- ATT AGA 
TAC CCT GGT AGT CCA –MGB), 15 µl Sensifast Probe No-rox (BIO-86020), 9.5 µl of MilliQ 
water and 1 µl each of 0.333 µM forward and reverse primer (16S-F1: 5′-CGA AAG CGT GGG 
GAG CAA A -3′ and 16S-R1: 5′-GTT CGT ACT CCC CAG GCG G-3′, respectively) (17). PCR 
cycling conditions were as follows: 50 °C for 2 mins. 95 °C for 10 mins; 45 cycles of 95 °C for 15 
s, 60 °C for 60 s, and 72 °C for 1 s (17).  
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5.2.4 Extraction and sequencing controls 
Extraction controls were processed alongside HBM specimens and were included for each 
batch of extractions (Appendix 2, Figure 1). Positive extraction controls consisted of 1000 µl elution 
buffer (provided by the ZR Fungal/Bacterial DNA MiniPrep™ kit) spiked with 75 µl 
Zymobiomics™ microbial community standard (Catalogue no. D6300, Zymo Research Corp., 
Irvine, CA, USA). Negative extraction controls (NTC; no template control) consisted of 1000 µl of 
un-spiked elution buffer. DNA extracts from negative extraction controls served as negative PCR 
and sequencing controls. A subset of DNA extracts from negative extraction controls were spiked 
with Mycobacterium smegmatis (M. smegmatis) DNA (Appendix 2, Figure 1B) at a 16S rRNA gene 
concentration similar to that obtained from HBM samples assessed by qPCR (herein referred to as 
“M. smegmatis-spiked-NTC”. M. smegmatis-spiked-NTC were used to correct for potential 
contamination, resulting from bacterial DNA in buffers and reagents, during bioinformatics 
processing of sequenced reads. To determine experimental reproducibility, library preparation and 
sequencing were carried out in duplicate for 11 HBM DNA extracts. These included seven DNA 
extracts randomly selected for repeat processing within a single run (“within-run repeats”); and four 
DNA extracts randomly selected for repeat processing between the two sequencing runs performed 
(“between-run repeats”). In addition, the ZymoBIOMICS™ Microbial Community DNA Standard 
(Catalogue no. D6305, Zymo Research Corp., Irvine, CA, USA) was used to assess library 
preparation, sequencing reproducibility and bias. 
5.2.5 16S ribosomal ribonucleic acid (rRNA) gene amplicon library preparation and 
sequencing  
Previously published primers (18) [with slight modifications (19)], PCR conditions and library 
preparation steps were followed to generate 16S rRNA gene libraries (19). Libraries were 
constructed using a two-step amplification approach described by Wu and colleagues (20). In the 
first PCR reaction, the hypervariable V4 region of the 16S rRNA gene was amplified using primers 
(515Fshort)-5’GTGCCAGCHGCYGCGGT3’ and (806Rshort)-
5’GGACTACNNGGGTNTCTAAT3’ respectively. Each 25.25 µl PCR reaction contained 12.5 µl 
2X MyTaq™ HS Mix (BIO-25046), 2 µl each of 0.8 µM forward and reverse primers, 1 µl of 
MilliQ water, 0.75µl dimethyl sulphoxide (Sigma-Aldrich®, MO, USA) and 7 µl bacterial genomic 
DNA. PCR was carried out under the following conditions: 95 °C for 3 min; 10 cycles of 95 °C for 
30 s, 50 °C for 30 s and 72 °C for 1 s; and finally, 72 °C for 5 min. Amplicon product (7 µl) from 
the first PCR reaction was used as template in the second PCR reaction. The second PCR reaction 
mixture was the same as the first except for the use of modified reverse primers. Reverse primers 
were modified at the 3′ end with Illumina adapter sequences and unique index barcodes for each 
sample. The use of index sequences allowed multiplexing of samples in a single sequencing run 
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(18). The PCR conditions for the second PCR were the same as for the first PCR but run for 30 
cycles. 
Amplicon products were cleaned with the Agencourt AMPure system (Beckman Coulter, UK) 
using an Agencourt SPRIPlate 96 super Magnet Plate. The QuantiFluor™ dsDNA System 
(Promega, Madison, WI, USA) was used to quantify the cleaned amplicons. The integrity of the 
cleaned amplicons was assessed by gel electrophoresis. Amplicons were normalized by pooling the 
different samples at 100 ng each. The pooled library was purified using the Agencourt AMPure 
system and extracted from a 1.5% agarose gel following gel electrophoresis (30 min at 35 V; 45 min 
at 40 V; and finally, 3h30 min at 70 V). Excision of the pooled 16S library was followed by 
purification using QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, United States) according to 
manufacturer’s protocol. The elution buffer, Tris-EDTA (pH 8.0), was heated at 70 °C to improve 
amplicon recovery (step 13). Finally, the Qubit® dsDNA BR Assay Kit was used for quantification 
of the pooled library. 
Sequencing was carried out at the Centre for Proteomic and Genomic Research, Cape Town, 
South Africa. Quality control pre-sequencing steps included quantification of adapter-ligated 
dsDNA using the KAPA Library Quantification Kit (Illumina®) (KAPA Biosystems, MA, USA) 
and analysis of the fragment size of the pooled library using the Agilent High-Sensitivity (HS) DNA 
Kit (Agilent Technologies, CA, USA). The library pool was diluted to 5.5 pM for sequencing and 
the internal sequencing control (PhiX control V3, Illumina, CA, USA) was spiked into the diluted 
library at 15% (v/v) according to the manufacturer’s instructions (21). The first and second library 
pool had 352 and 202 samples multiplexed per Illumina run. The pooled 16S library was paired-end 
sequenced on the Illumina MiSeq® system using the MiSeq® Reagent v3 kit (600 cycles) 
(Illumina, CA, USA). 
5.2.6 Processing of 16S rRNA gene sequences 
16S rRNA gene sequences were processed using an in-house pipeline. Briefly, the sequencing 
quality of FASTQ files were assessed using FastQC and MultiQC packages (22, 23). Forward and 
reverse sequences were then merged using UPARSE (24) allowing 3 mismatches in overlaps 
(uparse_merge_fastq, fastq_maxdiff set to 3), followed by quality filtering using uparse_filter_fastq  
fastq_filter (sequences truncated to 250bp). Reads with a maximum expected error >0.1 were 
discarded (fastq_maxee set to 0.1). USEARCH10 (25) sortbysize command was used to dereplicate 
and select sequences occurring more than once. Clustering of sequences into operational taxonomic 
units (OTUs) (with a clustering radius of 3) was performed with USEARCH10. The 
USEARCH10_uchime2_ref tool was used to detect and remove chimeras, and OTU counts were 
obtained using USEARCH10 usearch-global.  
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In-silico correction for contamination of biological HBM samples was carried out using a 
procedure to control for “over-compensation” during contaminant removal (Appendix 2, Figure 1). 
Firstly, M. smegmatis sequences were removed from the “M. smegmatis-spiked-NTC” controls. 
Background sequences present in the M. smegmatis-spiked-NTC controls after the removal of M. 
smegmatis sequences were screened against biological sample sequences by aligning biological 
sample sequences to background sequences at 100% identity using align_seq.py, based on PyNAST 
(26) algorithm and uclust (25) (Appendix 2, Figure 1D). The average number of reads was 
calculated for each of the “background sequences” across M. smegmatis-spiked-NTCs, and the 
corresponding number of reads was thereafter removed from the biological HBM samples 
(Appendix 2, Figure 1E). Further processing of data was performed using Quantitative Insights Into 
Microbial Ecology (QIIME) 1.9.0 suite of software tools (27). Taxonomy was assigned to 
representative sequences of the OTUs using assign_taxonomy.py (method set to Ribosomal 
Database Project (RDP)) Classifier (26) and identity was set to 97% with SILVA 132 release 
database (28). Sequence alignment and filtering was performed with align_seqs.py (97% identity) 
and filter_alignment.py, while construction of a phylogenetic tree was done using 
make_phylogeny.py script. 
Chao1 species richness (29) was used to estimate species richness and a rarefaction plot of 
Shannon diversity against sequencing depth was generated using alpha_rarefaction.py in QIIME 
1.9.0. Samples with <1000 reads were removed from further analysis as the rarefaction curve 
plateaued at a sequence depth of 1000 read counts. The core bacteriome, defined as the OTUs that 
were present in at least 80% of the samples, was determined with QIIME with the script 
“compute_core_microbiome.py”. Nextflow (30) was used to loop the entire processing workflow. 
The 16S rRNA gene sequencing datasets used in this study are stored in the National Center for 
Biotechnology Information (NCBI) Sequence Read Archive (SRA) repository (BioProject 
PRJNA520889). 
5.2.7 Statistical analyses  
Statistical analysis and graphical illustrations of the data (barplots, boxplots, dendograms) were 
generated in R statistical package (version 3.4.4) (31) and R studio 1.1.456, respectively. Alpha 
diversity was calculated using the Shannon–Weaver index (32). Analysis of Variance (Type II test) 
(33) was used to test the difference in alpha diversity between groups, while error estimates were 
based on Pearson residuals. 
Agglomerative clustering was performed for all OTUs with relative abundance of >0.5% and 
was generated by complete linkage hierarchical clustering (34) using the [hclust] function (35). This 
hierarchical clustering method is based on the Bray-Curtis dissimilarity index (36) of the R vegan 
package (37). To determine the relative abundances of bacterial profiles, the operational taxonomic 
unit (OTU) table (clustered at 97% sequence similarity) was transformed from count data to 
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compositional data (38). The hierarchical clustering tree was cut at a height of 0.8 to cluster samples 
into groups based on relative abundance of bacteria in HBM samples at genus level. The optimal 
number of clusters was determined by Calinski–Harabasz index (39) and validated by silhouette 
width index (40).  
Log-ratio biplots using a Bayesian prior technique for adjustments of zero counts were made as 
previously described (41) and lambda-scaling was employed to ensure evenness in the “total 
spread” of the data sets (42). Box-plots (43) were used for visualization of distribution of the data.  
A co-occurrence network was constructed using the R network package with centered log-ratio 
data (44). The cut-off was set to 0.28 to generate the network for each of the different clusters and 
for all samples, using bacteria with genus-level abundances >0.5%. A bivariate correlation analysis 
for the 16 most abundant genera was performed using Pearson correlation.  
Permutational Multivariate Analysis of Variance Using Distance Matrices (PERMANOVA) 
via “adonis” in the R package vegan (45, 46) with Aitchison’s distance (47, 48) in the R package 
robCompositions (49) was used to test the effects of potential influencing factors on the 
composition and diversity of HBM bacteriome. ADONIS was performed with 999 x permutations 
and method "bray". Benjamini–Hochberg method for multiple correction was used to correct all p-
values, set at a 5% significance level, by the false discovery rate (FDR) (50). All OTUs irrespective 
of their abundance at each taxonomy level were tested in the model and a multivariate p-value was 
generated for the covariates. Linear discriminant analysis (LDA) effect size (LEfSe) with default 
parameters (51) was used to asses taxa that differed between groups, for any covariate significant by 
ADONIS. 
The Beck Depression Inventory (BDI-II) is a self-report measure of depressive symptoms that 
assesses key symptoms of depression between 0 (absence of symptom) and 3 (severe, often with 
functional impairment). Individual items are summed and scores of ≥20 is indicative of 
moderate/severe depression (52, 53). Self-Regulation Questionnaire (SRQ) is a WHO-endorsed 
self-report measure assessing psychological distress, including symptoms of depressive and anxiety 
disorders in which individual items are scored according to whether or not the symptom is present. 
SRQ scores ≥8 is indicative of “high risk” participants (54, 55). PTSD was measured by the 
Modified Posttraumatic Stress Disorder Symptom Scale (MPSS) (56) which is a self-report measure 
with scale including items which assess 3 symptom clusters for PTSD: re-experiencing, avoidance/ 
emotional numbing, and increased arousal. Items assessing the re-experiencing symptom cluster 
were scored as “above threshold” if their sum totaled ≥1; avoidance/emotional numbing ≥3; and 
increased arousal ≥2. Participants who scored above threshold across all three symptom clusters and 
reported symptom duration of at least 1 month (scored ≥1 for item 18) were classified as “suspected 
PTSD cases”. An intimate partner violence (IPV) questionnaire was used to assess recent exposure 
87 
 
to physical, emotional and sexual IPV as previously described (57). The four psychosocial variables 
described above were collected at the 28-32 week antenatal visit. 
The Alcohol, Smoking and Substance Involvement Screening test (ASSIST) was used to assess 
maternal alcohol consumption based on a scoring system as previously described (57). Scores of 0–
10 for alcohol indicate that a participant is at low risk for substance-related health problems. 
Infant length was measured in centimeters to the nearest completed 0.5 cm, and weight was 
measured in kilograms to the nearest completed 10 g at the hospital as previously described (58). 
A coefficient of multiple determination was generated using linear regression analysis (59) to 
determine the reproducibility of the eleven DNA extracts which were processed in duplicate. The 
total read count of each OTU in a sample was compared with the total read count of each OTU in its 
duplicate set. 
5.3 RESULTS 
5.3.1 Participant characteristics  
HBM samples were collected from 554 mothers at 6-10 weeks (median 7.5 weeks) postpartum. 
Maternal characteristics can be found as Appendix 2, Table 1. The median maternal weight and 
body mass index (BMI) at time of HBM collection was 63.7kg and 25 kg/m2, respectively. The 
majority of the mothers were unemployed, and only 13% of participants had a household income of 
>ZAR5000/month (>360 USD/month). HIV prevalence was higher at the Mbekweni study site 
(18.4% of mothers) compared to TC Newman (2% of mothers). Smoking status, as measured by 
urine cotinine levels at the 28–32-week antenatal visit, classified 13% of women at Mbekweni as 
active smokers compared to 52% of mothers at TC Newman. At the 6-10-week postpartum study 
visit, only 53% of women were exclusively breastfeeding their babies. Most of the women delivered 
their infants vaginally (81%). Maternal post-traumatic stress disorder (PTSD) was documented in 
8% of mothers, while 25% and 22% of women were above the Beck Depression Inventory (BDI) 
and Self-Regulation Questionnaire (SRQ) threshold, respectively. The median household size was 5 
people across both sites. Twenty-three percentage (23%) of infants were delivered pre-term 
(Appendix 2, Table 1).  
5.3.2 Sequencing results and OTU analysis 
A total of 16,835,376 high-quality raw paired-end reads were obtained. The total number of 
post-filtered reads was 4,865,561. The median and mean sequence read count per sample was 8007 
and 8782.6 (range 48-40,919) respectively. A rarefaction curve of Shannon diversity plateaued at a 
sequence depth of 1000 read counts (Appendix 2, Figure 2), therefore 32 samples with sequence 
read counts <1000 were removed from further analysis. USEARCH9 mapping of sequences 
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revealed that the sequence reads clustered into 2284 OTUs. The OTUs were classified into 58 phyla, 
133 classes, 263 orders, 596 families and 1,300 genera.  
5.3.3 Profiling of human breast milk bacteriome 
HBM bacterial profiles revealed diverse bacterial communities. Four phyla had mean relative 
abundances >0.5%: Firmicutes (mean relative abundance [MRA]: 72%), Actinobacteria (16%), 
Proteobacteria (10%) and Cyanobacteria (0.9%) (Figure 5.1). At the genus level, 16 genera had 
MRAs >0.5%, of which Streptococcus (49%), Staphylococcus (18%) and Rothia (6%) were most 
abundant (Appendix 2, Figure 3). A core bacteriome consisting of 14 OTUs from 9 genera, 
Corynebacterium, Streptococcus, Staphylococcus, Rothia, Veillonella, Gemella, Acinetobacter, 
Micrococcus and a genus belonging to the family, Enterobacteriaceae, was observed (these genera 
were all present in HBM samples from >80% of women) (Appendix 2, Table 2).  
 
Figure 5. 1: Complete linkage unsupervised hierarchical clustering of relative abundances of human 
breast milk (HBM) bacterial phyla. Bar-plot of relative abundances of HBM bacteria genera at (A) 
Mbekweni and (B) TC Newman study sites. Each bar represents a mother’s HBM bacteriome profile and each 
coloured box, a bacterial phylum. Phyla with less than 0.5% abundance in a given sample are grouped 
together, herein referred to as “other” (grey boxes). 
5.3.4 Breast milk bacteriome profiles segregate into three major clusters 
Hierarchical complete linkage unsupervised clustering based on Bray-Curtis dissimilarities at 
the genus level resulted in an eleven-cluster best fit model. Clusters 4-11 however, had very few 
participants and were therefore excluded from further analysis (Appendix 2, Figure 4). 
Streptococcus and/or Staphylococcus were responsible for the formation of the three dominant 
clusters in our study population. Cluster 1 showed the highest abundance of Staphylococcus spp., 
Cluster 2 was dominated by relatively equal proportions of both Streptococcus spp. and 
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Staphylococcus spp., while Cluster 3 showed the highest relative abundance of Streptococcus spp. 
(Figure 5.2). Similar numbers of HBM samples were found in clusters 1 and 2, with the majority in 
cluster 3 (Figure 5.2A). 
Bacterial profiles of many of the most abundant taxa also differed between the cluster groups. 
At phylum level, Cluster 2 showed the highest abundance of Actinobacteria and Proteobacteria but 
lowest abundance of Firmicutes. Cluster 3, on the other hand, showed the highest abundance of 
Firmicutes but lowest abundance of Proteobacteria (Appendix 2, Table 3). At genus level, Cluster 1 
showed the highest abundance of OTU_24 (belonging to the family Enterobacteriaceae) and 
Corynebacterium, with the lowest abundance of Veillonella, and Rothia; Cluster 2 showed the 
highest abundance of Acinetobacter and the LAB-Lactobacillus and Bifidobacterium; Cluster 3 
showed the highest abundance of Veillonella and Rothia but lowest abundance of Corynebacterium, 
OTU_24 and Acinetobacter (Figure 5.2 and Appendix 2, Table 3). 
 
  
Figure 5. 2: Human breast milk (HBM) bacterial profiles of the three clusters in which samples were 
grouped at genus level.  (A) Pie charts show the mean relative abundances in each cluster at the genus level 
(for genera with abundance >0.05%). (B) Notched box plots show the mean relative abundance of the 
predominant bacteria genera in each cluster. The notched box signifies the 75% (upper) and 25% (lower) 
quartile showing the distribution of 50% of the samples. The median is represented by the line inside the box 
plot, and the notch shows the 95% confidence interval for the median. The whiskers (top and bottom) 
represent the maximum and minimum values. Outliers, which are beyond 1.5 times the interquartile range 
above the maximum value and below the minimum value, are shown with open circles. (∗∗∗p < 0.001). 
Furthermore, exploration of β-diversity using principal coordinate analysis (PCoA) revealed 
distinct separation of HBM samples based on the three dominant bacterial profile cluster groups 
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(Figure 5.3A). PERMANOVA “adonis” analysis identified significant dissimilarity in bacterial 
composition between the clusters at order, family and genus taxonomy levels (p≤0.001). Cluster 3 
was common at both study sites, but more prevalent at Mbekweni, while Cluster 1 was more 
prevalent at TC Newman (p=0.018) (Figure 5.3B). 
 
 
 
Figure 5. 3: Human breast milk (HBM) bacteriome profiles coloured by clusters. (A) Principal 
coordinate analysis (PCoA) of Bray-Curtis distance matrices of bacteria genera from all 522 HBM samples in 
the study. (B) Bar plots showing the proportion of different clusters detected from each study site.  
5.3.5 Alpha diversity of bacterial communities within the DCHS cohort study 
Of the 26 covariates tested in this study (Appendix 2, Table 1), only the phenotypic cluster 
groups and infant birth length showed significant differences in both alpha diversity measures 
(Shannon diversity and Chao1 index). Figure 5.4 shows the alpha diversity matrices for 5 selected 
covariates. For phenotypic cluster groups, cluster 1 had the lowest diversity by both measures, while 
Cluster 2 had the highest Shannon diversity and Cluster 3 had the highest Chao1 species richness 
(Figure 5.4). To analyse the association of infant birth length with HBM bacterial diversity, samples 
were stratified into three groups: mothers with infant birth length of 0-40cm, 40-48cm, and 48-
60cm. HBM from mothers with infant birth length 48-60cm had the lowest bacterial diversity by 
both measures (Appendix 2, Table 4). A significant difference in Shannon diversity was observed 
based on maternal age in all samples and at the Mbekweni study site, with older mothers (ages ≥35) 
having a higher Shannon diversity index (p<0.05) (Figure 5.4 and Appendix 2, Table 4).  
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Figure 5. 4: Alpha diversity indices of human breast milk bacteriome profiles. (A) Shannon diversity 
index, and (B) Chao1 index of HBM bacteriome profiles of participants based on cluster group, study site, 
maternal age (in years), infant feeding at 6–10 weeks, and smoking during pregnancy. M = Mbekweni, TCN = 
TC Newman, EBF = exclusive breastfeeding, MF = mixed feeding, NS = non-smoker, PS = passive smoker, 
AS = active smoker. 
5.3.6 Human breast milk bacterial profiles in relation to demographic, socio-economic 
and psychosocial variables 
Beta-diversity clustering at the genus level of all HBM samples based on Bray-Curtis 
dissimilarity index showed no clear association between bacterial profiles and the different 
covariates studied (Figure 5.5). We also visualized bacterial diversity at the genus level for genera 
with abundances >0.5% using log ratio biplots. Clustering was not observed for any covariates 
studied (Figure 5.6 and Appendix 2, Figure 5). Figure 5.6 shows results for a selection of 4 
covariates (study site, maternal smoking, maternal BMI and mode of delivery). Mothers with 
elective caesarean section delivery had bacterial profiles with less clustering towards 
Staphylococcus (Figure 6).   
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Figure 5. 5: Complete linkage unsupervised hierarchical clustering of human breast milk (HBM) bacterial profiles. (A) Dendogram of bacterial profiles present in 522 
HBM samples at genus level. (B) Horizontal coloured bars below the dendogram summarize covariate data for each sample. 
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Figure 5. 6: Log ratio biplot of human breast milk bacterial abundances at the genus level. Samples are coloured according to (A) study site, (B) maternal smoking, (C) 
Body Mass Index (BMI), and (D) delivery mode. Each sample is represented by a circle and is coloured based on group type. Samples (circles) that cluster together are similar in 
bacterial composition and abundance.  
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Associations between bacterial profiles and socio-demographic and psychosocial characteristics were also 
investigated at different taxonomy levels using PERMANOVA. At the phylum, order, family and genus levels, 
only study site (which was also a marker for ethnicity) was associated with significant dissimilarity of the 
HBM bacterial communities (ANOVA, p < 0.05). There were no statistically significant differences between 
HBM bacterial profiles in relation to the remaining covariates (Table 5.1). LEFSe was performed to further 
explore differences in specific bacterial taxa in relation to study site. In line with the prevalence of the 
different cluster groups between study sites, HBM samples from Mbekweni had significantly higher relative 
abundance of the genus Streptococcus while samples from TC Newman had significantly higher relative 
abundances of the genera Staphylococcus, Acinetobacter and Escherichia_Shigella (Appendix 2, Figure 6A). 
 
Table 5. 1: Permutational multivariate analysis of variance (PERMANOVA) analyses of HBM bacteriome and its 
association with maternal demographic and psychosocial factors. 
Covariates 
Phylum 
(p-value) 
Class Order Family  
(p-value) 
Genus  
(p-value) (p-value) (p-value) 
Study site (Ethnicity) 0.041* 0.0628 0.0036* 0.004* 0.0028* 
Mode of delivery 0.9756 0.9492 0.8276 0.8358 0.793 
Gestational age 0.1266 0.126 0.944 0.3424 0.3538 
Infant gender 0.7818 0.8142 0.3084 0.9608 0.7898 
Infant feeding options 0.1716 0.2244 0.9502 0.2888 0.4662 
Maternal education 0.275 0.3486 0.2202 0.189 0.1734 
Maternal employment 0.7434 0.7192 0.2346 0.6372 0.7988 
Maternal BMI 0.3886 0.3806 0.6206 0.714 0.5788 
Infant birth weight 0.836 0.933 0.6886 0.719 0.7824 
Infant birth length 0.9876 0.971 0.9006 0.895 0.9414 
Maternal age 0.3286 0.3986 0.8976 0.641 0.7316 
Dwelling type 0.5846 0.4892 0.6306 0.136 0.1158 
Marital status 0.4194 0.4406 0.1362 0.7608 0.7778 
Household income 0.6062 0.6988 0.663 0.0922 0.0988 
Maternal HIV status 0.7238 0.6582 0.0836 0.9242 0.9252 
Antibiotics 0.4178 0.4446 0.951 0.3334 0.2128 
Household size 0.559 0.4248 0.3374 0.9198 0.8276 
Maternal smoking 0.867 0.8698 0.837 0.7986 0.7448 
Alcohol score 0.1216 0.0974 0.8012 0.2018 0.8706 
IPV-emotional 0.9198 0.9132 0.806 0.8394 0.3256 
IPV-physical 0.2504 0.2432 0.1708 0.6604 0.817 
IPV-sexual 0.7438 0.8552 0.8676 0.2556 0.8092 
PTSD 0.847 0.6846 0.724 0.3232 0.1342 
BDI score 0.127 0.876 0.2598 0.3168 0.3246 
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SRQ 0.7408 0.5376 0.2576 0.8204 0.3012 
 
EBF=Exclusive breastfeeding; BMI=Body Mass Index; IPV=Induced Partner Violence; PTSD=post-traumatic stress 
disorder; BDI=Beck Depression Inventory; SRQ=Self-Regulation Questionnaire; smoking status was based on cotinine 
levels measured during an antenatal visit. Cotinine levels ≥ 500 (Active smoker); Cotinine levels >10<500 (Passive 
smoker); Cotinine levels ≤ 10 (Non-smoker). p-values were generated by multivariable PERMANOVA analyses and 
adjusted using Benjamini–Hochberg’s false discovery rate. Significant results (p<0.05) are labelled with asterisks. 
 
5.3.7 Co-occurrence networks in human breast milk bacterial communities  
Bacterial correlations within the HBM bacteriome were explored, since bacteria cohabit ecological 
niches, and interactions between bacterial species may be present (60). We constructed a network for all 
HBM samples, and across the 3 main clusters based on Pearson’s correlations of relative abundance ( -0.28 
>|r|<0.28) at genus level (Figure 5.7 and Appendix 2, Table 5). The network of all HBM samples contained 
12 nodes (bacterial genera) and 19 edges (interconnecting lines denoting correlations) (Figure 5.7A). 
Bacterial correlations within each cluster group were similar except for Streptococcus spp. and 
Staphylococcus spp. While a negative correlation was observed between these two genera in a co-
occurrence network involving all samples, a positive interaction was observed in cluster 2 where the 
relative abundances of Streptococcus spp. and Staphylococcus spp. were similar. 
Within the Firmicutes phylum, the abundance of Staphylococcus spp. was positively correlated with 
Corynebacterium spp. (both common commensals of the skin), but was negatively correlated with 
Streptococcus spp. and Veillonella spp. Streptococcus spp. abundance, on the other hand, was positively 
correlated with other members of the oral flora, Veillonella spp., Gemella spp., and Rothia spp., and 
negatively correlated with the Proteobacteria (Acinetobacter spp., and Enhydrobacter spp.), and with skin 
commensals such as Micrococcus spp. and Staphylococcus spp. A positive correlation was observed 
between Pseudomonas spp., Acinetobacter spp. and Enhydrobacter spp., all members of the order 
Pseudomonadales.  
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Figure 5. 7: Bacterial networks within the human breast milk bacteriome community based on correlation 
between relative abundances. Figures show correlations between predominant bacteria in (A), all HBM samples, (B), 
Cluster 1, (C), Cluster 2, and (D), Cluster 3. Nodes and node sizes represent bacterial genera and their relative 
abundances, respectively. Green and red lines represent positive and negative correlations respectively between the 
bacteria, with the thickness of the line indicating the degree of correlation. 
 
5.3.8 Reproducibility of bacterial profiling 
The bacterial composition of each sample and its repeat was evaluated to test for reproducibility. Multiple 
R-square values of >0.97 for both within-run and between-run repeats showed excellent reproducibility 
(Appendix 2, Figure 7). Hierarchical clustering also showed that replicate samples clustered together 
(Appendix 2, Figure 8). 
5.4 DISCUSSION 
In this study, the largest of its kind to date, we describe the composition of the HBM bacteriome in 
samples from mothers living in South Africa. We identify a core bacteriome consisting of 9 bacterial genera 
present in >80% of samples. We also show that there are three major HBM bacteriome profiles, distinguished 
by the relative abundance of the genera Streptococcus and Staphylococcus and that bacteria which are 
commonly found as part of the skin flora correlate in relative abundance in HBM, as do bacteria which are part 
of the oral microbiota. We are able to demonstrate an association between study site (a proxy for ethnicity in 
this study), infant birth length and maternal age, a range of potential determinants and the composition of the 
HBM bacteriome. 
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Previous studies of the HBM bacteriome have revealed a diverse bacterial population, including gram 
positive (Corynebacterium spp., Lactobacillus spp., Bifidobacterium spp., Staphylococcus spp.) and gram 
negative (Pseudomonas spp., Veillonella spp.) bacteria (7, 9, 61, 62). The most abundant bacterial phyla in our 
study were Firmicutes and Actinobacteria, in contrast to several other studies (8, 9, 63-65) which described a 
predominance of Proteobacteria and Firmicutes. Our findings are similar, however, to those of Williams et al 
(13) who showed similar relative abundances at the phylum level in HBM from mothers in the U.S.A. Many 
factors including geographical region (which influences diet and cultural practices) (66), lactational stage, and 
maternal health may influence the HBM bacterial community, with considerable diversity reported between 
individuals (5, 63). Methodological differences including sample processing and analytical techniques may 
also account for differences between studies. 
At the bacterial genus level, Streptococcus spp. and Staphylococcus spp. were most abundant, in line with 
previous studies (7-9, 63, 67, 68) and a recent systematic review (69). Other abundant genera included Rothia 
spp., Corynebacteria spp. and Acinetobacter spp. Of note, the relative abundance of Acinetobacter spp. 
observed in our cohort (2.2%) was low. When comparing our findings to those published previously; we found 
that studies with sample collection protocols similar to ours identified Acinetobacter spp. proportions 
comparable to those in our study (67). In contrast, proportions of Acinetobacter spp. were higher (32%) when 
the sample collection protocol omitted cleaning of breast skin prior to collection and discarding of the first few 
drops of milk during the collection procedure (67). 
Bifidobacterium spp. and Lactobacillus spp. [lactic acid bacteria (LAB)] were detected at low relative 
abundances (mean relative abundances of 1.0% and 0.9%) but detected in 72% and 76% of women in our 
study. Previous studies using quantitative polymerase chain reaction (qPCR) have estimated the absolute 
abundance of Lactobacillus spp. and Bifidobacterium spp. as 103–104 cells/ml and 102–105 cells/ml 
respectively (4, 70, 71), however, we are not able to determine absolute abundance using 16S rRNA gene 
amplicon sequencing. LAB have been identified as probiotics which colonize the infant gut even at relatively 
small dose, and function to competitively exclude pathogens (72, 73). Studies have suggested that HBM is an 
important source of Bifidobacterium for the infant gut. In support of this, it has been shown that 
Bifidobacterium dominates the gut of a breastfed full-term infant as early as the first 3-6 days of life and 
makes up 60-90% of the total bacteriome of the infant gut (74). Furthermore, identical strains of 
Bifidobacterium breve and Lactobacillus plantarum have been isolated from HBM and infant feces in a 
mother-infant pair, confirming vertical transmission (9).  
Our study confirmed the existence of a shared and conserved “core” bacteriome in HBM which is 
consistent with previous studies (7-9, 64, 65, 75). The core bacteriome identified from HBM samples assessed 
in our study included eight bacterial genera at 80% prevalence. Bifidobacterium and Lactobacillus were not 
part of the core bacteriome in our study, in contrast to a previous study in Ireland (9).   
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Further investigation into HBM bacterial profiles using clustering analysis revealed three major dominant 
profiles present in our samples, determined by the relative abundances of Streptococcus spp. and/or 
Staphylococcus spp. Similar to our study (76), the cluster dominated by Staphylococcus spp., was associated 
with a less diverse bacteriome. Previous studies among lactating women in Italy, and Taiwan and mainland 
China similarly described three bacterial profiles with clustering of bacterial profiles based on the dominance 
of Streptococcus spp. or Staphylococcus spp., either at the genus and family taxonomy level respectively (63, 
76). A Canadian cohort has however described four clusters based on the relative abundances of a different set 
of bacterial profiles including Moraxellaceae, Enterobacteriaceae, and Pseudomonadaceae (Cluster 1), 
Streptococcaceae, Staphylococcaceae, and Oxalobacteraceae (Cluster 2), Oxalobacteriaceae and 
Comamonadaceae (Cluster 3), and Streptococcaceae and Comamonadaceae (Cluster 4) (65).  
5.4.1 Bacterial interactions within the human breast milk bacterial community 
We explored the correlation between bacterial genera, based on relative abundance. We showed a positive 
relationship between the two skin commensals, Staphylococcus spp. and Corynebacterium spp. in line with 
previous findings by Ma et al. (2015) (77). Recently, an “evil alliance” was proposed to occur between these 
two genera, as both have been implicated as the cause of mastitis in breastfeeding women (77, 78). 
Staphylococcus epidermidis and Staphylococcus aureus are major causes of infectious mastitis, a major reason 
of premature cessation of breastfeeding among lactating women (1). Corynebacterium spp., has been 
implicated as the third most prevalent bacterial group causing infectious mastitis (78).  
Veillonella spp., Gemella spp., Rothia spp. and Streptococcus spp. which are commensals of the oral 
cavity, demonstrated positive correlations. A similar positive correlation was also observed between 
Pseudomonas spp., Acinetobacter spp. and Enhydrobacter spp. which are all members of the order 
Pseudomonadales and live in the nasal cavities.  
A negative correlation was observed between the abundances of Acinetobacter spp. and Staphylococcus 
spp. Unlike a previous study in Taiwan and Mainland China (63), Correlations between Streptococcus spp. 
and Staphylococcus spp. varied between cluster groups, being negative for clusters 1 and 3, but positive for 
Cluster 2 where both bacterial genera had high relative abundances.  
5.4.2 Impact of maternal and infant factors on human breast milk bacterial profiles 
We studied a broad range of potential influencing factors of the HBM bacteriome but showed no 
association of maternal, socio-economic and psychosocial variables with the HBM bacteriome, apart from 
maternal age, infant birth length and study site (which almost completely correlated with ethnicity). Our 
findings are similar to those of Urbaniak and colleagues (2016) who found that HBM bacterial profiles did not 
differ significantly based on mode of delivery, gestation or infant gender in a Canadian population (8). In 
support of our and Urbaniak and colleagues’ findings, a previous study conducted on HBM samples among 
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Chinese women (n=90), and a longitudinal study conducted among American women (n=104) also found that 
the mode of delivery had no influence on HBM bacteriome (13, 67).  
In contrast to these reports, two recent studies show separation of HBM bacterial profiles on principal 
component analysis of beta diversity in relation to mode of delivery (64, 79). Both studies, however, had 
relatively small sample sizes (12 and 84 participants). In our study, we observed separation of HBM bacterial 
profiles of women who underwent elective caesarean section from HBM profiles of women who underwent 
either vaginal or emergency caesarean section delivery in a log ratio biplot with less clustering around 
Staphylococcus, however this association did not show statistical significance on PERMANOVA testing. 
Kumar et al. (2016) showed that while delivery mode was not associated with HBM bacterial profiles among 
South African and Finnish women, Chinese and Spanish women showed different bacterial profiles based on 
mode of delivery (5). Li et al (2017) found no difference in the abundance of bacterial families in HBM based 
on delivery mode, however, the genus, Lactobacillus, differed between the two groups (63). In another recent 
study, mode of delivery was associated with bacterial composition of colostrum. Higher abundances of 
Pseudomonas spp., Staphylococcus spp. and Prevotella spp. were observed in the colostrum of mothers with 
caesarean section delivery. It is possible that differences in HBM profiles would be most marked in early 
HBM samples where the hormones involved in the delivery process still have an impact.  
Other factors which have been associated with HBM bacterial profiles include gestational age, maternal 
age, and maternal BMI. Interestingly one previous study, using qPCR showed differences in HBM 
composition between preterm and term milk, with higher Bifidobacterium spp. and lower Enterococcus spp. 
counts among women who delivered term babies (71). A more recent study and ours, using 16S rRNA gene 
sequencing, showed no impact of gestational age on the HBM bacteriome (8). With focus on infant gender, a 
previous study reported higher mean relative abundances of Streptococcus spp. and lower mean relative 
abundances of Staphylococcus spp. from HBM of mothers with male infants (13), although we did not find 
any significant association. Contrary to our study, BMI within the normal range was associated with higher 
proportions of Alphaproteobacteria and Betaproteobacteria at the class level (80). Maternal age, on the other 
hand, influenced the diversity of HBM bacterial profiles in our study and previous reports (63, 80). How 
maternal age or infant sex drives the bacteriome is largely unknown till date.  
A study in Taiwan showed no influence of BMI on HBM bacteriome (63), as was found in our study, 
however, higher Granulicatella spp. relative abundance was observed in another study of HBM from 
overweight and obese mothers (13). A more recent study showed that maternal obesity was inversely 
associated with Proteobacteria diversity but positively associated with Firmicutes diversity at the phylum level 
(65). 
There is increasing awareness of the microbiota-gut-brain axis, with several studies describing an 
association between the gut microbiota, neuropsychiatric and psychosocial variables in both mouse models 
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and humans (81-83). We however did not observe any association between psychosocial variables and the 
HBM bacteriome. To the best of our knowledge, this is the first study to examine the association of 
psychosocial variables with HBM bacteriome composition. 
In our study, we found an association between study site and the HBM bacteriome. However, since 
ethnicity was almost completely correlated with study site, we are unable to determine whether these 
differences were due to ethnicity or other unmeasured factors associated with study site. Li et al (63) 
demonstrated similar findings in a study characterizing the HBM bacteriome from various regions within 
Taiwan and Mainland China (63). Ethnicity has been found to have an influence on the gut microbiome in 
several studies (66, 84), and could be driven by a range of factors, such as genetic differences or diet (85). 
Strengths of our study include large sample size, consistent methods for sample collection, processing and 
sequencing, detailed metadata collection, a reproducible sequencing pipeline and robust multivariate statistical 
analysis. The major limitation of our study was the use of a single sampling time point, which precludes us 
from studying intra-individual variability or exploring changes in bacterial profiles and associated risk factors 
over time. 
5.5 CONCLUSION 
We used 16S rRNA gene sequencing to characterize the HBM bacteriome of a large cohort of mothers 
living in South Africa. We showed that the HBM bacteriome was dominated at the phylum level by Firmicutes 
and Actinobacteria, and at the genus level by Staphylococcus, Streptococcus and Rothia. We identified three 
major microbiome profile groups, defined by the relative abundances of Staphylococci and Streptococci. We 
found little evidence of the association of various socio-economic or psychosocial variables with the HBM 
bacteriome, but we showed that maternal age, infant birth length, and study site were associated with 
composition of the HBM bacteriome.   
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CHAPTER 6 
HUMAN BREAST MILK BACTERIAL DYSBIOSIS IS ASSOCIATED WITH 
LACTOSE FERMENTATION AND POOR BREAST-FEEDING OUTCOMES 
107 
 
Abstract 
Human breast milk (HBM) is universally regarded as the optimal source of nutrition for the growing infant, 
however the impact of variation in the different components of HBM on breastfeeding outcomes is not fully 
understood. In particular, the relationship between the HBM metabolome and microbiome has not been well-
studied. Here we show that a dysbiotic HBM microbiota is associated with evidence of fermentation of lactose 
in HBM, low lactose concentration and poor breastfeeding outcomes. We identified a subset of 45/519 (8.7%) 
South African lactating mothers with markedly reduced HBM lactose concentrations. Mothers with low-
lactose (vs normal lactose) HBM had reduced median duration of exclusive breastfeeding (27.6 vs. 55.2 days) 
and their infants grew less well during the period of exclusive breastfeeding (reduced weight and length z-
scores). Metabolomic profiling of low-lactose HBM revealed an increase in metabolites associated with mixed 
acid fermentation (characteristic of microbial carbohydrate metabolism) and depletion of metabolites in the 
tricarboxylic acid cycle. We therefore explored the bacterial composition of HBM using 16S rRNA amplicon 
sequencing and showed that the bacterial composition in samples with low lactose was markedly different 
from those with normal lactose. Low-lactose HBM had a strikingly higher median relative abundance of 
Staphylococcus species (19.0% vs. 5.0%), lower abundance of Streptococcus species (32% vs. 58%) and 
increased bacterial load. Since the HBM microbiota is a potentially modifiable risk factor, this may provide 
opportunity for diagnostic and therapeutic intervention to avert poor breastfeeding outcomes. These findings 
should be explored in other populations to identify women and their infants at risk. 
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6.1 INTRODUCTION 
Human breast milk (HBM) is a complex physiological fluid universally regarded as the optimal source of 
nutrition for growing infants (1-3). It consists of essential nutrients including fatty acids, carbohydrates and 
protein, a host of non-nutritive bio-molecules including glycoconjugates, oligosaccharides, and anti-microbial 
peptides, and a resident microbial flora (4, 5). Despite the importance of HBM in infant health (6), the 
relationship between the HBM metabolome and bacteriome has not been comprehensively characterized in 
large studies, and related to infant health and growth.  
6.2 MATERIALS AND METHODS 
6.2.1 Subjects and sample collection 
This cross-sectional study was nested within a birth cohort study, the “Drakenstein Child Health Study” 
(DCHS) which aims to investigate the early life determinants of child health within the Drakenstein sub-
district in South Africa (7). Pregnant women, 18 years of age or older (n = 1137), were recruited antenatally 
from clinics within the Drakenstein sub-district, Western Cape, South Africa between 20- and 28-weeks’ 
gestation and were followed up until their infants were 5 years old. On recruitment, detailed demographic and 
risk factor data were collected (7). HBM samples were collected from 554 women at 5-10 weeks postpartum. 
To ensure a narrow collection window, HBM samples collected before 5 weeks and after 10 weeks (n=35) 
were excluded from further analysis. None of the women described difficulties with breastfeeding at the time 
of breast milk collection. Women were asked to wash their hands, nipples and surrounding breast area with 
soap and water. Milk was collected manually by hand expression into a sterile collection bottle after 
discarding the first few drops. After collection, the samples were immediately refrigerated at 4 oC for a 
maximum of 4 hours, then transported on ice to the laboratory and then stored at −80 oC until further 
processing. Ethical approval for the present study and DCHS study was obtained from the Human Research 
Ethics committee of the University of Cape Town (reference numbers 649/2016 and 401/2009). 
6.2.2 Demographic and growth measures 
Socio-demographic and health information were obtained from questionnaires administered to mothers during 
antenatal and postnatal study visits. Birthweight and length were measured at the hospital. Gestational age at 
birth was estimated based on an antenatal ultrasound carried out in the second trimester. Trained study staff 
collected serial anthropometric measurements on the infants across 8 different time points (weeks+days: 5+0-8+6, 
9+0-11+6, 12+0-19+6, 20+0-34+6, 35+0-45+6, 46+0-70+6, 71+0-95+6, 96+0-120+6). Infant length was measured in 
centimetres to the nearest completed 0.5 cm, and weight was measured in kilograms to the nearest completed 
10 g. Maternal height was measured to the nearest 0.1 cm at enrolment. BMI was calculated using weight in 
kilograms divided by length in centimetres squared. All anthropometric measurements were carried out twice 
for each child, with a third measurement if the difference between the first and second measurement differed 
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by more than 0.5 cm for length or more than 0.5 kg for weight. Birth weight, length, and BMI were converted 
to z-scores for gender and gestational age using the INTERGROWTH-21st standards (8). Infants were 
classified into low birthweight (LBW) if they weighed less than 2500g at birth, preterm if born at less than 37 
weeks of gestational age and small for gestational age (SGA) if weighted less than the 10th percentile for 
gestational age, based on gender and gestational age. Corrected gestational age was used to calculate the WHO 
z-score for preterm infants. The weight and length measurements following birth were converted to z-scores 
based on age and gender, using Anthro software (9). Weight-for-age z-scores (WFAZ), height-for-age z-scores 
(HFAZ) and BMI for age z scores (BMIZ) were calculated.  
Infant feeding practice was categorized based on the World Health Organization’s (WHO) Infant and Young 
Child feeding indicators, namely exclusive breastfeeding or mixed feeding, which included infant cow milk-
based formula with or without breastmilk or semisolids (10). 
Validated questionnaires were administered to mothers at the 28-32 week antenatal visit to assess psychosocial 
factors. Beck’s Depression Inventory is a self-report measure of depressive symptoms that assesses key 
symptoms of depression between 0 (absence of symptom) and 3 (severe, often with functional impairment). 
Individual items are summed and ≥ 20 is indicative of moderate/severe depression (11, 12). The Self-
Regulation Questionnaire (SRQ) is a WHO-endorsed self-report measure assessing psychological distress in 
which individual items are scored according to whether or not the symptom is present; score ≥ 8 is indicative 
of “high risk” participants (13, 14). Post-traumatic Stress Disorder (PTSD) was measured by the Modified 
PTSD Symptom Scale (MPSS) (15) which is a self-report measure with scale including items which assess 3 
symptom clusters for PTSD. An intimate partner violence (IPV) questionnaire was used to assess recent 
exposure to physical, emotional and sexual IPV as previously described (16). Exposure was categorized as 
above the threshold if a participant reported more than one incident of IPV during the previous year. 
Peritraumatic Distress Inventory (PDI) is a self-report measure assessing the level of distress experienced 
during and immediately after a traumatic event with each item that assesses symptoms of distress related to the 
event scored between 0 (“not at all”) and 4 (“extremely”) (17). 
The Alcohol, Smoking and Substance Involvement Screening test (ASSIST) was used to assess maternal 
alcohol consumption based on a scoring system as previously described(16). Scores of 0–10 for 
alcohol indicate that a participant is at low risk for substance-related health problems. Tobacco smoke 
exposure was measured using maternal urinary cotinine levels at antenatal visit. A urinary cotinine level of 
≥500 ng/mL was used as the threshold to categorize mothers into active smokers. Maternal diet was assessed 
at 6 weeks postpartum with a validated food frequency questionnaire (18). 
6.2.3 Human breast milk sample preparation 
HBM samples were homogenized by vortexing and skim milk was prepared using an adaptation of a 
previously published protocol (19). In brief, 1 ml of each sample was centrifuged at 3500 g, -10 °C for 20 
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mins to remove the fatty layer. The remaining sample was thereafter centrifuged at 7600 g for 10 mins at room 
temperature to sediment the pellets. 800 µL of sample supernatant was collected into tubes and stored at -80 
°C for NMR processing, whilst pellets were stored at -80 °C for bacterial profiling.  
NMR experiments were carried out at the Centre for Human Metabolomics, Potchefstroom, South Africa. 
Samples were filtered using a pre-rinsed 2ml Amicon® Ultra 10 kDa centrifugal filter unit (Merck; Ref 
UFC201024) by centrifuging at 4500 g for 30 mins to remove residual lipids and protein. The filter was pre-
rinsed twice with distilled water by centrifugation at 4500 g for 15 mins to remove trace amounts of glycerol 
and glycerin from membrane filters. A 60 μl volume of NMR buffer solution (pH 7.4) was added to 540 µL 
filtrate in a microcentrifuge tube. The NMR buffer solution consisted of 1.5 M potassium phosphate buffer 
(pH 7.4) in deuterium oxide and 5.805 mM of trimethylsilyl-2,2,3,3-tetradeuteropropionic acid (TSP; Sigma-
Aldrich, St. Louis, MO, USA). A trace amount of sodium azide was included in the buffer to prevent bacterial 
growth in the sample. A 600 µL filtrate-buffer solution was mixed under vortex to ensure complete 
homogeneity and transferred to a 5 mm NMR tube (Wilmad Royal Imperial; Wilmad LabGlass, USA). A total 
of 6 samples were excluded from the analysis because their sample preparation did not reach the standard of 
quality. 
6.2.4 Nuclear magnetic resonance (NMR) profiling 
Samples were measured at 500 MHz on a Bruker Avance III HD NMR spectrometer (Bruker Analytische 
Messtechnik, Karlsruhe, Germany) equipped with a triple-resonance inverse (TXI) 1H probe head and x, y, z 
gradient coils. 1H NMR spectra were acquired as 128 transients in 32K data points with a spectral width of 
6002 Hz and acquisition time of 2.72 sec (relaxation delay time of 4s; 8μs (90°) pulse; sample temperature 
300 K). Receiver gain was set to 64 and water suppression was by single frequency irradiation focused on H2O 
resonance. Shimming of the samples was performed automatically on the deuterium signal. The resultant raw 
spectral data were Fourier transformed. These transformed spectra were automatically corrected for phase and 
baseline using Bruker Topspin (V3.5) (Bruker Biospin, Germany). Spectra were calibrated in automation to 
the TSP signal (0.00 pm). Spectral regions belonging to water (4.70–5.00 ppm) and urea (5.68–5.96 ppm) 
were removed from subsequent analysis. Spectral analysis was by “fixed-width” binning - dividing the spectra 
into set widths of 0.02 ppm.  
Identification of signals was undertaken using the SBASE database in Amix (v3.9.11; Bruker BioSpin, 
Germany) or available assignments in the literature (20). A commercial spectral library from Bruker, along 
with pure compound spectral libraries of oligosaccharides (Elicityl-OligoTech®, France), were used to 
identify HMO signals. In addition, two-dimensional analysis (JRES and COSY) of pooled HBM samples was 
done to confirm metabolite identification. The peaks of the identified metabolites (Appendix 3, Table 6) were 
fitted by a combination of Voigt functions based on the multiplicity of the NMR signal (21) using an in-house 
R script. The absolute concentration of each metabolite was calculated according to the equation described by 
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Serkova et al (22). To consider the variability introduced by the preparation of the NMR samples, the area of 
the spectra was corrected using the area of TSP (Appendix 3, Figure 1A) with the following formula: 
Ni = 1 - (TSPi x 0.1 / TSPmedian) 
Where N is the coefficient multiplied to ith spectrum, TSPi is the area of the TSP signal of the i
th spectrum, and 
TSPmedian is the median value of the TSP signals. 
Pooled supernatant from all HBM samples was used as a quality control sample and was included in each 
batch for qualitative assessment of repeatability by overlaying the raw spectra. No notable deviations were 
detectable (Appendix 3, Figure 1B). We did not detect any deviations in the lactose concentration among the 
quality control samples (Appendix 3, Figure 1C). 
The HMO phenotype of each sample was assigned according to the presence of 3’FL, 2’FL and LNDFH I 
HMOs as described in the Appendix 3, Figure 2. 
6.2.5 Human breast milk bacterial profiling by 16S rRNA amplicon sequencing 
Total genomic DNA was extracted from pellets using the ZR Fungal/Bacterial DNA MiniPrep™ (Zymo 
Research Corp., Irvine, USA), which incorporates a bead-beating step. DNA yield was assessed using a 16S 
qPCR protocol previously described (23). PCR amplicon libraries were constructed using a two-step 
amplification approach described by Wu and colleagues (24) to avoid PCR amplification biases associated 
with the use of adapter and index sequences. The hypervariable V4 region of the 16S rRNA gene was 
amplified as previously described (25) with primers containing Illumina adapters and various unique index 
sequences at the 3’ end for each sample (26). Amplicons were normalized by pooling at an equimolar 
concentration of 100 ng, and purified using the Agencourt AMPure system (Beckman Coulter, UK). Excision 
of the pooled 16S library was followed by purification using the QIAquick Gel Extraction Kit (Qiagen, 
Valencia, CA, United States). The Qubit® dsDNA BR Assay Kit was used for final quantification of the 
pooled library. The quantitation of adapter-ligated dsDNA and analysis of fragment size of the pooled library 
was done with the KAPA Library Quantification Kit (Illumina®) (KAPA Biosystems, MA, USA) and Agilent 
High-Sensitivity (HS) DNA Kit (Agilent Technologies, CA, USA), respectively. The library pool was diluted 
to 5.5 pM for sequencing and the internal sequencing control (PhiX control V3, Illumina, CA, USA) was 
spiked into the diluted library at 15% (v/v)(27). The pooled 16S library was paired-end sequenced on the 
Illumina MiSeq® system using the MiSeq® Reagent v3 kit (600 cycles) according to the manufacturer’s 
instructions (27). Reagents used for DNA extraction and PCR amplification were also sequenced as no 
template controls. 
6.2.6 Processing of 16S rRNA gene sequences 
The quality of FASTQ files was assessed using FastQC and MultiQC packages (28, 29). Forward and reverse 
sequences were then merged using UPARSE (30) allowing 3 mismatches in overlaps (uparse_merge_fastq, 
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fastq_maxdiff set to 3), followed by quality filtering using uparse_filter_fastq  fastq_filter (sequences 
truncated to 250bp). Reads with a maximum expected error >0.1 were discarded (fastq_maxee set to 0.1). 
USEARCH10 (31) sortbysize command allowed for dereplication and selection of sequences occurring more 
than once. Clustering of sequences into operational taxonomic units (OTUs) (with a clustering radius of 3) was 
performed with USEARCH10. The USEARCH10_uchime2_ref tool was used to remove chimeras, and OTU 
counts were obtained using USEARCH10 usearch-global. OTU picking was at 97% sequence identity and 
taxonomic assignment was carried out using assign_taxonomy.py (method set to Ribosomal Database Project 
(RDP)) Classifier (32) and identity was set to 97% with SILVA 132 release database (33) in Quantitative 
Insights Into Microbial Ecology (QIIME) 1.9.0 suite of software tools (34). The dataset supporting the bacteria 
profiling results of this article is available in the National Center for Biotechnology Information (NCBI) 
Sequence Read Archive (SRA) repository (BioProject PRJNA520889). 
6.2.7 Statistical and data analysis 
Statistical analysis and graphical illustrations of the data were generated in R statistical package (version 
3.4.4) (35) and R studio 1.1.456 using scripts developed in-house. The Iglewicz and Hoaglin outlier test (36) 
was used to classify the HBM samples into low and normal level of lactose based on the lactose concentration. 
P less than 10-3 was considered significant.  
Wilcoxon Rank Sum test (37) and Kruskal-Wallis Rank Sum Test (38) were used to compare differences in 
numerical covariates (e.g., maternal age). Fisher's exact test (39) was used to assess differences between 
categorical variables (e.g., ethnicity). Kaplan–Meier plot (40) was used to visualize the difference of the 
percentage of exclusive breastfeeding between low and normal lactose level across time. The Wald test was 
used to calculate the statistical significance (P) of the differences between curves. Spearman rank correlation 
was used to explore the relationships of lactose across time postpartum. PCA was performed on the processed 
spectra to obtain an overview of the structure of the data. The KODAMA algorithm was used to facilitate 
identification of patterns representing underlying metabolic phenotypes on all samples in the data set. A fuzzy 
version of the known k-means clustering algorithm (41) was used to identify the different bacterial signatures 
in the KODAMA plot. Only entries with membership grades higher than 60% were considered in the 
classification of the bacteria signatures. Dendrograms were performed using Euclidean distance and Ward 
linkage. P<0.05 was considered to be significant. To account for multiple testing, a false discovery rate (FDR) 
of <20% was applied (42). 
6.3 RESULT AND DISCUSSION 
6.3.1 Participant characteristics  
Here, we characterized HBM samples from 519 women enrolled in a birth cohort study, the Drakenstein Child 
Health Study (7). The socio-demographic features of the study participants are shown in Appendix 3, Table 1. 
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Many participants are poor with 41% of women having a mean household income of less than US$70 per 
month. HIV infection among mothers was low (9%). Each woman donated a HBM sample between 5 and 10 
weeks postpartum.  
6.3.2 Metabolic profiles of human breast milk (HBM) cluster according to lactose level and HMO 
phenotype.  
We first used Nuclear Magnetic Resonance (NMR) spectroscopy to identify lactose (Figure 6.1) and 
characterize the specific pattern of fucosylated human milk oligosaccharides (HMOs) of each sample (Figure 
6.2A). The fucosylation pattern of HMOs correlates with the activity of the enzymes, α1,2 fucosyltransferase 
(FUT2) and α1,3/4 fucosyltransferase (FUT3), encoded by the Secretor gene (Se) and the Lewis gene (Le) 
respectively (43, 44) (Figure 6.2B). We identified HMO phenotypes (i.e., Se+/Le+, Se-/Le+, Se+/Le- and Se-
/Le-) based on the presence of 3′ fucosyllactose (3′FL), lacto-N-fucopentaose I (LNFP I), and lacto-N-
difucohexaose I (LNDFH I) in the NMR spectra of HBM samples (Figure 6.2B). Se+/Le+ was the largest 
group, with 310 women, followed by Se-/Le+, Se+/Le- and Se-/Le- phenotypes with 120, 84 and 5 women 
respectively (Appendix 3, Table 1). 
 
Figure 6. 1: 1H-NMR spectrum of a representative HBM sample. Representative HBM sample showing NMR signals 
of lactose. 
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Figure 6. 2: Distinct metabolic profiles of human breast milk (HBM) are observed based on HMO phenotype. (A) 
HMO phenotype detection using the NMR signals of 3’-FL, 2’-FL and LNDFHI. (B) Graphical representation of the 
enzymatic processes that lead to the different HMO phenotypes. The figure was adapted from Bode 2012 (45). 
FUT2=Fucosyltransferase 2; FUT3=Fucosyltransferase 3; 3’-FL=3'-fucosyllactose; 2’-FL=2'-fucosyllactose; LNDFH 
I=Lacto-N-difucohexaose I.  
 
Next, we performed unsupervised analysis of the NMR spectra to explore patterns representing underlying 
metabolic phenotypes on all samples. Although separation among the different HMO phenotypes was 
observed (Figure 6.3A-B), a subset showed a distinct metabolic signature characterized by a substantially 
lower lactose concentration than other samples (Figure 6.3B). We identified 45 (8.7%) samples with atypically 
low lactose concentration (Figure 6.3C) below a threshold of 128 mM (4.4 g/dL). We then investigated if the 
Se/Le status, could affect the concentration of lactose (Figure 6.3D). We show reduced concentration of 
lactose with presence of FUT2 and/or FUT3 however this did not account for the strikingly lower levels of 
lactose in the low-lactose subset. We also did not observe any statistically significant correlation between 
lactose concentrations and time postpartum, within the 5-10 week window for collection (Figure 6.3E).  
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Figure 6. 3: Metabolic profiles of human breast milk (HBM) cluster according to lactose levels and HMO 
phenotype. (A) Principal components analysis (PCA) and, (B) unsupervised Knowledge Discovery by Accuracy 
Maximization (KODAMA) of HBM metabolic profiles.  Major variance in the dataset, which was driven mainly by the 
lactose concentration, was explained by the first component of PCA (PC1). KODAMA shows separation of samples 
based on lactose concentration. (C) Distribution of lactose concentration and classification into low (pink) and normal 
(green) lactose levels. (D) Lactose concentration within the four different HMO phenotypes. P value is calculated by 
Wilcoxon rank sum test on the normal lactose level subset. (E) Lactose concentration over time postpartum. Spearman’s 
coefficients (ρ) and P values are calculated on the normal lactose level subset. 
 
6.3.3 Low lactose level associates with reduced duration of exclusive breastfeeding, lower infant 
growth and metabolites from mixed acid fermentation.  
Since lactose is the major carbohydrate in HBM and plays a key role as a source of energy for the infant (46, 
47), we explored the relationship between reduced lactose concentration and breastfeeding and infant 
outcomes. Strikingly, the median duration of exclusive breastfeeding was half as long (27.6 vs. 55.2 days, 
P=2.61x10-4) in mothers with low (n=45) vs. normal (n=474) lactose concentrations (Figure 6.4 and Appendix 
3, Table 2). 
 
Figure 6. 4: Low lactose level in human breast milk (HBM) associates with reduced duration of exclusive 
breastfeeding. Kaplan-Meier plot shows duration of exclusive breastfeeding as assessed at the different clinic visits 
(Wald test was used to detect significance). HR: Hazard ratio. Low lactose samples are coloured pink and normal lactose 
samples green. 
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The proportion of calories from carbohydrate in HBM has been reported to positively correlate with infant 
weight, BMI and adiposity gains (48). Here, we found that infants breastfed by mothers with low HBM lactose 
had poorer anthropometric measures of growth, including lower z-scores for body length, body weight, and 
BMI; the differences in weight and BMI z-scores disappeared after the end of the exclusive breastfeeding 
period (Figure 6.5, Appendix 3, Table 3). The effect of low HBM lactose on infant length lasted longer (until 6 
months) than the effect on weight, presumably since weight is a measure of acute nutritional status whilst 
length reflects longer-term effects.   
We compared socio-demographic and psychosocial features between the groups of women whose HBM had 
normal and low levels of lactose (Appendix 3, Table 2). Low lactose level was more common amongst 
younger women (P=1.21x10-2, Wilcoxon rank sum test). Daily consumption of organ meat, such as liver, 
heart, kidney, and tripe was less frequent (P=2.01x10-2, Wilcoxon rank sum test), while daily consumption of 
fruit juice (P= 2.46x10-2, Wilcoxon rank sum test) and cold drink (P= 2.79x10-2, Wilcoxon rank sum test) were 
more frequent amongst women with low HBM lactose. Mothers with low HBM lactose were more likely to 
score above the threshold on Beck’s Depression Inventory (P=1.20x10-2, Fisher’s exact test). Whilst we have 
few data on sleep or feeding patterns in the two groups, it would be interesting to explore the relationship 
between these patterns, low lactose HBM and maternal depression. 
 
 
Figure 6. 5: Low lactose level in human breast milk (HBM) associates with lower infant growth. (A) Infant weight 
z-scores, (B) Infant height z-scores, and (C) Infant BMI z-scores at different study visits based on the level of lactose in 
the HBM. Low lactose samples are coloured pink and normal lactose samples green. 
 
Next, we quantified 50 metabolites in all HBM samples (Appendix 3, Table 6) and we noted that the metabolic 
profile of samples with low lactose was very different from samples from the rest of the cohort (Figure 6.6A; 
Appendix 3, Table 4). Low lactose HBM samples showed evidence of mixed acid fermentation of lactose, 
with accumulation of pyruvate, lactate, acetate and formate, and a substantial reduction in all energetic 
117 
 
metabolites in the Krebs cycle (Figure 6.6B). Mixed acid fermentation is characteristic of microbial 
metabolism. Lactose is a major substrate for some micro-organisms including lactic acid bacteria which 
naturally occur in breast milk (49). There was also an increased concentration of uracil and its glycosylated 
form, uridine, in samples with low lactose (Figure 6.6B). Uridine is a precursor of uridine diphosphate (UDP) 
that plays a key role in the Leloir pathway to convert galactose (lactose is a disaccharide comprising galactose 
and glucose) into glucose. 
 
 
Figure 6. 6: Low lactose level in human breast milk (HBM) associates with metabolites from mixed acid 
fermentation. (A) Heatmap of metabolite concentrations in HBM samples. The samples were ordered based on the 
lactose concentration and metabolites using a hierarchical clustering algorithm. LNDFH II=Lacto-N-difucohexaose II; 
LNDFH I=Lacto-N-difucohexaose I; LDFT= Lactodifucotetraose; LNFP III= Lacto-N-fucopentaose III. (B) Schematic 
representation of metabolic changes in HBM samples with low lactose levels. Low lactose samples are coloured pink and 
normal lactose samples green. 
6.3.4 Human breast milk (HBM) samples with low lactose level are associated with distinct 
bacterial profiles. 
To evaluate the hypothesis that the depletion of lactose could be caused by fermentation associated with 
bacterial dysbiosis, we performed 16S rRNA gene amplicon sequencing (bacterial community analysis). In 
Figure 6.7A, we show bacterial profiles in HBM samples. We noted a strong association between bacterial 
profiles and lactose concentration. Strikingly higher abundance of Staphylococcus (order: Bacillales) and a 
lower abundance of Streptococcus and Lactobacillus (order: Lactobacillales), traditionally identified as using 
lactose as a substrate, was observed among low-lactose HBM samples. In addition, Rothia, Gemella and 
Veillonella which are members of the oral flora were also significantly lower among low-lactose HBM 
samples (Figure 6.7B, Appendix 3, Table 5). Staphylococcus is able to utilize lactose as energy source, with 
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particular animal-associated strains showing increased efficiency of lactose fermentation (50). We also 
observed a significantly higher absolute abundance of bacterial DNA in HBM with low lactose levels, as 
measured by quantitative polymerase chain reaction (PCR) targeting the 16S rRNA gene (Figure 6.7C). 
 
 
Figure 6. 7: Low lactose samples are associated with distinct bacterial profiles. (A) Relative abundances of HBM 
bacterial genera ordered based on the lactose concentration. Genera with a low relative abundance in a given sample are 
included as “Others”. (B) Boxplot showing differences in relative abundances of the most abundant bacterial genera 
between samples with low and normal lactose level, ** P<0.01, *** P<0.001. The line inside the box plot represents the 
median, while the box signifies the 75% (upper) and 25% (lower) quartile showing the distribution of 50% of the 
samples. P is calculated by Wilcoxon rank sum test. (C) 16S qPCR DNA copies/ul values of samples with low vs. normal 
lactose levels. The line inside the box plot represents the median, while the box signifies the 75% (upper) and 25% 
(lower) quartile showing the distribution of 50% of the samples. P is calculated by Wilcoxon rank sum test. 
 
Unsupervised analysis of HBM bacterial profiles (Figure 6.8A) revealed three bacterial signatures, 
distinguished by the relative abundances of Staphylococcus spp. and/or Streptococcus spp (Figure 6.8B). We 
observed a higher percentage of samples with low lactose in signature 2 dominated by Staphylococcus spp. 
Mastitis, an infection of the breast tissue in breastfeeding women, is most commonly caused by staphylococcal 
infection (51) and has previously been associated with relatively lower levels of lactose in HBM (52, 53). The 
women in our cohort did not report symptoms of mastitis, however it is possible that sub-clinical mastitis may 
have been present. Whilst the phenomenon of subclinical mastitis has been reported in animals in the dairy 
industry (54, 55), it is not widely recognized as a distinct condition in humans. 
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Figure 6. 8: Low lactose samples are associated with distinct bacterial signatures. (A) Unsupervised KODAMA of 
the HBM bacterial profile data showing three different bacterial signatures. (B) Boxplots of the relative abundance of 
major bacterial genera in the three different signatures and proportion of samples with low lactose. Low lactose samples 
are coloured pink and normal lactose samples green throughout. 
6.4 CONCLUSION 
In summary, we describe here a subset of breastfeeding women whose HBM had very low levels of lactose. 
Low lactose was associated with reduced duration of exclusive breastfeeding and poorer infant growth during 
the period of exclusive breastfeeding. Low lactose concentration was associated with HBM bacterial dysbiosis 
(evidence of mixed acid fermentation of lactose by an HBM bacteriome dominated by staphylococci). Our 
study has several limitations.  
Despite the large sample size, the population studied comes from a single semi-rural geographical setting. This 
was a cross-sectional study with only one sampling time point; we were not able to assess whether this 
phenotype is persistent. Further work is required to determine whether this finding is generalizable to other 
populations or stages of lactation. If these findings are replicated in other populations, they may have 
relevance for the health of mother and child populations, and consideration should be given to diagnostic and 
therapeutic studies.    
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CHAPTER 7  
GENERAL CONCLUSIONS  
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HBM is a unique physiological fluid adapted for the growth and wellbeing of an infant. Its composition is 
complex; this thesis focuses on two components: the bacteriome and metabolome. The HBM bacteriome is 
diverse but understudied. We used culture independent techniques, specifically, next generation sequencing to 
explore its composition and determinants. The metabolome also has an important role in infant health and is 
increasingly studied for its nutritive and bioactive molecules; here we studied the metabolome in the context of 
the associated microbiome. 
In the first two chapters, we reviewed the scientific literature on the constituents of the HBM bacteriome and 
metabolome, the role they play in infant health and well-being, and their determinants including maternal, 
infant and environmental factors. We also identified existing gaps in HBM research – and these include 
limited studies on HBM bacteriome and metabolome and their influencing factors in low socio-economic 
regions, particularly in African populations. Furthermore, there are few integrative studies exploring the 
interplay between the HBM bacteriome and the metabolome, and their collective role in infant health and 
growth. 
The first part of the original research towards this thesis highlighted the importance of optimisation of 
laboratory technical procedures in HBM bacteriome research, including DNA extraction as well as milk 
skimming on HBM bacterial profiles. Illumina MiSeq sequencing targeting the V4 region of the 16S rRNA 
gene was used to assess the bacterial profiles using ten healthy donor breast milk samples. Although 
optimization of DNA extraction kits has been conducted on other biological samples, to the best of our 
knowledge, this is the first of such studies to be published on HBM samples. We showed that DNA extraction 
kits, but not milk skimming, impacted significantly on both DNA yield and purity, the recovery of specific 
bacterial genera, and the efficiency of DNA extraction from bacterial communities present in a commercial 
mock microbial community standard spiked into HBM. Although the extraction kits all gave similar bacterial 
diversity measures, the relative abundances of bacteria obtained with each kit differed. An interesting 
observation was the influence of benzonase pre-treatment on DNA recovery, a step included in one of the kits 
used in this optimisation step. Benzonase treatment led to low DNA yield, and biased representation of 
bacteria in the mock community. Since this kit is routinely recommended for microbiome studies, optimization 
of extraction kits and methods is important as this influences the downstream analysis of next generation 
sequencing experiments. 
The result of this optimisation was that ZR Fungal/Bacterial DNA MiniPrep™ was chosen for further DNA 
extraction from HBM samples. This was based on the higher DNA yield obtained, best DNA purity measures, 
and its ability to most accurately represent the bacteria in the mock community.  
In the next research chapter of this thesis, the bacteriome of HBM in a cohort of lactating women living in 
South Africa was comprehensively described. By analysing the V4 region of the 16S rRNA gene of HBM 
bacterial communities, we confirmed that a diverse bacteriome exists. We identified a core bacteriome that is 
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shared among 80% of samples. Three bacterial cluster groups (biotypes) were identified based on the relative 
abundances of Staphylococcus and/or Streptococcus. Inter-individual variability was observed in the bacterial 
profiles of samples.  A major strength of this study is the detailed metadata collected. A robust multivariate 
statistical analysis showed that study site (a proxy for ethnicity) was an important factor associated with the 
composition of the HBM microbiome. While the HBM samples from Mbekweni had significantly higher 
relative abundance of the genus Streptococcus (which has been associated with health), HBM samples from 
TC Newman had significantly higher relative abundances of the genera Staphylococcus, Acinetobacter, and 
Escherichia Maternal age influenced the diversity of HBM bacterial profiles, with older mothers having a 
higher Shannon diversity index. Though limited by the cross-sectional design of this study, a longitudinal 
study would have afforded us the opportunity to study the determinants of the HBM bacteriome (i.e. 
antibiotics use, diet and maternal stress) over time.  
Lastly, correlations between bacterial abundances were observed within the HBM bacteriome, notably 
between bacteria that are members of the skin microbiota, and, separately, those that are members of the oral 
microbiota. Although not within the scope of this research, research has shown that HBM bacteria originates, 
among others, from the oral microbiome of the infant due to a retrograde flow of milk during suckling, and 
from the surrounding breast skin and areola which is open to the external environment. It is therefore not 
surprising to see interactions between bacteria based on the assumed origin. Being limited by the targeted 16S 
rRNA sequence analysis approach, we could not assess the functional capacity of the bacterial communities 
within the HBM. Future work will involve the use of shotgun metagenomic sequencing to comprehensively 
sample all genes of all bacterial organisms present to determine species-level identity and functional capacity 
and relate this to infant gut health. 
The final stage of this thesis investigated the metabolome of HBM. The nutritive and non-nutritive bio-active 
metabolites in HBM are considered extremely important in the first six months of life. We were able to detect 
a total of 49 metabolites from HBM samples included in this study, with nuclear magnetic resonance 
spectroscopy. More importantly, a subset of lactating women with unusually low lactose concentration in their 
HBM sample was detected in the cohort. This subset of women exclusively breastfed for shorter than the rest 
of the cohort, and their infants demonstrated lower growth during the period of exclusive breastfeeding. This 
subset of women also had a higher prevalence of depression. Metabolites characteristic of mixed acid 
fermentation were also observed in the HBM samples of this subset of women, and this was associated with a 
dysbiotic, staphylococcal-predominant microbiota. While the cross-sectional study design employed in this 
study and the peri-urban settings from which participants are recruited limits the generalizability of these 
results, the use of NMR spectroscopy provides new insight to detecting variability in HBM metabolites.  
In summary, this thesis presents a detailed description of the bacteriome, and metabolome in HBM samples 
using 16S rRNA gene amplicon sequencing and nuclear magnetic resonance spectroscopy respectively. We 
identified factors that influence the HBM composition and showed that HBM bacteriome and metabolome 
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modulates the growth of an infant and breastfeeding outcomes. The results presented in this thesis clearly 
highlight the need for further HBM research in an African setting. 
 
In addition to future work highlighted in each research chapter, future work will include: 
i. Characterizing the HBM lipidome in this cohort of lactating South African mothers enrolled in the 
Drakenstein Child Health Study. 
ii. Determining maternal, infant and environmental factors that influences the HBM lipidome in this 
cohort. 
iii. Investigating the association between HBM lipidome and infant growth in the first year of life and 
determining the association (if any) between these three components of HBM. 
  
127 
 
APPENDIX 1: Chapter 4 supplementary tables and figures 
Appendix 1, Table 1: Zymobiomics™ microbial community standard composition as per manufacturer’s 
specifications. 
 
Bacteria species gDNA abundance 
(%) 
mOTU abundance 
(%) 
Gram stain 
Pseudomonas spp. 12% 4.6 - 
Enterobacteriaceae 1 12% 11.3 - 
Enterobacteriaceae 2 12% 10.0 - 
Listeria spp. 12% 15.9 + 
Staphylococcus spp. 12% 13.3 + 
Lactobacillus spp. 12% 18.8 + 
Enterococcus spp. 12% 10.4 + 
Bacillus spp. 12% 15.7 + 
 
 
Appendix 1, Table 2: Primers, probes and cycling conditions 
  Forward primer Reverse primer Probe PCR cycling conditions 
A qPCR 16S-F1(5′-CGA AAG CGT 
GGG GAG CAA A -3′) 
16S-R1(5′-GTT CGT ACT CCC 
CAG GCG G-3′) 
16S-P1 (FAM-
 ATT AGA TAC 
CCT GGT AGT 
CCA –MGB 
                             45 cycles  
50 oC    95 oC     95 oC 60 °C 72 °C  
2min    10min   15s   60s    1s      
 
B Short 
PCR 
(515Fshort) 
GTGCCAGCHGCYGCGGT 
(806Rshort) 
GGACTACNNGGGTNTCTAAT 
-                10 cycles  
95 oC   95 oC   50 °C 72 °C 72 °C   4 °C 
3min   30s     30s    1s     5min     ∞ 
 
C Long 
PCR 
(515Flong) 
GTGCCAGCHGCYGCGGT 
(806Rlong_barcoded) 
GGACTACNNGGGTNTCTAAT 
-                30 cycles  
95 oC   95 oC   50 °C 72 °C 72 °C   4 °C 
3min   30s     30s    1s      5min   ∞ 
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Appendix 1, Figure 1: DNA yield and purity based on skim milk and whole milk. Notched box plots showing (A) the 
DNA yield and (B) the DNA purity (260/280 absorbance) obtained from skim and whole milk. The notched box signifies 
the 75% (upper) and 25% (lower) quartile showing the distribution of 50% of the samples. The line inside the box plot 
represents the median, and the notch the 95% confidence interval for the median. The whiskers (top and bottom) 
represent the maximum and minimum values. Outliers, which are beyond 1.5 times the interquartile range above the 
maximum value and below the minimum value, are shown with open circles. 
 
 
Appendix 1, Figure 2: 16SqPCR DNA concentration based on kit and milk type (skim milk and whole milk). 
Notched box plots showing the 16SqPCR DNA concentration obtained by using (A) the kits, and (B) skim and whole 
milk. The notched box signifies the 75% (upper) and 25% (lower) quartile showing the distribution of 50% of the 
samples. The line inside the box plot represents the median, and the notch the 95% confidence interval for the median. 
The whiskers (top and bottom) represent the maximum and minimum values. Outliers, which are beyond 1.5 times the 
interquartile range above the maximum value and below the minimum value, are shown with open circles. SM=skim 
milk, WM=whole milk. 
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Appendix 1, Figure 3: Complete linkage hierarchical clustering of human breast milk spiked with the microbial 
mock community standard. (A) Dendogram of bacterial profiles present in the HBM sample spiked with ZMCS 
processed as skim and whole milk using four DNA extraction kits. (B) Relative abundances of ZMCS bacterial 
composition in the HBM sample spiked with ZMCS. Each column represents milk type (skim or whole) extracted by one 
of the four kits. W: whole milk, S: skim milk; S2 and W2: replicates of S and W respectively. ZMCS: Zymobiomics 
Microbial Community Standard reference (“theoretical” bacterial profile) specified by the manufacturer. 
130 
 
Appendix 1, Table 3: Bacterial 16S DNA concentration in the spiked and un-spiked human breast milk sample.  
Sample_ID Spike/Unspiked_Kit 
Donor 
sample 
Template DNA 16SqPCR 
concentration (ng/ul) 
Median 16S qPCR DNA 
concentration 
%16S DNA in HBM 
sample 
BM_AO_KITdnam_extractioncontrolspike_1_kitcomparison_P3_A06 Spiked_Kit A 1 0.251124139 0.195487886 99.975% 
BM_AO_KITdnam_extractioncontrolspike_1_kitcomparison_P3_A07 Spiked_Kit A 1 0.175701367   
BM_AO_KITdnam_extractioncontrolspike_1_kitcomparison_P3_B06 Spiked_Kit A 1 0.215274404   
BM_AO_KITdnam_extractioncontrolspike_1_kitcomparison_P3_B07 Spiked_Kit A 1 0.047838204   
BM_AO_KITdnam_skim_1_kitcomparison_P3_C01 Unspiked_Kit A 1 0.000047258 0.000047105 0.024% 
BM_AO_KITdnam_skim_1_kitcomparison_P3_C08 Unspiked_Kit A 1 0.000046952   
BM_AO_KITdnam_whole_1_kitcomparison_P3_A01 Unspiked_Kit A 1 0.000068726   
BM_AO_KITdnam_whole_1_kitcomparison_P3_A08 Unspiked_Kit A 1 0.000045226   
BM_AO_KITqias_extractioncontrol_1_kitcomparison_P4_A06 Spiked_Kit C 1 0.332685221 0.151318187 99.983% 
BM_AO_KITqias_extractioncontrol_1_kitcomparison_P4_A07 Spiked_Kit C 1 0.293789111   
BM_AO_KITqias_extractioncontrol_1_kitcomparison_P4_B06 Spiked_Kit C 1 0.002849745   
BM_AO_KITqias_extractioncontrol_1_kitcomparison_P4_B07 Spiked_Kit C 1 0.008847263   
BM_AO_KITqias_skim_1_kitcomparison_P4_C01 Unspiked_Kit C 1 0.000060109 0.000025238 0.016% 
BM_AO_KITqias_skim_1_kitcomparison_P4_C08 Unspiked_Kit C 1 0.000024687   
BM_AO_KITqias_whole_1_kitcomparison_P4_A01 Unspiked_Kit C 1 0.000025790   
BM_AO_KITqias_whole_1_kitcomparison_P4_A08 Unspiked_Kit C 1 0.000020727   
BM_AO_KITzymob_extractioncontrol_1_kitcomparison_P4_G06 Spiked_Kit D 1 1.214408365 0.843423774 99.989% 
BM_AO_KITzymob_extractioncontrol_1_kitcomparison_P4_G07 Spiked_Kit D 1 0.397619204   
BM_AO_KITzymob_extractioncontrol_1_kitcomparison_P4_H06 Spiked_Kit D 1 0.792653652   
BM_AO_KITzymob_extractioncontrol_1_kitcomparison_P4_H07 Spiked_Kit D 1 0.894193897   
BM_AO_KITzymob_skim_1_kitcomparison_P4_G01 Unspiked_Kit D 1 0.000066957 0.000087592 0.01% 
BM_AO_KITzymob_skim_1_kitcomparison_P4_G08 Unspiked_Kit D 1 0.000108227   
BM_AO_KITzymob_whole_1_kitcomparison_P4_E01 Unspiked_Kit D 1 0.000059373   
BM_AO_KITzymob_whole_1_kitcomparison_P4_E08 Unspiked_Kit D 1 0.000198393   
BM_AO_KITzymo_extractioncontrol_1_kitcomparison_P3_G06 Spiked_Kit B 1 0.703367972 0.898759654 99.984% 
BM_AO_KITzymo_extractioncontrol_1_kitcomparison_P3_G07 Spiked_Kit B 1 1.094151336   
BM_AO_KITzymo_extractioncontrol_1_kitcomparison_P3_H06 Spiked_Kit B 1 0.654916126   
BM_AO_KITzymo_extractioncontrol_1_kitcomparison_P3_H07 Spiked_Kit B 1 1.123935714   
BM_AO_KITzymo_skim_1_kitcomparison_P3_G01 Unspiked_Kit B 1 0.000194474 0.000141692 0.015% 
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BM_AO_KITzymo_skim_1_kitcomparison_P3_G08 Unspiked_Kit B 1 0.000211923   
BM_AO_KITzymo_whole_1_kitcomparison_P3_E01 Unspiked_Kit B 1 0.000025031   
BM_AO_KITzymo_whole_1_kitcomparison_P3_E08 Unspiked_Kit B 1 0.000088910   
 
ZMCS: Zymobiomics Microbial Community Standard; HBM: Human breast milk 
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Appendix 1, Table 4: Beta diversity (Bray-Curtis dissimilarity index) measuring dissimilarity between 
Zymobiomics microbial community standard (ZMCS) and the milk type, for each of the kits. 
 
Milk type 
Kits Skim milk Whole milk 
Kit A vs. ZMCS 0.29 0.25 
Kit B vs. ZMCS 0.06 0.16 
Kit C vs. ZMCS 0.16 0.16 
Kit D vs. ZMCS 0.11 0.20 
 
 
Appendix 1, Figure 4: Alpha diversity rarefaction curve. A line graph relating the sequencing depth to 
Shannon diversity index of sequenced un-spiked breast milk samples at a sub-sampling depth of 100. 
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Appendix 1, Figure 5: Relative abundances of bacterial composition in un-spiked human breast milk 
samples at genus level. Each bar represents a sample and each coloured box, a bacterium. Genera less than 
0.5% abundance in a given sample are included in the “other” at the top of the graph (grey boxes). 
 
 
Appendix 1, Figure 6: Log ratio biplot human of human breast milk bacterial abundances at the 
phylum level. Samples are coloured according to (a) extraction kit used, and (b) whole and skim milk (c) 
donors. Points (circles) that cluster together are similar in bacterial composition and abundance. 
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Appendix 1, Figure 7: Log ratio biplot human of human breast milk bacterial abundances at the genus 
level. Samples are coloured according to (a) extraction kit used, and (b) whole and skim milk (c) donors. 
Points (circles) that cluster together are similar in bacterial composition and abundance. 
 
Appendix 1, Table 5: Differential abundances of statistically significant bacteria taxa in relation to extraction 
kits and milk type in un-spiked breast milk samples.  
Taxonomy level Kit B Kit C Kit D p-value 
KITS     
Proteobacteria 0.3436 0.4761 0.3772 0.005 
Alphaproteobacteria 0.0135 0.0162 0.0093 0.001 
Sphingomonadales 0.0058 0.0087 0.0039 <0.001 
   Rhodobacterales      
OTU_52          0.0712 0.0564 0.0561 0.035 
Betaproteobacteria 0.0294 0.089 0.0271 <0.001 
Burkholderiales 0.0244 0.0856 0.0242 <0.001 
Burkholderiaceae 0.007 0.0758 0.0176 <0.001 
Ralstonia 0.007 0.075 0.0175 <0.001 
Gammaproteobacteria    
Pseudomonadales 0.1157 0.2086 0.1607 <0.001 
Pseudomonadaceae 0.0167 0.0259 0.024 0.016 
Pseudomonas 0.0165 0.0259 0.024 0.016 
Pasteurellales  0.1109 0.2205 0.0045 <0.001 
Pasteurellaceae 0.011 0.2205 0.0045 <0.001 
Haemophilus 0.011 0.022 0.0045 <0.001 
Moraxellaceae     
Acinetobacter 0.0606 0.1544 0.1026 <0.001 
Firmicutes     
Bacillus     
Lactobacillales     
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Lactobacillaceae 0.1084 0.0632 0.1088 <0.001 
Lactobacillus 0.1084 0.0632 0.1088 <0.001 
WM/SM     
 Skim milk Whole milk   
Pseudomonadales 0.1948 0.1288 -- 0.009 
Moraxellaceae 0.1721 0.1068 -- 0.004 
Enhydrobacter 0.0078 0.0039 -- 0.002 
Acinetobacter 0.1353 0.0767 -- 0.003 
 
Mean values of relative abundance proportions for statistically significant bacteria at different taxonomy 
levels are shown. p-values are Benjamini-Hochberg corrected. p-values are represented as ‘***’ 0.001; ‘**’ 
0.01; and ‘*’ 0.05. WM and SM represents whole milk and skim milk respectively. 
 
Appendix 1, Table 6: Reproducibility of extractions tested using multiple R-squared. 
 Multiple R-square 
 Whole milk Skim milk 
Kit B 0.4908 0.7581 
Kit C 0.7421 0.4751 
Kit D 0.9483 0.7976 
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APPENDIX 2: Chapter 5 supplementary tables and figures 
 
 
 
Appendix 2, Figure 1: In-silico de-contamination of biological human breast milk samples.  
 
Appendix 2, Table 1: Demographic and clinical characteristics of mothers and their infants 
 
Mbekweni TC Newman Both study sites 
Maternal demographic and psychosocial characteristics 
   
Maternal age at enrolment (years),  
25.5 [18.5 39.5] 25.3 [18.7 39.6] 25.3 [18.6 39.6] 
median [95%CI] 
Maternal weight (kg), median [95%CI] 68.1 [48 110.6] 59.5 [42.7 95.3] 63.7 [43.7 102.3] 
Maternal BMI, median [95%CI] 26.7 [19.1 41.1] 23.6 [17.6 37.7] 25 [17.9 40.6] 
Lactation stage (weeks), median [range] 7.7 [5.3 19.5] 7.4 [2.4 18.7] 7.5 [2.4 19.5] 
Ethnicity, n (%) 
   
   Black African 244 (99.2%) 0 (0.0%) 244 (44.0%) 
   Mixed ancestry 2 (0.8%) 308 (100.0%) 310 (56.0%) 
Maternal education, n (%) 
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   Primary 152 (61.8%) 191 (62.0%) 343 (61.9%) 
   Secondary 72 (29.3%) 102 (33.1%) 174 (31.4%) 
   Tertiary 22 (8.9%) 15 (4.9%) 37 (6.7%) 
Mother employed, n(%) 56 (22.8%) 79 (25.6%) 134 (24.4%) 
Household income, n (%) 
   
   <ZAR1000/m 126 (51.2%) 99 (32.1%) 225 (40.6%) 
   >ZAR5000/m 17 (6.9%) 58 (18.8%) 75 (13.5%) 
   ZAR1000-5000/m 103 (41.9%) 151 (49.0%) 254 (45.8%) 
HIV infected mothers, n(%) 46 (18.7%) 6 (1.9%) 52 (9.4%) 
Maternal smoking status, n (%) 
   
   Active smoker 30 (12.9%) 154 (51.9%) 184 (34.8%) 
   Non-smoker 81 (34.9%) 30 (10.1%) 111 (21.0%) 
   Passive smoker 121 (52.2%) 112 (38.0%) 234 (44.2%) 
Infant feeding at 6-10 weeks, n (%) 
   
   Exclusive breastfeeding 131 (54.8%) 155 (51.2%) 286 (52.8%) 
   Mixed breastfeeding 108 (45.2%) 148 (48.8%) 256 (47.2%) 
Exclusive breastfeeding at 4 months, n (%) 66 (27.5%) 82 (27.0%) 148 (27.2%) 
Mode of delivery, n (%) 
   
   Elective C/S 18 (7.4%) 16 (5.2%) 34 (6.2%) 
   Emergency C/S 37 (15.2%) 34 (11.0%) 71 (12.9%) 
   Vaginal 189 (77.5%) 258 (83.8%) 447 (81.0%) 
Maternal PTSD, n (%) 
   
   No exposure 178 (83.6%) 243 (86.2%) 421 (85.1%) 
   Suspected PTSD 20 (9.4%) 16 (5.7%) 36 (7.3%) 
   Trauma exposed 15 (7.0%) 23 (8.2%) 38 (7.7%) 
Maternal BDI Threshold, n (%) 
   
   Above threshold 49 (22.5%) 77 (27.3%) 126 (25.2%) 
   Below threshold 169 (77.5%) 205 (72.7%) 374 (74.8%) 
Maternal SRQ Threshold, n (%) 
   
   Above threshold 41 (18.7%) 71 (25.2%) 112 (22.4%) 
   Below threshold 178 (81.3%) 211 (74.8%) 389 (77.6%) 
Household size, median [95%CI] 4 [1 11] 5 [2 12] 5 [2 12] 
Maternal alcohol score, median [95%CI] 0 [0 30.2] 0 [0 25.9] 0 [0 26] 
Infant characteristics 
   
Infant weight for age z-score, median [95%CI] -0.36 [-2.5 1.86] -0.74 [-2.92 1.06 -0.6 [-2.81 1.62] 
Infant height for age z-score, median [95%CI] 0.1 [-3.44 2.74] -0.27 [-3.44 2.11] 0 [-3.4 2.6] 
Infant gestational age, n (%) 
   
   Preterm 55 (22.4%) 71 (23.1%) 126 (22.7%) 
   Term 184 (74.8%) 230 (74.7%) 414 (74.7%) 
   Very preterm 7 (2.8%) 7 (2.3%) 14 (2.5%) 
Infant gender, n (%) 
   
   Female 122 (49.6%) 143 (46.6%) 265 (47.8%) 
   Male 123 (50.0%) 165 (53.6%) 288 (52.0%) 
   Triplets 1 (0.4%) 0 (0.0%) 1 (0.2%) 
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BMI=Body Mass Index; HIV= Human Immunodeficiency Virus; EBF=Exclusive breastfeeding; PTSD= post-
traumatic stress disorder; BDI= Beck Depression Inventory; SRQ= Self-Regulation Questionnaire; Smoking 
status was measured as Active smoker (cotinine levels ≥ 500); Passive smoker (cotinine levels 10 – 500); 
Non-smoker (cotinine levels ≤ 10). Term, Preterm and Very-preterm infants are infant with gestational age of 
>37 weeks, 32-37 weeks and 28-31.9 weeks respectively. C/S=caesarean section. 
 
 
 
Appendix 2, Figure 2: Alpha rarefaction curve relating the sequencing depth to Shannon diversity index of 
all sequenced breast milk samples.   
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Appendix 2, Figure 3: Bar-plot of relative abundances of bacteria genera. (A) Complete linkage 
unsupervised hierarchical clustering of bacterial abundances within the human breast milk bacteriome at 
Mbekweni study site (n =235). (B) Complete linkage unsupervised hierarchical clustering of bacterial 
abundances within the human breast milk bacteriome at TC Newman study site (n =287). Each bar represents 
a mother’s HBM bacteriome profile and each coloured box, a bacterial genus. Genera with less than 0.5% 
abundance in a given sample are grouped together, herein referred to as “other” (grey boxes).  
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Appendix 2, Table 2: Core taxa in human breast milk bacteriome. 
Phylum Class Order Family Genus OTU MRA of taxa in the cohort Percentage of women with specific taxa (%) 
Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus OTU_18 0.177 99.8 
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus OTU_20 0.222 99.6 
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus OTU_1 0.262 96.4 
Firmicutes Clostridia Clostridiales Veillonellaceae Veillonella OTU_33 0.015 84.5 
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus OTU_1557 0.002 83.3 
Firmicutes Bacilli Bacillales Family_XI_Incertae_Sedis Gemella OTU_42 0.006 83.3 
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus OTU_2110 0.001 82 
Actinobacteria Actinobacteria Corynebacteriales Corynebacteriaceae Corynebacterium OTU_34 0.012 98.3 
Actinobacteria Actinobacteria Micrococcales Micrococcaceae Rothia OTU_38 0.059 94.1 
Actinobacteria Actinobacteria Corynebacteriales Corynebacteriaceae Corynebacterium OTU_30 0.015 92.9 
Actinobacteria Actinobacteria Micrococcales Micrococcaceae Micrococcus OTU_41 0.013 92.5 
Actinobacteria Actinobacteria Corynebacteriales Corynebacteriaceae Corynebacterium OTU_113 0.003 84.9 
Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae Acinetobacter OTU_35 0.013 92.1 
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified OTU_24 0.02 86.2 
Core taxa in human breast milk bacteriome at different taxonomy levels.  Core is defined by the presence of taxa found in HBM from 80% of all mothers enrolled in the study. 
MRA=Mean relative abundance.  
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Appendix 2, Figure 4: Dendogram of relative abundances of bacteria in HBM samples at genus level. Hierarchical complete linkage unsupervised clustering on Bray-Curtis 
dissimilarities shows 11 clusters at a clustering of height 0.8. Cluster 1 (65 members), cluster 2(68 members), cluster 3 (319 members), cluster 4 (6 members), cluster 5 (31 
members), cluster 6 (3 members), cluster 7 (9 members), cluster 8 (5 members), cluster 9 (5 members), cluster 10 (3 members), and cluster 11 (8 members).  
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Appendix 2, Table 3: Mean relative abundance of dominant phyla and genera (>0.5%) across 
phenotypic clusters in HBM samples. 
 Cluster 1 Cluster 2 Cluster 3 p-value 
Shannon diversity 1.07 1.65 1.23 < 0.001 
Chao1 index 128.84 155.96 174.44 < 0.001 
Phylum     
Firmicutes 79.16 68.04 79.62 < 0.001 
Actinobacteria 10.93 18.22 14.1 < 0.001 
Proteobacteria 9 10.66 5.14 < 0.001 
Cyanobacteria 0.43 2.51 0.43 < 0.001 
Genus     
Staphylococcus 70.8 32.89 5.62 < 0.001 
Streptococcus 6 31.16 68.91 < 0.001 
Rothia 0.99 7.24 7.72 < 0.001 
Corynebacterium 6.16 5.57 2.45 < 0.001 
Acinetobacter 2.17 2.58 1.28 0.0144 
Chloroplast 0.4 2.5 0.35 < 0.001 
Micrococcus 1.01 1.49 0.73 0.057 
OTU_24 2.75 1.43 0.6 < 0.001 
Enhydrobacter 0.91 1.42 0.23 < 0.001 
Escherichia-
Shigella 
0.36 1.38 0.3 < 0.001 
Lactobacillus 0.1 1.08 0.95 0.101 
Bifidobacterium 0.7 0.81 0.71 0.956 
Veillonella 0.16 0.71 2.47 < 0.001 
Kocuria 0.39 0.52 0.45 < 0.001 
Gemella 0.12 0.44 0.74 < 0.001 
Pseudomonas 0.47 0.28 0.13 < 0.001 
 
Appendix 2, Table 4: Mean Shannon diversity and mean chao1 index of HBM bacteriome profiles 
across different socio-economic and psychosocial factors. 
 Shannon diversity      
 All samples  Mbekweni clinic  TC Newman clinic  
Covariates 
Mean Shannon 
diversity p-value Mean Shannon diversity p-value Mean Shannon diversity p-value 
Study site (Ethnicity)  0.535  -  - 
Mbekweni 1.343  -  -  
TC Newman 1.3882  -  -  
Mode of delivery 
 0.337  0.527  0.602 
Vaginal  1.3649  1.3287  1.3925  
Elective CS  1.5284  1.5303  1.526  
Emergency CS  1.3219  1.3486  1.2945  
Gestational age 
 0.492  0.201  0.5 
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Term  1.3655  1.3713  1.3606  
Pre-term  1.3773  1.2808  1.4565  
Very pre-term  1.3492  1.0337  1.6121  
Infant gender 
 0.886  0.388  0.386 
Male  1.3697  1.3594  1.3777  
Female  1.3651  1.3243  1.4004  
Infant feeding 
options  0.575  0.991  0.995 
Exclusive BF  1.3799  1.3434  1.4111  
Mixed BF  1.3519  1.3409  1.3602  
Maternal education  0.236  0.404  0.247 
Primary  1.3724  1.3454  1.3946  
Secondary  1.3661  1.3326  1.3895  
Tertiary  1.3371  1.3587  1.3053  
Maternal 
employment  0.277  0.459  0.423 
Working  1.4339  1.3209  1.4399  
Not working  1.3468  1.4247  1.3696  
Maternal BMI  0.667  0.443  0.645 
0-18.5  1.333  1.563  1.3089  
18.5-25  1.3521  1.3006  1.3877  
25-30  1.3585  1.4047  1.3138  
30-50  1.4453  1.4138  1.4825  
Infant birth weight  kg 0.346  0.929  0.264 
0-2.5  1.3297  1.3525  1.3176  
2.5-4.5  1.3738  1.395  1.4042  
Infant birth length  cm 0.041*  0.934  0.012* 
0-40  1.4105  1.13  1.7844  
40-48  1.4229  1.4023  1.4343  
48-60  1.3502  1.3365  1.3632  
Maternal age  years 0.036*  0.032*  0.454 
17-22  1.3151  1.2956  1.3306  
22-35  1.3667  1.3106  1.4128  
35-45  1.5333  1.6809  1.3976  
Dwelling type  0.249  0.705  0.329 
Shack  1.3556  1.3156  1.5876  
House  1.3974  1.3653  1.4429  
Flat  1.3076  1.5755  1.3026  
Backyard  1.3378  1.05  1.3648  
Household income 
 
0.807  0.548  0.98 
>R5000/m  1.4479 
 1.5093  1.4315  
R1000-5000/m  1.377 
 1.351  1.3948  
<R1000/m  1.33  1.3161  1.3496  
Maternal HIV status  0.379  0.247  0.779 
Negative  1.3594  1.3151  1.3898  
Positive  1.453  1.4737  1.3118  
Household size  0.473  0.133  0.814 
1-5 1.346  1.2882  1.3988  
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5-10 1.3951  1.436  1.3667  
10-17 1.5016  1.6911  1.4069  
Maternal smoking  0.644  0.877  0.585 
Non-smoker  1.3395  1.3213  1.3937  
Passive smoker  1.3241  1.318  1.3306  
Active smoker  1.4403  1.4714  1.4341  
Alcohol score  0.948  0.707  0.672 
0-10.5  1.3635  1.3409  1.3829  
10.5-20.5  1.4996  1.0649  1.5589  
20.5-35  1.3106  1.4172  1.2395  
Maternal PTSD  0.384  0.307  0.961 
No exposure  1.3562  1.3404  1.3681  
Trauma exposed  1.2782  1.1243  1.3719  
Suspected PTSD 1.6087  1.5046  1.7607  
Maternal BDI  0.574  0.854  0.902 
Above threshold  1.4243  1.3946  1.4438  
Below threshold  1.3457  1.3293  1.3663  
Maternal SRQ  0.211  0.188  0.428 
Above threshold  1.4483  1.4413  1.4525  
Below threshold  1.3457  1.3208  1.3663  
 
 
Appendix 2, Table 4: Mean Shannon diversity mean chao1 index of HBM bacteriome profiles across 
different socio-economic and psychosocial factors (cont’d). 
 
Chao1 index 
     
 
All samples 
 
Mbekweni clinic 
 
TC Newman clinic 
 
Covariates Mean Chao1 index p-value Mean Chao1 index p-value Mean Chao1 index p-value 
Study site (Ethnicity)   0.401   -   - 
Mbekweni 159.25 
 
- 
 
- 
 
TC Newman 169.33 
 
- 
 
- 
 
Mode of delivery   0.971   0.754   0.452 
Vaginal  164.22 
 
158.2 
 
168.81 
 
Elective CS  181.72 
 
166.62 
 
198.82 
 
Emergency CS  162.11 
 
164.43 
 
159.71 
 
Gestational age   0.552   0.428   0.415 
Term  163.4 
 
157.97 
 
167.85 
 
Pre-term  170.6 
 
166.11 
 
174.29 
 
Very pre-term  149.47 
 
128.42 
 
167.02 
 
Infant gender   0.725   0.036*   0.085 
Male  162.34 
 
160.46 
 
163.8 
 
Female  167.46 
 
157.89 
 
175.74 
 
Infant feeding options   0.569   0.681   0.906 
Exclusive BF  167.01 
 
159.01 
 
173.74 
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Mixed BF  161.72 
 
158.15 
 
164.44 
 
Maternal education   0.044*   0.057   0.077 
Primary  172.11 
 
163.41 
 
179.32 
 
Secondary  153.58 
 
156.98 
 
151.19 
 
Tertiary  151.51 
 
138.82 
 
170.09 
 
Maternal employment   0.744   0.863   0.929 
Working  169.12 
 
163.1 
 
173.09 
 
Not working  163.42 
 
158.21 
 
167.98 
 
Maternal BMI   0.29   0.776   0.11 
0-18.5  149.33 
 
116.78 
 
152.76 
 
18.5-25  162.93 
 
162.92 
 
162.95 
 
25-30  168.5 
 
166.41 
 
170.52 
 
30-50  172.95 
 
156.52 
 
192.33 
 
Infant birth weight    0.246   0.689   0.196 
0-2.5  159.11 
 
158.12 
 
159.63 
 
2.5-4.5  165.86 
 
159.83 
 
171.19 
 
Infant birth length    0.002**   0.205   0.0009** 
0-40  204.49 
 
196.35 
 
215.36 
 
40-48  172.16 
 
165.58 
 
175.78 
 
48-60  161.22 
 
157.59 
 
164.67 
 
Maternal age    0.63   0.884   0.541 
17-22  156.8 
 
152.38 
 
160.29 
 
22-35  166.33 
 
159.09 
 
172.28 
 
35-45  176.21 
 
178.5 
 
174.1 
 
Dwelling type   0.209   0.881   0.365 
Shack  163.29 
 
157.3 
 
198.04 
 
House  164.03 
 
158.16 
 
172.36 
 
Flat  157.45 
 
197.12 
 
156.7 
 
Backyard  179.72 
 
171.12 
 
180.53 
 
Marital status   0.891   0.229   0.623 
Living together  170.89 
 
158.39 
 
178.6 
 
Not living together  160.76 
 
159.62 
 
161.87 
 
Household income   0.278   0.883   0.115 
>R5000/m  162.26 
 
168.27 
 
160.65 
 
R1000-5000/m  170.35 
 
157.45 
 
179.13 
 
<R1000/m  159.22 
 
159.58 
 
158.71 
 
Maternal HIV status   0.686   0.133   0.345 
Negative  164.74 
 
158.99 
 
168.71 
 
Positive  165.32 
 
160.47 
 
198.51 
 
Household size   0.743   0.474   0.604 
1-5 166.01 
 
157.53 
 
173.76 
 
5-10 161.39 
 
161.64 
 
161.22 
 
10-17 172.31 
 
175.33 
 
170.79 
 
Maternal smoking   0.274   0.136   0.762 
Non-smoker  156.78 
 
153.33 
 
167.01 
 
Passive smoker  162.3 
 
162.12 
 
162.22 
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Active smoker  173.44 
 
158.97 
 
170.79 
 
Alcohol score   0.046*   0.177   0.183 
0-10.5  166.36 
 
161.11 
 
170.87 
 
10.5-20.5  153.01 
 
105.01 
 
159.55 
 
20.5-35  152.7 
 
136.9 
 
163.24 
 
Maternal PTSD   0.218   0.096   0.634 
No exposure  163.13 
 
155.69 
 
168.74 
 
Trauma exposed  158.68 
 
154.95 
 
160.88 
 
Suspected PTSD  189.87 
 
185.66 
 
196.01 
 
Maternal BDI   0.012*   0.607   0.096 
Above threshold  181.08 
 
176.08 
 
184.37 
 
Below threshold  159.19 
 
153.89 
 
163.65 
 
Maternal SRQ   0.185   0.839   0.259 
Above threshold  165.64 
 
146.57 
 
177.26 
 
Below threshold  164.49 
 
161.7 
 
166.88 
 
 
BMI=Body Mass Index; HIV= Human Immunodeficiency Virus; EBF=Exclusive breastfeeding; PTSD= post-
traumatic stress disorder; BDI= Beck Depression Inventory; SRQ= Self-Regulation Questionnaire; 
CS=Caeserean section. P<0.001, ***; p<0.01, **; p<0.05*. 
 
 
Appendix 2, Figure 5: Log ratio biplot of human breast milk bacterial abundances at the genus level. 
Samples are coloured according to (A) gestational age, (B) maternal smoking, (C) Body Mass Index (BMI), 
and (D) delivery mode. Each sample is represented by a circle and is coloured based on group type. Samples 
(circles) that cluster together are similar in bacteria composition and abundance.  
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Appendix 2, Figure 6: LEFSe plots showing differences between the HBM bacteriome of participants 
based on study site. The histograms show the linear discriminant analysis (LDA) scores of bacteriome at (A) 
genus, (B) family, (C) order and (D) phylum level. The higher the LDA score, the more likely it is that the 
specific taxon is differentially abundant in one group compared to the other group. HBM samples of mothers 
from Mbekweni study site have higher relative abundance of the taxa shown in red, while HBM samples of 
mothers from TC Newman study site have higher relative abundance of the taxa shown in green. 
LEFSe=Linear Discriminant Analysis Effect Size. 
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Appendix 2, Table 5: Pearson’s correlations between the relative abundances of the predominant bacterial genera in the human breast milk samples.                            
Co-occurrences between the relative abundances of the sixteen most predominant bacteria genera. Negative and positive values represent negative and positive correlations 
respectively between the bacteria. Cut-off value was set to 0.28. 
All samples (n=522) 
               
  
Acinetoba
cter 
Bifidobacte
rium 
Chlorop
last 
Corynebacte
rium 
Enhydrob
acter 
Escherichia-
Shigella 
Geme
lla 
Kocu
ria 
Lactobaci
llus 
Microco
ccus 
OTU_
24 
Pseudom
onas 
Roth
ia 
Staphyloco
ccus 
Streptoco
ccus 
Veillon
ella 
Acinetobacter 1                               
Bifidobacteriu
m 
-0.12 1                             
Chloroplast 0.07 -0.09 1                           
Corynebacteri
um 
-0.06 -0.08 0.06 1                         
Enhydrobacter 0.3 -0.16 0.02 0.01 1                       
Escherichia-
Shigella 
0.07 -0.06 -0.09 -0.15 0.02 1                     
Gemella -0.3 -0.03 -0.1 -0.1 -0.2 -0.25 1                   
Kocuria -0.09 -0.12 -0.11 0.04 -0.04 -0.11 -0.13 1                 
Lactobacillus -0.19 0.01 0 -0.09 -0.19 -0.02 -0.08 -0.07 1               
Micrococcus 0.08 0 -0.17 0.11 0.19 -0.12 -0.09 0.13 -0.12 1             
OTU_24 0.19 -0.15 -0.07 -0.12 0.03 0.42 -0.25 0.01 -0.14 -0.07 1           
Pseudomonas 0.34 -0.19 0.16 -0.09 0.06 0.15 -0.3 -0.12 -0.1 -0.09 0.26 1         
Rothia -0.25 -0.09 -0.19 -0.21 -0.22 -0.23 0.17 -0.09 -0.14 -0.16 -0.3 -0.26 1       
Staphylococcu
s 
-0.12 -0.11 -0.03 0.4 0.05 -0.04 -0.13 0.07 -0.07 -0.02 -0.02 -0.02 -
0.25 
1     
Streptococcus -0.32 -0.01 -0.14 -0.27 -0.32 -0.25 0.39 -0.16 0.12 -0.3 -0.37 -0.28 0.48 -0.33 1   
Veillonella -0.25 0.05 -0.15 -0.21 -0.27 -0.3 0.26 -0.16 -0.05 -0.18 -0.33 -0.24 0.37 -0.34 0.49 1 
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Appendix 2, Figure 7: 16S rRNA gene sequencing reproducibility. Scatter plots represent the relative 
abundance of each OTU from (A) seven within-run repeats and (B) four between-run repeats together with 
their technical repeats. A multiple R-square which is the proportion of variance reproduced by replicating the 
reads is generated. 
 
 
Appendix 2, Figure 8: Bar-plot of relative abundances of bacteria genera in human breast milk (HBM) 
samples and their technical repeats. Complete linkage unsupervised hierarchical clustering of human breast 
milk bacterial profiles within a sample and its repeat (paired bar-plots). Each bar represents a sample and each 
coloured box, a bacteria genus. Genera with less than 0.5% abundance in a given sample are grouped together, 
herein referred to as “other” (grey boxes). W-Within run repeat, B-Between run repeat.  
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APPENDIX 3: Chapter 6 supplementary tables and figures 
Appendix 3, Table 1: Sociodemographic, psychosocial and clinical characteristics of mothers and their 
infants. 
 
Feature Participants (n=519) (%) 
Socio-demographics characteristics 
 
Self-defined ethnicity, n (%) 
 
   Black African 229 (44.1%) 
   Mixed ancestry 290 (55.9%) 
Household income, n (%) 
 
   <ZAR1000/m 214 (41.2%) 
   ZAR1000-5000/m 233 (44.9%) 
   >ZAR5000/m 72 (13.9%) 
Household size, median [95%CI] 5 [2 12] 
Maternal characteristics 
 
Maternal age at enrolment (years), median [95%CI] 25.37 [18.6 39.57] 
Maternal BMI, median [95%CI] 25.1 [18.12 40.51] 
HIV infected mothers, n (%) 47 (9.1%) 
Infant characteristics 
 
Infant weight at birth (kg), median [95%CI] 3.08 [1.94 3.94] 
Infant length at birth (cm), median [95%CI] 50 [41.88 56] 
Infant gestational age, n (%) 
 
   Term 403 (77.6%) 
   Preterm 113 (21.8%) 
   Very preterm 3 (0.6%) 
Infant gender, n (%) 
 
   Female 248 (47.8%) 
   Male 271 (52.2%) 
Pregnancy characteristics 
 
Exclusive breastfeeding (day), median [95%CI] 55.2 [0 181.75] 
Antibiotic during pregnancy, n (%) 7 (1.4%) 
Smoking status, n (%) 
 
   Non-smoker 101 (20.4%) 
   Passive smoker 223 (45.0%) 
   Active smoker 172 (34.7%) 
Alcohol intake during pregnancy, n (%) 67 (14.3%) 
HBM sample characteristics 
 
Collection time (weeks), median [95%CI] 7.43 [5.86 9.43] 
Human milk oligosaccharide (HMO) phenotype, n (%) 
   Se-/Le- 5 (1.0%) 
   Se-/Le+ 120 (23.1%) 
   Se+/Le- 84 (16.2%) 
   Se+/Le+ 310 (59.7%) 
Lactose concentrations (mM), median [95%CI] 168.16 [80.05 188.49] 
Pregnancy characteristics 
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IPV Emotional category, n (%) 
 
   No IPV 218 (46.5%) 
   Isolated incident 64 (13.6%) 
   Low frequency 38 (8.1%) 
   Mid frequency 100 (21.3%) 
   High frequency 49 (10.4%) 
Maternal PTSD, n (%) 
 
   No exposure 395 (84.9%) 
   Suspected PTSD 34 (7.3%) 
   Trauma exposed 36 (7.7%) 
PDI score, median [95%CI] 1.23 [0 3.29] 
BDI score, median [95%CI] 11 [0 39] 
Maternal BDI Threshold, n (%) 
 
   Above threshold 122 (26.0%) 
   Below threshold 347 (74.0%) 
Maternal SRQ Threshold, n (%) 
 
   Above threshold 102 (21.7%) 
   Below threshold 368 (78.3%) 
Diet characteristics 
 
Adult food frequency-fish, n (%) 
 
   Never 45 (9.3%) 
   Monthly 120 (24.8%) 
   Weekly 256 (53.0%) 
   Daily 62 (12.8%) 
Adult food frequency-starch, n (%) 
 
   Never 0 (0.0%) 
   Monthly 10 (2.1%) 
   Weekly 87 (18.0%) 
   Daily 386 (79.9%) 
Adult food frequency- Red meat, n (%) 
 
   Never 81 (16.8%) 
   Monthly 157 (32.6%) 
   Weekly 208 (43.2%) 
   Daily 36 (7.5%) 
Adult food frequency-Organ meat, n (%) 
 
   Never 109 (22.7%) 
   Monthly 173 (36.0%) 
   Weekly 175 (36.5%) 
   Daily 23 (4.8%) 
Adult food frequency-Poultry, n (%) 
 
   Never 28 (5.8%) 
   Monthly 20 (4.1%) 
   Weekly 246 (50.9%) 
   Daily 189 (39.1%) 
Adult food frequency-Eggs, n (%) 
 
   Never 48 (9.9%) 
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   Monthly 58 (12.0%) 
   Weekly 253 (52.4%) 
   Daily 124 (25.7%) 
Adult food frequency-Processed meat, n (%) 
 
   Never 44 (9.1%) 
   Monthly 76 (15.8%) 
   Weekly 247 (51.2%) 
   Daily 115 (23.9%) 
Adult food frequency-Legumes, n (%) 
 
   Never 60 (12.5%) 
   Monthly 150 (31.2%) 
   Weekly 230 (47.8%) 
   Daily 41 (8.5%) 
Adult food frequency-Dairy, n (%) 
 
   Never 29 (6.0%) 
   Monthly 36 (7.5%) 
   Weekly 172 (35.7%) 
   Daily 245 (50.8%) 
Adult food frequency-Vegetables, n (%) 
 
   Never 16 (3.3%) 
   Monthly 23 (4.8%) 
   Weekly 206 (42.7%) 
   Daily 238 (49.3%) 
Adult food frequency-Fruit, n (%) 
 
   Never 13 (2.7%) 
   Monthly 26 (5.4%) 
   Weekly 171 (35.4%) 
   Daily 273 (56.5%) 
Adult food frequency-Crisps, n (%) 
 
   Never 34 (7.1%) 
   Monthly 76 (15.8%) 
   Weekly 253 (52.5%) 
   Daily 119 (24.7%) 
Adult food frequency-Cold drinks, n (%) 
 
   Never 38 (7.9%) 
   Monthly 53 (11.0%) 
   Weekly 209 (43.3%) 
   Daily 183 (37.9%) 
Adult food frequency-Fruit juice., n (%) 
 
   Never 58 (12.0%) 
   Monthly 125 (25.9%) 
   Weekly 184 (38.1%) 
   Daily 116 (24.0%) 
BMI=Body Mass Index; HIV= Human Immunodeficiency Virus; EBF=Exclusive breastfeeding; PTSD= post-
traumatic stress disorder; IPV= Induced Partner Violence; BDI= Beck Depression Inventory; SRQ= Self-
Regulation Questionnaire; Smoking status was measured as Active smoker (cotinine levels ≥ 500); Passive 
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smoker (cotinine levels 10 – 500); Non-smoker (cotinine levels ≤ 10). Term, Preterm and Very-preterm 
infants are infant with gestational age of >37 weeks, 32-37 weeks and 28-31.9 weeks respectively. 
 
Appendix 3, Table 2: Comparison of sociodemographic, psychosocial and clinical characteristics 
between mothers with low and normal breast milk lactose levels.  
 
Feature Low lactose level (n=45) Normal lactose level (n=474) p-value 
Socio-demographics characteristics 
   
Ethnicity, n (%) 
  
9.82E-01 
   Black African 19 (42.2%) 210 (44.3%) 
 
   Mixed ancestry 26 (57.8%) 264 (55.7%) 
 
Household income, n (%) 
  
2.42E-01 
   <ZAR1000/m 23 (51.1%) 191 (40.3%) 
 
   ZAR1000-5000/m 16 (35.6%) 217 (45.8%) 
 
   >ZAR5000/m 6 (13.3%) 66 (13.9%) 
 
Household size, median [95%CI] 5 [2 11.9] 5 [2 12] 4.77E-01 
Maternal clinical characteristics 
   
Maternal age at enrolment, median [95%CI] 22.98 [18.45 39.02] 25.85 [18.67 39.6] 1.21E-02 
Maternal BMI, median [95%CI] 24.8 [17.8 40.88] 25.1 [18.2 39.77] 5.66E-01 
HIV infected mothers, n (%) 3 (6.7%) 44 (9.3%) 9.28E-01 
Infant clinical characteristics 
   
Infant weight at birth(kg), median [95%CI] 3.04 [2.33 3.83] 3.1 [1.94 4] 3.95E-01 
Infant length at birth(cm), median [95%CI] 49 [43 55.9] 50 [41 56] 1.20E-01 
Infant gestational age, n (%) 
  
7.43E-01 
   Term 34 (75.6%) 369 (77.8%) 
 
   Preterm 11 (24.4%) 102 (21.5%) 
 
   Very preterm 0 (0.0%) 3 (0.6%) 
 
Infant gender, n (%) 
  
7.41E-01 
   Female 24 (53.3%) 224 (47.3%) 
 
   Male 21 (46.7%) 250 (52.7%) 
 
Pregnancy characteristics 
   
Exclusive breastfeeding (months), median [95%CI] 27.6 [0 150] 55.2 [0 182.4] 2.61E-04 
Antibiotic use during pregnancy, n (%) 1 (2.2%) 6 (1.3%) 6.16E-01 
Smoking status, n (%) 
  
2.36E-01 
   Non-smoker 7 (17.1%) 94 (20.7%) 
 
   Passive Smoker 16 (39.0%) 207 (45.5%) 
 
   Active Smoker 18 (43.9%) 154 (33.8%) 
 
Alcohol exposure, n (%) 8 (19.5%) 59 (13.8%) 5.60E-01 
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HBM sample characteristics 
   
Collection time (weeks), median [95%CI] 7.29 [5.6 9.39] 7.43 [5.86 9.43] 1.56E-01 
Human milk oligosaccharide (HMO) phenotype, n (%) 
 
5.07E-01 
   Se-/Le- 1 (2.2%) 4 (0.8%) 
 
   Se-/Le+ 10 (22.2%) 110 (23.2%) 
 
   Se+/Le- 3 (6.7%) 81 (17.1%) 
 
   Se+/Le+ 31 (68.9%) 279 (58.9%) 
 
Lactose concentrations (mM), median [95%CI] 97.65 [32.78 126.54] 169.61 [139.38 188.66] 1.36E-28 
Pregnancy characteristics 
   
IPV Emotional category, n (%) 
  
9.03E-01 
   No IPV 19 (46.3%) 199 (46.5%) 
 
   Isolated incident 6 (14.6%) 58 (13.6%) 
 
   Low frequency 5 (12.2%) 33 (7.7%) 
 
   Mid frequency 6 (14.6%) 94 (22.0%) 
 
   High frequency 5 (12.2%) 44 (10.3%) 
 
Maternal PTSD, n (%) 
  
7.90E-01 
   No exposure 34 (82.9%) 361 (85.1%) 
 
   Suspected PTSD 5 (12.2%) 29 (6.8%) 
 
   Trauma exposed 2 (4.9%) 34 (8.0%) 
 
BDI score, median [95%CI] 16 [0 39] 11 [0 39] 4.51E-02 
Maternal BDI Threshold, n (%) 
  
1.20E-02 
   Above threshold 19 (46.3%) 103 (24.1%) 
 
   Below threshold 22 (53.7%) 325 (75.9%) 
 
Maternal SRQ Threshold, n (%) 
  
2.55E-01 
   Above threshold 13 (31.7%) 89 (20.7%) 
 
   Below threshold 28 (68.3%) 340 (79.3%) 
 
Diet characteristics 
   
Adult food frequency-fish, n (%) 
  
4.65E-01 
   Never 4 (9.3%) 41 (9.3%) 
 
   Monthly 8 (18.6%) 112 (25.5%) 
 
   Weekly 25 (58.1%) 231 (52.5%) 
 
   Daily 6 (14.0%) 56 (12.7%) 
 
Adult food frequency-starch, n (%) 
  
1.85E-01 
   Never 0 (0.0%) 0 (0.0%) 
 
   Monthly 2 (4.7%) 8 (1.8%) 
 
   Weekly 3 (7.0%) 84 (19.1%) 
 
   Daily 38 (88.4%) 348 (79.1%) 
 
Adult food frequency-Red meat, n (%) 
  
3.89E-01 
   Never 4 (9.3%) 77 (17.5%) 
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   Monthly 16 (37.2%) 141 (32.1%) 
 
   Weekly 19 (44.2%) 189 (43.1%) 
 
   Daily 4 (9.3%) 32 (7.3%) 
 
Adult food frequency-Organ meat, n (%) 
  
2.01E-02 
   Never 16 (37.2%) 93 (21.3%) 
 
   Monthly 14 (32.6%) 159 (36.4%) 
 
   Weekly 13 (30.2%) 162 (37.1%) 
 
   Daily 0 (0.0%) 23 (5.3%) 
 
Adult food frequency-Poultry, n (%) 
  
9.38E-01 
   Never 3 (7.0%) 25 (5.7%) 
 
   Monthly 1 (2.3%) 19 (4.3%) 
 
   Weekly 22 (51.2%) 224 (50.9%) 
 
   Daily 17 (39.5%) 172 (39.1%) 
 
Adult food frequency-Eggs, n (%) 
  
6.57E-01 
   Never 5 (11.6%) 43 (9.8%) 
 
   Monthly 4 (9.3%) 54 (12.3%) 
 
   Weekly 25 (58.1%) 228 (51.8%) 
 
   Daily 9 (20.9%) 115 (26.1%) 
 
Adult food frequency-Processed meat, n (%) 
  
7.44E-01 
   Never 1 (2.3%) 43 (9.8%) 
 
   Monthly 10 (23.3%) 66 (15.0%) 
 
   Weekly 21 (48.8%) 226 (51.5%) 
 
   Daily 11 (25.6%) 104 (23.7%) 
 
Adult food frequency-Legumes, n (%) 
  
3.95E-01 
   Never 3 (7.0%) 57 (13.0%) 
 
   Monthly 13 (30.2%) 137 (31.3%) 
 
   Weekly 24 (55.8%) 206 (47.0%) 
 
   Daily 3 (7.0%) 38 (8.7%) 
 
Adult food frequency-Cold drinks, n (%) 
  
2.79E-02 
   Never 2 (4.7%) 36 (8.2%) 
 
   Monthly 3 (7.0%) 50 (11.4%) 
 
   Weekly 15 (34.9%) 194 (44.1%) 
 
   Daily 23 (53.5%) 160 (36.4%) 
 
Adult food frequency-Fruit juice., n (%) 
  
2.46E-02 
   Never 3 (7.0%) 55 (12.5%) 
 
   Monthly 6 (14.0%) 119 (27.0%) 
 
   Weekly 20 (46.5%) 164 (37.3%) 
 
   Daily 14 (32.6%) 102 (23.2%) 
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BMI=Body Mass Index; HIV= Human Immunodeficiency Virus; EBF=Exclusive breastfeeding; PTSD= post-
traumatic stress disorder; IPV= Induced Partner Violence; BDI= Beck Depression Inventory; SRQ= Self-
Regulation Questionnaire; Smoking status was measured as Active smoker (cotinine levels ≥ 500); Passive 
smoker (cotinine levels 10 – 500); Non-smoker (cotinine levels ≤ 10). Term, Preterm and Very-preterm 
infants are infant with gestational age of >37 weeks, 32-37 weeks and 28-31.9 weeks respectively. 
 
Appendix 3, Table 3: Comparison of infant anthropometric measures between infants receiving breast 
milk with low and normal lactose levels. 
 
Features Low lactose level (n=45) Normal lactose level (n=474) p-value 
7 weeks 
   
   Z-score for weight, median [95%CI] -0.46 [-3.74 1.11] -0.3 [-3.07 1.45] 1.20E-01 
   Z-score for length, median [95%CI] -0.74 [-3.35 1.14] -0.41 [-3.5 1.73] 2.14E-01 
   Body mass index z-score, median [95%CI] -0.54 [-2.66 1.57] -0.13 [-2.45 1.97] 9.64E-02 
10 weeks 
   
   Z-score for weight, median [95%CI] -0.58 [-3.21 1.05] -0.18 [-2.77 1.87] 1.38E-02 
   Z-score for length, median [95%CI] -0.7 [-4.34 2.28] -0.34 [-3.84 3] 1.61E-01 
   Body mass index z-score, median [95%CI] -0.26 [-3.53 1.95] 0.13 [-3.21 2.54] 1.45E-01 
14 weeks 
   
   Z-score for weight, median [95%CI] -0.64 [-3.81 1.31] -0.13 [-2.34 1.88] 3.68E-03 
   Z-score for length, median [95%CI] -1.13 [-3.64 2.47] -0.3 [-3.59 3.39] 1.95E-02 
   Body mass index z-score, median [95%CI] -0.47 [-2.75 2.19] 0.12 [-2.79 2.68] 3.87E-02 
6 months 
   
   Z-score for weight, median [95%CI] -0.04 [-2.23 2.44] 0.08 [-2.65 2.21] 2.67E-01 
   Z-score for length, median [95%CI] -0.7 [-3.96 2.62] -0.07 [-3.18 3.39] 4.85E-02 
   Body mass index z-score, median [95%CI] 0.38 [-1.59 3.13] 0.32 [-2.41 2.86] 6.57E-01 
9 months 
   
   Z-score for weight, median [95%CI] 0.3 [-2.09 2.38] 0.15 [-2.45 2.47] 9.98E-01 
   Z-score for length, median [95%CI] -0.35 [-3.36 2.57] -0.12 [-2.9 2.72] 4.76E-01 
   Body mass index z-score, median [95%CI] 0.98 [-1.96 2.55] 0.38 [-2.18 2.79] 3.82E-01 
12 months 
   
   Z-score for weight, median [95%CI] 0 [-2.55 2.4] -0.12 [-2.58 2.37] 6.07E-01 
   Z-score for length, median [95%CI] -0.1 [-3.15 1.87] -0.35 [-2.56 1.98] 8.64E-01 
   Body mass index z-score, median [95%CI] 0.36 [-2.08 2.34] 0.11 [-2.18 2.53] 2.05E-01 
18 months 
   
   Z-score for weight, median [95%CI] 0.05 [-2.85 2.16] 0.03 [-2.42 2.42] 7.36E-01 
157 
 
   Z-score for length, median [95%CI] -0.77 [-2.65 1.85] -0.62 [-3.71 1.93] 8.54E-01 
   Body mass index z-score, median [95%CI] 0.5 [-2.5 2.54] 0.7 [-2.63 3.74] 4.59E-01 
24 months 
   
   Z-score for weight, median [95%CI] -0.35 [-2.97 2.25] -0.42 [-2.87 1.95] 9.76E-01 
   Z-score for length, median [95%CI] -1.31 [-3.49 0.88] -1.05 [-3.58 1.34] 2.68E-01 
   Body mass index z-score, median [95%CI] 0.82 [-1.48 2.94] 0.45 [-1.82 2.97] 2.41E-01 
 
Appendix 3, Table 4: Differences in metabolite profiles of human breast milk from mothers with low and 
normal lactose levels. 
 
Feature Low lactose level (mM) Normal lactose level (mM) p-value FDR 
2-Fucosyllactose, median [95%CI] 3.535 [0 11.824] 4.435 [0 13.788] 7.83E-02 8.90E-02 
2-oxoglutarate, median [95%CI] 0.118 [0.048 0.225] 0.113 [0.036 0.374] 4.97E-01 5.18E-01 
3-Fucosyllactose, median [95%CI] 0.862 [0 5.789] 1.715 [0 6.276] 8.91E-02 9.90E-02 
3-Sialyllactose, median [95%CI] 0.154 [0.048 0.289] 0.093 [0.039 0.183] 6.22E-11 1.20E-10 
6-Sialyllactose, median [95%CI] 0.078 [0 0.19] 0.091 [0 0.195] 5.14E-02 5.98E-02 
Acetate, median [95%CI] 0.097 [0.04 0.261] 0.047 [0.026 0.103] 7.15E-16 1.88E-15 
Acetone, median [95%CI] 0.004 [0.001 0.031] 0.002 [0.001 0.009] 5.66E-07 9.13E-07 
Acetyl carnitine, median [95%CI] 0.026 [0.001 0.115] 0.007 [0 0.034] 1.25E-12 2.84E-12 
Alanine, median [95%CI] 0.302 [0.093 0.64] 0.302 [0.131 0.598] 6.78E-01 6.92E-01 
Asparagine, median [95%CI] 0.025 [0 0.081] 0.034 [0 0.082] 6.30E-03 7.88E-03 
Aspartate, median [95%CI] 0.097 [0 0.186] 0.07 [0 0.2] 1.58E-02 1.88E-02 
Butyrate, median [95%CI] 0 [0 0.39] 0.203 [0 0.481] 1.62E-10 2.89E-10 
Caprate, median [95%CI] 0 [0 0.558] 0.352 [0 0.733] 5.59E-14 1.33E-13 
Caprylate, median [95%CI] 0.164 [0 0.627] 0.341 [0 0.617] 1.12E-04 1.56E-04 
Choline, median [95%CI] 0.353 [0.073 0.759] 0.197 [0.054 0.675] 4.52E-05 6.46E-05 
cis-aconitate, median [95%CI] 0.008 [0 0.04] 0.025 [0.012 0.043] 3.94E-18 1.41E-17 
Citrate, median [95%CI] 3.099 [0.685 6.199] 6.025 [3.389 9.345] 8.89E-20 4.04E-19 
Creatine, median [95%CI] 0.07 [0.018 0.129] 0.073 [0.026 0.142] 8.12E-01 8.12E-01 
Creatinine, median [95%CI] 0.071 [0.036 0.099] 0.052 [0.033 0.081] 8.61E-12 1.79E-11 
Cytidine triphosphate, median [95%CI] 0.003 [0 0.044] 0.034 [0 0.101] 1.39E-18 5.35E-18 
Cytidine, median [95%CI] 0 [0 0.022] 0.027 [0.005 0.058] 2.13E-21 1.33E-20 
Difucosyllactose, median [95%CI] 0.978 [0 8.118] 0.226 [0 1.822] 5.34E-06 8.09E-06 
Dimethylamine, median [95%CI] 0 [0 0.004] 0.003 [0 0.007] 5.54E-12 1.20E-11 
Formate, median [95%CI] 0.015 [0 0.056] 0.011 [0 0.025] 1.54E-02 1.88E-02 
Fumarate, median [95%CI] 0.004 [0.002 0.013] 0.007 [0.002 0.021] 3.35E-06 5.23E-06 
Galactose, median [95%CI] 0 [0 0.816] 0 [0 0.77] 4.97E-01 5.18E-01 
Glucose, median [95%CI] 0.094 [0 0.383] 0.546 [0 1.109] 2.73E-20 1.52E-19 
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Glutamate, median [95%CI] 0.69 [0.163 2.038] 1.437 [0.508 2.333] 2.67E-14 6.67E-14 
Glutamine, median [95%CI] 0 [0 0] 0.014 [0 0.086] 1.19E-18 4.96E-18 
Glycerophosphocholine, median [95%CI] 0.061 [0.015 0.384] 0.613 [0.22 1.079] 2.58E-27 6.45E-26 
Isoleucine, median [95%CI] 0.234 [0.052 0.399] 0.041 [0 0.222] 9.14E-22 6.53E-21 
Lactate, median [95%CI] 1.606 [0.495 8.114] 0.352 [0.167 1.288] 1.51E-22 1.26E-21 
Lactose, median [95%CI] 97.654 [32.783 126.535] 169.608 [139.379 188.661] 1.36E-28 6.80E-27 
Leucine, median [95%CI] 0.195 [0.049 0.383] 0.033 [0.011 0.177] 4.95E-24 4.95E-23 
LNDFH I, median [95%CI] 2.698 [0 5.886] 0.807 [0 3.685] 8.63E-06 1.27E-05 
LNDFH II, median [95%CI] 0.143 [0 1.476] 0.097 [0 0.898] 1.22E-01 1.33E-01 
LNFP I, median [95%CI] 2.283 [0 8.4] 1.049 [0 6.563] 4.05E-03 5.19E-03 
Lysine, median [95%CI] 0.119 [0.038 0.402] 0.068 [0.008 0.248] 3.33E-07 5.55E-07 
Methylguanidine, median [95%CI] 0 [0 0] 0 [0 0.01] 1.06E-03 1.43E-03 
Methylhistidine, median [95%CI] 0.05 [0.008 0.102] 0.035 [0.011 0.076] 2.97E-03 3.91E-03 
Phenylalanine, median [95%CI] 0.048 [0 0.09] 0.022 [0.01 0.062] 1.23E-09 2.12E-09 
Phosphocholine, median [95%CI] 0 [0 0.381] 0.646 [0.033 1.045] 7.04E-25 1.17E-23 
Phosphocreatinine, median [95%CI] 0 [0 0.043] 0.035 [0.006 0.09] 3.42E-20 1.71E-19 
Pyruvate, median [95%CI] 0.04 [0.017 0.085] 0.022 [0.006 0.055] 1.21E-11 2.42E-11 
Succinate, median [95%CI] 0.021 [0.006 0.058] 0.037 [0.015 0.077] 1.54E-10 2.85E-10 
Tryptophan, median [95%CI] 0.015 [0.006 0.042] 0 [0 0.016] 1.60E-24 2.00E-23 
Tyrosine, median [95%CI] 0.089 [0.025 0.164] 0.031 [0.011 0.114] 1.59E-16 4.68E-16 
Uracil, median [95%CI] 0.004 [0 0.072] 0 [0 0.007] 6.29E-17 1.97E-16 
Uridine, median [95%CI] 0.078 [0.023 0.197] 0.031 [0.011 0.101] 2.01E-16 5.58E-16 
Valine, median [95%CI] 0.236 [0.056 0.411] 0.079 [0.034 0.263] 5.23E-18 1.74E-17 
LNDFH II=Lacto-N-difucohexaose II; LNFP I=Lacto-N-fucopentaose I; LNDFH I=Lacto-N-difucohexaose I; 
FDR: False Discovery Rate 
  
Appendix 3, Table 5: Median relative abundances of predominant human breast milk bacterial genera 
in mothers with low and normal breast milk lactose levels. 
 
Feature Low lactose level (n=44) Normal lactose level (n=441) p-value FDR 
Streptococcus, median [95%CI] 0.32 [0 0.86] 0.58 [0.01 0.87] 1.10E-04 1.32E-03 
Staphylococcus, median [95%CI] 0.19 [0 0.98] 0.05 [0 0.84] 4.54E-04 2.00E-03 
Rothia, median [95%CI] 0.01 [0 0.18] 0.03 [0 0.35] 1.57E-03 3.77E-03 
Corynebacterium, median [95%CI] 0.02 [0 0.38] 0.01 [0 0.27] 5.11E-02 8.76E-02 
Veillonella, median [95%CI] 0 [0 0.07] 0.01 [0 0.09] 6.63E-03 1.33E-02 
Acinetobacter, median [95%CI] 0 [0 0.12] 0 [0 0.19] 4.57E-01 4.99E-01 
Micrococcus, median [95%CI] 0 [0 0.39] 0 [0 0.07] 2.97E-01 3.56E-01 
Gemella, median [95%CI] 0 [0 0.01] 0 [0 0.04] 1.56E-03 3.77E-03 
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Kocuria, median [95%CI] 0 [0 0.01] 0 [0 0.09] 1.01E-01 1.52E-01 
Enterobacteriaceae OTU_24, median [95%CI] 0 [0 0.07] 0 [0 0.21] 2.15E-01 2.87E-01 
Lactobacillus, median [95%CI] 0 [0 0.01] 0 [0 0.08] 4.99E-04 2.00E-03 
Others, median [95%CI] 0.07 [0 0.7] 0.07 [0 0.6] 9.96E-01 9.96E-01 
Median values refer to the median relative abundance of bacteria genera. FDR: False Discovery Rate  
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Supplementary Table 6: List of the metabolites identified in the Nuclear Magnetic Resonance (NMR) 
spectra. 
 
Metabolite Multiplicity Number of 
protons 
2-Fucosyllactose 4.53 (dd), 4.65 (d), 5.32 (d) 0.5 
2-oxoglutarate 2.44 (t), 3.01 (t) 2 
3-Fucosyllactose 5.20 (d), 5.39 (d), 5.45 (d) 0.5 
3-Sialyllactose 2.75 (d), 2.78 (d) 2 
6-Sialyllactose 2.71 (d), 2.73 (d) 2 
Acetate 1.92 (s) 3 
Acetone 2.24 (s) 6 
Acetyl carnitine 3.19 (s) 9 
Alanine 1.49 (d) 3 
Asparagine 2.89 (qd) 2 
Aspartate 2.83 (dd) 1 
Butyrate 0.90 (t) 3 
Caprate 0.88 (t), 2.18 (t) 3 
Caprylate 0.87 (t) 3 
Choline 3.20 (s) 9 
cis-aconitate 3.12 (d), 5.70 (t) 1 
Citrate 2.67 (d) 1 
Creatine 3.04 (s) 3 
Creatinine 3.05 (s) 3 
Cytidine 6.08 (d), 7.84 (d) 1 
Cytidine triphosphate 6.13 (d), 7.96 (d) 1 
Difucosyllactose 5.29 (d), 5.40 (d), 5.46 (d) 0.5 
Dimethylamine 2.72 (s) 6 
Formate 8.46 (s) 1 
Fumarate 6.53 (s) 2 
Galactose 4.59 (d) 0.5 
Glucose 3.24 (dd), 4.65 (d) 1 
Glutamate 2.37 (m) 2 
Glutamine 2.48 (m) 2 
Glycerophosphocholine 3.23 (s) 9 
Isoleucine 0.94 (t), 1.01 (d) 3 
Lactate 1.33 (d) 3 
Lactose 4.46 (dd), 4.68 (d), 5.25 (d) 0.5 
Leucine 0.96 (dd) 6 
LNDFH I 2.07 (s), 5.03 (d), 5.16 (d), 8.45 (d) 0.5 
LNDFH II 2.05 (s), 5.03 (d), 5.37 (d), 5.43 (d), 8.42 (d) 0.5 
LNFP I 2.07 (s), 5.20 (d), 8.41 (d) 0.5 
Lysine 3.03 (t) 2 
Methylguanidine 2.83 (s) 3 
Methylhistidine 7.12 (d), 7.93 (d) 1 
Phenylalanine 7.38 (m) 5 
Phosphocholine 3.22 (s) 9 
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Phosphocreatine 3.05 (s) 3 
Pyruvate 2.38 (s) 3 
Succinate 2.41 (s) 4 
Tryptophan 7.74 (d) 1 
Tyrosine 7.20 (m) 2 
Uracil 5.81 (d) 1 
Uridine 7.88 (d) 1 
Valine 0.99 (d), 1.04 (d) 3 
TSP 0.00 (t) 9 
Peak multiplicity: s = singlet, d = doublet, dd = double doublet, t = triplet, h = hextet, m = multiplet. TSP = 
Trimethylsilylpropionic acid, (internal standard). 
 
 
 
Appendix 3, Figure 1: Quality control analysis of the nuclear magnetic resonance (NMR) experiments. 
a, Trimethylsilylpropionic acid (TSP; internal standard) concentration of the samples and quality controls 
calculated on the NMR signal at 0.00 ppm. b, Principal components analysis (PCA) of the samples and 
quality controls showing the high reproducibility of the quality controls. c, Lactose concentration of the 
quality control samples.  
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Appendix 3, Figure 2: Assignment of the Human milk oligosaccharides (HMO) phenotype. The HMO 
phenotype was associated to each sample according to the presence of 3’FL, LNFP, and LNDFH I signals. 
